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Kainate receptors (KAR) mediate synaptic transmission at pre- and post- synaptic locations 
at excitatory and inhibitory synapses. KARs also have powerful roles in the synchronisation 
of neuronal networks at a physiological and pathological level. The medial entorhinal cortex 
(MEC) has been strongly linked to pathological synchrony, particularly in 
neurodevelopmental disorders such as epilepsy and schizophrenia. This thesis aims to 
determine the physiological functions of KARs in the MEC during development. 
My initial work focused on the developmental changes in the baseline background synaptic 
transmission in LII and LV MEC, followed by the developmental changes in the ability of 
KAR to modulate spontaneous transmitter release. I have provided evidence for the 
involvement of two types of KAR in excitatory glutamatergic neurotransmission in the 
juvenile rat MEC: 1) A tonically active GluK1-containing KAR located at presynaptic 
terminals, and 2) a postsynaptic non GluK1-containing KAR at recurrent excitatory synapses 
with roles in synchronised network activity. KAR modulation was largely the same in both 
age groups. For inhibitory neurotransmission, I have provided evidence for a presynaptic 
facilitatory GluK1-containing KAR at interneurone terminals, acting to tonically increase 
GABA release onto principal neurones, and a KAR which may be located on the 
soma/dendrites of interneurones, driving GABA release via direct excitation. However, in 
the immature MEC, activation of the GluK1-containing KAR caused a substantial increase in 
GABA release, which was not evident in juvenile rats, showing this receptor may be 
developmentally downregulated or have different levels of tonic activation.   
Next, I determined a developmental profile of oscillatory activity induced by KAR activation 
in the MEC. Synchronised activity was a slow beta frequency in the neonate MEC, compared 
to a gamma frequency in juvenile slices. Activity in LII showed a large age-dependent 
increase in amplitude which was not present in LV. Moreover, the increase in amplitude 
(LII) and frequency (LII & LV) coincided with the onset of eye-opening, and may bare 
consequences for the synaptic organisation of the MEC.  
Taken together, the results from this study show KARs have many roles in mediating 
synaptic transmission and synchronised neuronal activity in the MEC, and may have 
transient developmentally regulated roles in the immature MEC. This work has implications 
for understanding neuronal synchrony and normal development of cognitive function, and 







ACSF  Artificial cerebrospinal fluid 
AD  Alzheimer’s disease 
AMPA  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate 
ATP  Adenosine triphosphate 
ATPA  (RS)-2-Amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid 
Bicuculline ([R-(R*,S*)]-6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-
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CCK  Cholecystokinin 
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DGC  Dentate granule cells 
DHPG  Dihydroxyphenylglycine 
DL-AP5 DL-2-Amino-5-phosphonopentanoic acid 
EC  Entorhinal cortex 
EEG  Electroencephalogram 
EPSC  Excitatory postsynaptic potential 
EPSP  Excitatory postsynaptic current 
GABA  γ-aminobutyric acid 
GFO  Gamma-frequency oscillations 
GYKI 52466 4-(8-Methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)-benzenamine 
dihydrochloride 
HC  Hippocampus 
Hz  Frequency 
IEI   Interevent interval 
iGluRs  Ionotropic glutamate receptors 
Ih  Hyperpolarising current 
IMPC  Intermediate pyramidal cell 
IMSC  Intermediate stellate cell 
ING  Interneurone network gamma 
IPSC  inhibitory postsynaptic current 
IPSP  Inhibitory postsynaptic potential 
JUV  Juvenile 
KA   Kainic acid 
KA-O  Kainic acid oscillations 
KAR  Kainate receptors 
L  Layer 
LEC  Lateral entorhinal cortex 
MEC  Medial entorhinal cortex 




MF  Mossy fibre 
mGluR  Metabotropic glutamate receptor 
mIPSCs Miniature inhibitory postsynaptic current 
MTL  Medial temporal lobe 
NEO  Neonate 
NMDA  N-methyl-d-aspartate  
O-LM  Oriens lacunosum moleculare 
P  Postnatal day 
PC   Pyramidal cell 
PG  Persistent gamma 
PING  Pyramidal-interneurone network gamma 
PV  Parvalbumin 
R  Receptor 
SC  Stellate cell 
SOM  somatostatin 
STDP  Spike timing dependent plasticity 




Tg  Transgenic 
TLE  Temporal lobe epilepsy 
TM  Transmembrane domain 
TTX  Tetrodotoxin  
UBP-310 (S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-thiophene-3-yl-methyl)-5-
methylpyrimidine-2,4-dione 
VFO  Very fast oscillations 
VG  Voltage-gated 
VIP  Vasoactive intestinal peptide 
α  Alpha 
β  Beta 
γ  Gamma 



















The overarching aim of this project has been to investigate role and functions of the kainic 
acid receptor (KAR) in the entorhinal cortex (EC). KARs are increasingly being shown to be 
important in neuronal communication, particularly in physiological (e.g. cognitive 
processing) and pathological (e.g. epilepsy) synchronization of brain activity.  
The EC plays a vital role in learning, memory and cognition, but is also a site where epileptic 
activity frequently arises. Previously, this laboratory has shown that KARs have multiple 
roles in layer III (LIII) of the EC (Chamberlain et al, 2010). In this project, I have used patch 
clamp and local field potential recordings in rat brain slices to further understand the roles 
of KARs in synaptic networks in the layer II (LII) of the EC, which processes incoming cortical 
activity and relays information to the hippocampus. This has been compared to layer V (LV), 
which receives hippocampal output and links back to neocortical areas.  
Activating KARs leads to strong synchronisation of activity in neuronal networks, causing 
them to generate gamma-frequency oscillations (GFO) and this activity is known to be 
involved in processes of learning, memory and cognition. On the other hand, excessive 
activation of KAR can lead to pathological synchronisation in the form of epileptic-like 
activity. The original hypothesis to be tested in this thesis was that epileptogenesis in the 
EC involve changes in KAR function that reflected a recapitulation of the developmental 
profile in KAR expression seen during early postnatal development. This was based on two 
sets of data from collaborating laboratories. (1) Electrophysiological studies conducted at 
the University of Aston with Professor Gavin Woodhall used KA-induced GFO to monitor 
functional network changes in the EC in a pilocarpine model of epilepsy (Modebadze et al 
2016). As yet unpublished results showed that during the early latent period (1 week) 
following an acute status epilepticus, GFO induced by KA are undetectable in EC slices 
compared to control tissue. Recovery of KAR function is detectable at 2 weeks, particularly 
in LV, and by 10 weeks when spontaneous seizures are becoming manifest, sensitivity is 
dramatically increased with the superficial layers most susceptible. (2) 
Immunohistochemical studies (unpublished) in the laboratory of Professor Elek Molnar at 
the University of Bristol established a differential developmental profile of KAR subtype 
expression in hippocampal areas of the rat brain, which, to a degree, reflected the change 




Thus, the aims of my project have been: 
1. To compare the characteristics of excitatory transmission and its developmental profile 
in deep (LV) and superficial (LII) layers of the MEC, in comparison to previous work on the 
mid-layer (LIII) of the same structure. 
2. To compare the characteristics and developmental profile of inhibitory transmission in 
LII and LV of the MEC, in comparison to previous work on LIII. 
3. To determine the role of KARs in modulation of both excitatory and inhibitory 
transmission in deep and superficial layers of the EC, and the developmental profile of 
these effects. 
4. To determine the developmental profile of KAR function in the EC in relationship to the 
development of epileptic activity in this region using KA-induced GFO as a functional 
reporter. At this point my work diverged somewhat from its original aims and concentrated 
more on the functional development of GFO per se, which proved to be interesting and 
instructive in relationship to how this oscillatory activity arises in networks of the EC, and 
how this could contribute developing processes of learning/cognition. 
1.1  Synaptic Transmission 
Synaptic transmission is the biological process that allows neurones to communicate with 
each other across synapses. In the late 19th century, dramatic advances in our 
understanding of the complex organisation of the nervous system were made after the 
Spanish neuroanatomist, Ramon y Cajal, used a silver staining technique, or the ‘Golgi’ 
method, to visualise whole neurones under light microscopy (Van der Loos, 1988). All 
neurones, despite differing classifications and structural complexity, shared a common 
general morphology consisting of a cell body (soma) containing the nucleus, an axon and 
dendrites. At a similar time, Charles Sherrington pushed our understanding of functional 
neuronal physiology, showing how reflexes are part of a complicated interplay in which the 
spinal cord and brain process neuronal impulses, turning them into new impulses in 




Later, the neurophysiologist John Eccles, along with Charles Sherrington, discovered how 
nerve impulses are conveyed from one cell to another. They showed that different types 
of neurones can have a stimulating or inhibitory effect, and the output of a particular 
neurone is determined by the net input from these cell types (Eccles, 1945). This ground 
breaking work was further complimented by physiologists Alan Hodgkin and Andrew 
Huxley in 1952, who showed that electrical discharges transferred from cell to cell were 
the result of the opposite passage of sodium and potassium ions across the neuronal cell 
wall (Hodgkin and Huxley, 1952). Together, Eccles, Hodgkin and Huxley were jointly 
awarded the Nobel Prize in physiology in 1963.  
More major advances in understanding the physiological functioning of neurones occurred 
in the late 1970’s when Erwin Neher and Bert Sakmann developed the patch clamp 
technique for use in small mammalian neurones (Neher and Sakmann, 1976). This 
technique made it possible to record the electrical properties of single ion channels and 
therefore help understand fundamental cell processes.  
The neuronal membrane has diverse ion pumps, channels and exchangers embedded in it, 
across which concentration gradients for principal ions are maintained between the 
intracellular and extracellular environments. Activation and subsequent opening of 
voltage-gated (VG) ion channels allows ions to flow into or out of the neurone according to 
their electrochemical gradients. Sufficient net influx of positive ions, or depolarisation of 
the neuronal membrane, can lead to the generation of an action potential. If the threshold 
is met, an action potential will propagate down the axon and throughout the neurone due 
to consecutive depolarisation of the membrane mediated by VG-sodium channels.  
The action potential can be transmitted to neighbouring neurones in two distinct ways. It 
can be transmitted directly, as an electrical signal, through specialised channels called gap 
junctions. More commonly, communication is achieved via chemical synapses. When 
action potentials invade the presynaptic terminals, VG-calcium channels are activated. This 
leads to an influx of calcium ions that triggers exocytosis of vesicles containing a 
neurotransmitter, which is released and diffuses across the synaptic cleft. 




excitation (depolarisation) or inhibition (hyperpolarisation). Feedback mechanisms are also 
in place to maintain a dynamic equilibrium within the network. For example, 
neurotransmitters can bind to receptors on the same presynaptic terminal from which they 
were released, triggering positive or negative feedback systems. 
In the central nervous system, excitatory neurones, or ‘principal cells’, use the amino acid 
glutamate as the neurotransmitter, and they exhibit long range and diverse connectivity 
within neuronal networks. Inhibitory neurones, or interneurones, exhibit local connectivity 
enabling feedforward and feedback inhibition, and the neurotransmitter is another amino 
acid, γ-aminobutyric acid (GABA). 
Two studies in the early 1950’s revolutionised our understanding of the basic principles of 
synaptic transmission using intracellular recordings from muscle fibres of the frog 
neuromuscular junction. In the first study, the presence of small, spontaneous 
depolarisations or miniature potentials’ at the postsynaptic membrane was documented 
in the absence of neuronal stimulation (Fatt and Katz, 1952). These potentials had 
numerous properties resembling the events evoked by direct presynaptic stimulation, 
suggesting they were the result of spontaneous presynaptic transmitter release. The 
second study undertook a retrospective quantitative analysis of both evoked and miniature 
potentials (del Castillo and Katz, 1954). They noticed that, when the concentration of 
calcium was lowered, the amplitude of evoked events was decreased, however, the 
frequency (but not amplitude) of spontaneous miniature events was decreased. Moreover, 
the fluctuations in the amplitude of the evoked events occurred at multiples of the mean 
amplitude of the spontaneous events. This lead to the conclusion that spontaneous events 
represent the minimum units of release, termed ‘quanta’.  
This knowledge has formed the basis of our current understanding of neurotransmitter 
release mechanisms. In a later series of studies by Heuser in the 1970’s, electron 
microscopy confirmed that each quantum that is discharged correlates to the 
neurotransmitter contained within one vesicle undergoing exocytosis (Heuser et al., 1979, 
Heuser and Reese, 1973). Spontaneous release of neurotransmitter was proportional to 




recent molecular studies hint towards differences in vesicle fusion between evoked and 
spontaneous release in terms of their presynaptic machineries, neuromodulation and 
second messenger pathways (Melom et al., 2013). The existence of these seemingly two 
non-mutually exclusive mechanisms for transmitter release would point toward a distinct 
role for spontaneous transmitter release. However, the exact physiological roles of these 
synaptic events remain unclear, though are thought to have relevance to synaptic plasticity 
and neurodevelopment (Kavalali, 2014). For the purpose of this thesis, these autonomous 
events are used as a selective substrate for the investigation of spontaneous 
neurotransmitter release in the rat medial entorhinal cortex (MEC).  
1.2  The Entorhinal Cortex 
The EC (Brodman area 28), meaning ‘inside rhinal’, is so called as a result of it being partially 
enclosed by the rhinal (olfactory) sulcus. It is the largest cortical field in the 
parahippocampal region. This region also consists of the perirhinal areas 35 and 36, the 
parahippocampal cortex, the presubiculum and the parasubiculum (Furtak et al., 2007, 
Pereira et al., 2016), (Witter et al., 2017). Although we need to be cautious when making 
anatomical comparisons between species, the parahippocampal cortex is comparable to 
the ‘postrhinal’ cortex in the rat (Burwell and Amaral, 1998a, Furtak et al., 2007). Interest 
in the entorhinal cortex arose at the turn of the 20th century when it was described by 
Ramon y Cajal in his ground-breaking studies on the anatomy of the nervous system. Cajal 
was intrigued by this ‘peculiar’ part of the posterior temporal cortex and noted the 
prominent connections to the hippocampal formation, which consists of the dentate gyrus, 
fields CA3, CA2 and CA1, and the subiculum. We now know that the EC is the nodal point 
between the hippocampal formation and many association areas of the cortex, such as the 
parietal, temporal and frontal cortices (Fig. 1.1). This unique positioning of the EC allows it 
to act as a gateway between cortical and subcortical areas, where multimodal sensory and 
highly processed unimodal inputs converge, and can be bi-directionally conveyed to the 





Figure 1.1: Positioning of the EC within the medial temporal lobe. Figure shows position 
of the EC in light purple, ideally located to receive and convey information between 
neocortical association areas (blue) and the hippocampus (green). Purple: the perirhinal 
cortex, dark purple: the parahippocampal cortex. From (Dickerson and Eichenbaum, 2010). 
On a larger scale, the hippocampal and parahippocampal regions are a part of the ‘Papez 
circuit’, later termed the limbic system, after scientist James Papez injected rabies virus 
into the cat hippocampus (HC) and traced its progression (Bard, 1933). The circuit begins 
and ends with the hippocampal formation, passing through the following structures: the 
fornix, mammillary bodies, mammillothalamic tract, anterior thalamus nucleus, cingulum, 
parahippocampal gyrus and EC. The limbic system has major roles in a variety of cognitive 
functions, particularly regarding emotion and memory, but also sexual behaviour, 
motivation and olfaction (Papez, 1937). Systems that specifically involve the EC are pivotal 
for the storage of new memories. More recently, the role of the EC in cognitive behaviours 
such as spatial navigation has been emphasised (Moser et al., 2008). Cognitive deficits 
apparent in neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease 
and schizophrenia, have been attributed to neuropathological changes in these regions, 
especially in the EC (Zhou et al., 2016, Baiano et al., 2008, Kovari et al., 2003) Moreover, 
dysfunction of the EC has strong implications in the development of temporal lobe epilepsy 




1.2.1 Anatomical organisation  
1.2.2 Extrinsic connectivity  
Using retrograde tract tracing experiments, where tract tracer injections were placed in the 
EC, extrinsic connectivity of the MEC has been identified by quantifying retrogradely-
labeled cells in hippocampal, cortical and sub-cortical structures.  
For the purpose of these following sections, the MEC is characterised into three divisions 
to identify the specific areas of afferent and efferent connectivity, namely medial, 
intermediate and lateral MEC bands (Fig. 1.2). 
 
Figure 1.2: The entorhinal cortex in the rat. A: Ventral posterior view of the rat brain with 
the cerebellum removed. A schematic overlay shows the position of the lateral (LEA) and 
the medial (MEA) areas of the entorhinal cortex. In each panel, the lateral band (LB) is 
shown in dark grey, the intermediate band (IB) in medium grey, and the medial band (MB) 
in light gray. B: An unfolded map of the pial surface of the entorhinal cortex. The asterisk is 
located in the dorsocaudal MEA, the location in which grid cells have been described. Other 
abbreviations: C, caudal; D, dorsal; L, lateral; M, medial; R, rostral; rs, rhinal sulcus; V, 
ventral. (Adapted from Kerr et al. 2007). 
1.2.2.1 Hippocampal connections of the MEC 
The EC has prominent reciprocal connections with the HC and acts as a gateway between 




from other areas of the hippocampal system, with the heaviest input being from the 
parahippocampal region. Specifically, the three main MEC afferents arise from, in order of 
strongest connectivity, the caudal parasubiculum, dorsal presubiculum and postrhinal 
cortex, and are directed to the lateral portion of the MEC. Afferents from the hippocampal 
formation also exist though are not as strong as from the parahippocampal region. They 
include the dorsal CA1 field, which projects to the lateral MEC, and the ventral CA1 and 
subicular area, which have inputs to the medial MEC (Canto et al., 2008, Witter and Amaral, 
2004). 
The MEC also has efferent connections to the hippocampal system. The strongest 
projections arise in the lateral and intermediate bands of the MEC and input heavily to 
areas of the hippocampal formation, including the dorsal dentate gyrus and dorsal CA1 
field. These bands of the MEC also have connections to other areas of the hippocampal 
formation, though are less prominent, and include the ventral HC, dentate gyrus, fields CA3 
and CA1 and the subiculum. However, as with the MEC afferent inputs, efferent 
connections from the MEC are much stronger to the parahippocampal region. All 
connections arise in the medial and intermediate bands of the MEC and preferentially input 
to the perirhinal, although the postrhinal connection is also strong. Moderate efferent 
outputs from MEC also project from the pre- and parasubiculum (Witter et al., 2017, Canto 
et al., 2008).  
The main connectional route from the EC to the HC is via the perforant pathway (Cajal, 
1893). This unidirectional pathway predominantly arises from stellate neurones (SC) in LII 
of the MEC, although a minor component comes from LV and LVI (Steward and Scoville, 
1976, Köhler, 1985). Axons project to the middle third of the molecular layers of the 
dentate gyrus, where 85% of the total synapses originate from the EC. Their primary 
contacts are excitatory and are on the dendritic spines of dentate granule cells (DGC), 
carrying highly processed polymodal sensory information (Hjorth-Simonsen and Jeune, 
1972).  
The perforant pathway is the first relay of the tri-synaptic loop, a polysynaptic circuit with 




(above), 2) the mossy fibre pathway, where DGCs project via their axons (the mossy fibres) 
onto the proximal apical dendrites of CA3 (PC) neurones, 3) the Schaffer collateral-
commissural pathway, consisting of CA3 (and contralateral CA1) PCs synapsing onto CA1 
pyramidal cells. The loop is completed when outputs from the CA1 return to the MEC, via 
the subiculum where they terminate in LV (Witter, 2007).  
The final pathway to mention is the temporo-ammonic input to the hippocampal CA1 field. 
Here, the distal apical dendrites of CA1 pyramidal neurones receive information directly 
from LIII cells of the EC, forming a one-to-one, monosynaptic connection. The pathway 
originates from pyramidal neurones in LIII and terminates on CA1 neurones. A similar 
pathway originating from LII of the MEC, which terminates directly on pyramidal neurones 
in CA3, has also been identified (Hjorth-Simonsen and Jeune, 1972, Steward, 1976). 
Entorhinal fibres most often synapse on the spines of dendrites on excitatory principal cells, 
though they also form both excitatory and inhibitory synapses on the dendrites of 
interneurones (Baks-te Bulte et al., 2005, Kajiwara et al., 2008). 
1.2.2.2 Cortical and sub-cortical connections of the MEC 
One fifth of the total afferent inputs arise from the neocortex either directly, or indirectly 
via the perirhinal cortex. The perirhinal and parahippocampal (postrhinal, for rodent 
cortices (Koganezawa et al., 2015)) provide the main cortical links to the EC (Van Hoesen 
and Pandya, 1975). Other inputs to the MEC include those from the pre- and parasubiculum 
(Caballero-Bleda and Witter, 1993), as well as from olfactory related structures, such as the 
olfactory bulb and the anterior olfactory nucleus. The piriform and other cortices related 
to sense of smell dominate input to the superficial layers of the MEC, which is reciprocated 
by similarly strong outputs from the MEC to the olfactory domains. Cortical inputs to the 
MEC also arise from frontal (Kondo and Witter, 2014), cingulate, retrosplenial, insular, 
parietal and visual areas. Superficial layers of the lateral MEC also receive moderate input 
from the orbitofrontal cortex (Kondo and Witter, 2014), postrhinal cortex (Koganezawa et 
al., 2015) and pre- and parasubiculum (Caballero-Bleda and Witter, 1993). 
As already mentioned, afferents to the MEC are largely distributed to the superficial layers. 




influencing neurones in LV MEC, as well as the superficial layers, suggesting that LV could 
be acting as an integrator of EC inputs (Canto and Witter, 2012). In fact, many other cortical 
inputs have been shown to project to LV from regions such as the infralimbic, prelimbic and 
retrosplenial cortex, as well as from the visual cortex (Olsen et al., 2017). 
Cortical efferents are widespread and are mainly represented by return reciprocal afferent 
connections to the MEC. It is important to note that most entorhinal to cortical projections 
arise from pyramidal neurones from LV of the MEC, although the infralimbic and olfactory 
structures have additional projections from LII and LIII (Vertes, 2004). 
Sub-cortical connectivity of the MEC has also been identified in areas such as claustrum, 
amygdala, basal ganglia, thalamus, hypothalamus and brainstem. However, by far the 
strongest efferent connection is to the basal ganglia, specifically the caudate-putamen and, 
to a lesser extent, the nucleus accumbens (Insausti et al., 1987). There is evidence for these 
connections arising from both LII and LV of the MEC (Pereira et al., 2016). Reciprocal 
connections between the amygdala and the MEC are also evident, with most studies 
pointing towards amygdala afferents terminating in LIII, and return projections originating 
in cells from LV (McDonald, 1998). Finally, thalamic and hypothalamic sub-cortical 
connections have also been identified in the MEC, although details about these pathways 





Figure 1.3: Summary of the major connections of the LEC and MEC. Strong, moderate and 
weak connections are indicated by black, dark grey and light grey arrows, respectively. This 
thesis focuses on the MEC only.  
1.2.3 Intrinsic organisation and morphology of the MEC 
The entorhinal network comprises elements receiving input and providing output, but also 
elements contributing to its intrinsic organisation. As mentioned, the EC can be divided into 
6 layers, although LIV (lamina dissecans) is acellular and often referred to as the plexiform 
layer, which separates the deep and superficial layers. Similarly, LI contains mostly fibres 
and few neuronal cell bodies. The cells that do reside here are either spinous multipolar or 
horizontal cells with local connections. The remainder of this section will focus on the layers 
central to this thesis, namely LII and LV.  
1.2.3.1 Layer II morphology 
The first description of MEC neurones was published in 1933 when Lorente de Nó used the 
‘Golgi’ stain to determine their morphology (Bard, 1933). Since then, much effort has gone 
into defining the intrinsic organisation of the MEC. LII is densely packed with large and 
medium sized pyramidal cells (PCs) and stellate cells (SCs), which are defined chemically 
with calbindin and reelin positive staining, respectively (Winterer et al., 2017). However, 




calbindin and reelin have also been identified and classified into separate subgroups. IMSCs 
are all reelin positive with a few sub-types also co-expressing calbindin. IMPCs are generally 
calbindin positive but more diverse variations can include reelin positive, as well as 
calbindin and reelin positive co-expression (Witter et al., 2017). These four sub-groups of 
excitatory principal neurones in the MEC appear to have distinct individual 
electrophysiological profiles (Fuchs et al., 2016, Canto and Witter, 2012).  
SCs are the most abundant cell type in LII, residing preferentially in the superficial and 
middle area of the layer. Their defining morphological characteristics include the presence 
of multiple, and roughly equally sized, primary spiny dendrites with wide reaching 
branches, often projecting to the dentate gyrus via the perforant path. PCs are so called 
due to their triangular, or pyramidal, shaped soma, and seem to reside in the deep parts of 
LII. They possess a prominent, thick and long spiny apical dendrite branching at the border 
of LI, and thin and short basal dendrites which branch at the border of LIII (Klink and Alonso, 
1997). SCs and PCs can also be defined in terms of their electrophysiological profiles. SCs 
display prominent sag potentials mediated by a hyperpolarising current (Ih) (Jones, 1994) 
along with intrinsic theta-like (4-10 Hz) membrane potential activity and resonance 
properties that are not evident in PCs (Pastoll et al., 2012, Burgalossi and Brecht, 2014). 
Inhibitory interneurons present in LII can be classified into three main sub-groups: 
parvalbumin (PV), somatostatin (SOM) and 5-HT3a expressing cells (Rudy et al., 2011). By 
far the most abundant are the PV containing basket cells, which constitute about half of 
the total interneurone population. PV-containing interneurones innervate and surround 
both reelin and calbindin positive principal cells, and have fast-spiking physiological profiles 
(Jones and Bühl, 1993, Armstrong et al., 2016). Interestingly, a clear gradient of PV staining 
is apparent in the MEC, with stronger expression in portions close to the rhinal fissure 
compared to ventral portions. SCs receive strong local inhibition from presynaptic PV-
positive interneurones, and the dorsal-ventral inhibitory gradient has major implications 
for changing network oscillations along this axis (Beed et al., 2013). Another sub-type of 
basket cell present in LII expresses cholecystokinin (CCK), and falls under a sub-group of the 
5-HT3a category of interneurone. These interneurones preferentially innervate calbindin-




dendrites, and an extensive axonal arbor, which appear to be confined to LII (Klink and 
Alonso, 1997). They form complexes around the cell somas of principal neurones, which 
they locally inhibit.  
The second type of interneurone commonly found in LII is the called chandelier cell, 
reflecting the specific shape of its axon arbor. These are also PV-positive but are defined 
morphologically by vertical, as well as horizontal, aggregations of axonal boutons, known 
as ‘candles’. Chandelier axon branches are confined to LII and LIII of the MEC and synapse 
onto the initial segments of principal cells (Soriano et al., 1993). 
There is limited and conflicting knowledge available on the distribution of SOM 
interneurones in the MEC, although immunoreactivity experiments do confirm they are 
present in LII (Wouterlood and Pothuizen, 2000). In terms of morphology, they are 
generally multi-polar and have a low threshold for spiking.  
Lastly, there are many interneurones in sub-groups of the 5-HT3a group that reside in LII. 
They have diverse morphological and physiological profiles and include: calretinin-, 
Vasoactive intestinal peptide (VIP) and CCK-expressing cells (Witter et al., 2017). 
1.2.3.2 Layer II intrinsic organisation  
The SC microcircuit in the superficial layers of the MEC has been well-established using in 
vitro patch clamp techniques. Interestingly, it appears that communication between SCs is 
not through monosynaptic connections, but via an intermediate inhibitory interneurone 
(Couey et al., 2013). In this network, activation of one or more SCs leads to inhibitory 
currents in neighbouring SCs, a mechanism which seems to be mediated by PV-containing 
interneurones (Buetfering et al., 2014). Similarly, PCs in LII have sparse monosynaptic 
connections, and generally communicate via inhibitory interneurones, though in this case, 
exclusively from the 5-HT3a expressing population (Fuchs et al., 2016). As such, inhibition 
dominates the microcircuits of SCs and PCs in LII (Berretta and Jones, 1996, Greenhill et al., 




Information on the connectivity between PCs and SCs themselves is limited and conflicting. 
Some experimental evidence points towards minimal recurrent excitatory connectivity 
between SCs and PCs (Couey et al., 2013, Pastoll et al., 2013a, Fuchs et al., 2016). This would 
be indicative of two independent microcircuits in LII of the MEC, whereby the information 
relayed by SCs to the dentate gyrus is processed separately from the information relayed 
to downstream areas, such as the CA1, by PCs. On the other hand, a recent study, using 
eight simultaneous patch clamp recordings, suggests there is a prevalent feed-forward 
excitation from PCs (in both LII and LIII) onto SCs in LII of the MEC (Winterer et al., 2017). 
Nevertheless, more work is needed to identify the functional implications of the 
remarkable cellular diversity of LII, including the roles of intermediate PCs and SCs in the 
MEC network, as its plausible they could be co-ordinating the two microcircuits (Witter et 
al., 2017).  
1.2.3.3 Layer V morphology and intrinsic organisation  
It is generally accepted that LV of the MEC can be further sub-divided into LVa and LVb due 
to their differing molecularly defined circuitry. LVa lies adjacent to LIV (lamina dissecans), 
and is therefore more superficial than LVb. LVa is mainly comprised of large neurones with 
rounded somata, known as superficial PCs, which can be further sub-divided depending on 
their basal dendritic trees: multidirectional or horizontal sparsely spiny (Lorente de No, 
1933, Canto and Witter, 2012). Superficial PCs generally have one distinct spiny apical 
dendrite that reaches towards the pial surface, firstly branching close to the soma, 
sometimes extending into the lamina dissecans, before extending up to LII and LI. The basal 
dendritic tree is spiny to sparsely spiny and extends in all directions in LV, and occasionally 
LVI (Canto and Witter, 2012).  
Deep PCs residing in layer Vb, on the other hand, have smaller somata and a sparsely spiny 
apical dendrite that extends to the pia, branching profusely in LV, LII and LI. Basal dendrites 
generally leave the soma in all directions, and project deeper towards LVI.  
The third type of neurones found in LV, generally LVb, are bipolar PCs with spindle-like 
somas. They possess a sparsely spiny apical dendrite that branches near the soma and 




The last morphological neurone group consists of multipolar and horizontal principal cells, 
the latter comprising a distinctive polygonal shaped soma. They both have sparsely spiny 
dendritic trees that are mainly confined to the deep layers, avoiding the superficial layers. 
Whereas multipolar PCs have dendrites that are of a similar length spreading in all 
directions, horizontal cells have one main dendrite which spreads horizontally to the border 
with, and often extending into, LVI. Of note, any LV pyramidal neurones located near the 
border of the parasubiculum have the potential for their dendrites to extend into this area 
(Canto and Witter, 2012). 
The different molecularly defined circuitry in LVa and LVb also reveals input-output 
segregation. Layer Va principal neurones appear to be the major outputs projecting to 
diverse cortical and sub-cortical structures, whereas LVb principal neurones are selectively 
targeted by outputs originating from the hippocampus, specifically the CA1 field and the 
subiculum, as well as from LVa, LIII and LII of the MEC itself. The principal neurones in LII 
that project to LVb of the MEC have been identified as reelin-positive SCs. These cells are 
ideally suited to integrate inputs from the superficial MEC and the hippocampus, as well as 
forming a major component of the intrinsic deep to superficial circuits (Sürmeli et al., 2015, 
Witter et al., 2017). Generally, inhibitory interneurones are sparsely distributed in LV MEC, 
which contributes to the weak overall synaptic inhibition in this layer compared to more 
superficial layers (Woodhall et al., 2005, Greenhill et al., 2014).  
The electrophysiological profiles of neurones in the deep layers of the MEC are less 
understood, but they appear to have a notably high input resistance compared to all other 
layers, reflecting low conductance and therefore an increased amount of closed channels 
(Fransén, 2010, Jones and Woodhall, 2005, Dhillon and Jones, 2000) . The deep layers also 
show much less grid cell activity, and no theta modulation, compared with LII neurones 





Figure 1.4: Connectivity of the EC. Diagram depicts the different cell types and morphology 
of each layer of the MEC, along with their intrinsic connectivity. Principal neurones are 
largely pyramidal neurones in LIII and LV, whereas SCs reside in LII MEC. Superficial layers 
are subject to increased inhibitory control. Adapted from (van Haeften et al., 2003). 
 1.2.4 The EC in memory 
One of the first associations between the EC and cognition, particularly memory, was made 
by surgeon Wilder Penfield in 1937. During neurosurgery in patients with TLE he observed 
that with mild stimulation of the medial temporal lobe (MTL), patients could recall precise 
personal experiences that had previously been forgotten (Penfield and Boldrey, 1937). The 
second association came from the famous patient, H.M, who became severely amnesic 
following an experimental bilateral medial temporal lobectomy (including the EC), to treat 
incapacitating and refractory seizures (Penfield and Milner, 1958). It was striking that 
although declarative memory formation (conscious, intentional recollection of factual 
information, previous experiences and concepts) was severely impaired, all other cognitive 
functions were retained, including general intelligence and perception, suggesting memory 
is a distinct cerebral function (Scoville and Milner, 1957). These studies heralded the 




The MTL consists of the perirhinal cortex, parahippocampal cortex and the hippocampus. 
Recent evidence from neuroimaging and fMRI studies has shown that these structures, 
including the EC, engage with many aspects of memory, including memory encoding and 
retrieval (Kirwan and Stark, 2004, Bellgowan et al., 2009), as well as associative learning 
(Hargreaves et al., 2012), episodic (Maass et al., 2014) and working memory (Schon et al., 
2016). Hence, at an anatomical level we can associate the EC with cognition, but a 
functional representation of cognition at the molecular level is not yet fully understood. 
Despite this, certain observable phenomena at the synaptic and network level are thought 
to be important.  
Donald Hebb initially formulated the conception of synaptic plasticity, a rule whereby 
neuronal assemblies are brought together on the basis of temporal relations among them 
(Morris, 1999). Essentially, activity-dependent changes in the strength of synapses are 
thought to provide a cellular basis of learning and memory. Still, single synapses cannot be 
viewed in isolation because neurones are a part of an extensive network with co-ordinated, 
or synchronised, patterns of activity. Synchronised neuronal activity is known as a network 
oscillation and is thought to be intimately involved in the formation of new memories, 
though the exact mechanisms are still debated. Nevertheless, a recent study has shown a 
particular oscillation (gamma frequency, also found in the EC) strengthens excitatory 
synapses in the hippocampus, allowing future signals to be transmitted more easily 
(Zarnadze et al., 2016). This provides insights into how synaptic strengthening and 
synchronised network activity could underlie memory formation in the EC, through 
synaptic plasticity mechanisms such as long-term potentiation.  
1.2.5 The EC in spatial navigation 
The EC has recently been recognised as a fundamental contributor to the process of spatial 
navigation (Squire and Zola-Morgan, 1991, O'Keefe and Dostrovsky, 1971, Hafting et al., 
2005). In 2005, grid cells were discovered in the MEC. These cells fire at similar spacing and 
orientation in response to location in an environment (Hafting et al., 2005). The distinctive 




is thought to arise from neural dynamics that depend on the local microcircuitry (Winterer 
et al., 2017).  
The representation of space is not achieved by grid cells alone, but multiple functional cell 
types. The first spatial cell type to be described was found in the adjacent hippocampus, 
called the ‘place’ cell, discovered by John O’Keefe in the 1970s in freely moving rats 
(O'Keefe and Dostrovsky, 1971, O'Keefe, 1976). These cells fire selectively when animals 
are at a specific location in the environment. The discovery of grid cells in the MEC, one 
synapse upstream of place cells, came 30 years later by Edvard and May-Britt Moser in 
2005, who also identified other spatial selective cells in the MEC including head-direction 
and border cells (Hafting et al., 2005, Sargolini et al., 2006, Giocomo et al., 2014). Unlike 
place cells, which change their firing fields unpredictably in differing environments, grid 
cells maintain their positional relationship and therefore act as a metric of local space, 
reflecting the structure of that space independently of specific contextual details about the 
environment itself (Fyhn et al., 2007, Moser et al., 2008). Although grid cell firing patterns 
are fixed between environments, the spacing of the grid does increases topographically 
along the dorsal-ventral axis of the MEC, mirroring the scale expansion also observed in 
place cells in the hippocampus (Hafting et al., 2005, Brun et al., 2008, Jung et al., 1994). The 
discovery of these cells garnered attention to the EC beyond the neuroscientific community 
when John O’Keefe, May-Britt Moser and Edvard Moser won the Nobel Prize in Physiology 
and Medicine, in 2014.  
Information about the development of grid cell firing patterns is mainly theoretical. 
However, in vivo experiments have shown that the firing fields of neighbouring grid cells 
share similar spacing and axes of orientation, suggesting these patterns are interdependent 
and mediated by the local microcircuit (Couey et al., 2013). Moreover, computational 
studies on the development of grid cell firing fields hypothesise the involvement of an 
attractor network, with specific local connectivity of both excitatory and inhibitory 
connections (Burak and Fiete, 2009).  
Grid cells are principal neurones residing mainly in LII of the MEC, and can be either PCs or 




of the MEC suggest that calbindin-positive grid cells (mainly PCs) tend to cluster into 
islands, arranged in a hexagonal grid, and often project to the CA1 field of the 
hippocampus. Conversely, calbindin-negative border cells (mainly SCs) are homogenously 
distributed throughout layer II, avoiding the islands, and propagate spatial input to the 
dentate gyrus. Moreover, PC discharges showed over two-fold stronger spike locking to the 
theta oscillation compared with SCs (Ray et al., 2014). This is suggestive of two distinct 
principal cell networks contributing to grid cell activity in LII MEC. 
The mechanisms underlying the brains representation of space are more recently being 
linked to those underlying memory formation and sensory processing (Doeller et al., 2010, 
Eichenbaum and Cohen, 2014). Buzsaki and Moser (2013) identified parallels between 
declarative memory and navigation, suggesting they could share the same fundamental 
mechanism, providing an overarching functional picture of the hippocampal formation 
(Buzsaki and Moser, 2013). In addition, studies on patients with EC deficits show not only 
memory, but also spatial impairment, often coexistent with abnormal oscillatory activity. 
Again, until recently, these lines of research have been studied separately, but are 
beginning to converge (Buzsaki and Moser, 2013).  
1.2.6 The EC in CNS disorders. 
1.2.6.1 Epilepsy 
The EC is commonly implicated in the pathology of TLE, which is a chronic, debilitating 
neurological disorder affecting over 65 million people worldwide. It can be caused by 
numerous factors including genetic mutations, developmental disorders or by an insult to 
the brain, although the majority of cases are idiopathic/cryptogenic (Banerjee et al., 2009). 
The primary characteristic of epilepsy is the onset of recurrent spontaneous seizures that 
arise due to aberrant changes in neuronal activity, involving massively increased 
synchronisation of neuronal firing. Epilepsy can be subdivided into over 40 different 
syndromes, of which, TLE is the most common form. There is currently no known consistent 
mechanism underlying the various epilepsies, but decades of experimental work conclude 
that, in the broadest sense, it arises due to an imbalance of the normal excitation and 




acts to maintain this balance, including at the level of ions, neurones, synapses and 
networks, an overarching mechanism for epilepsy may not be feasible. However, the 
imbalance in excitability is exemplified with clinical examples such as the marine toxin, 
domoic acid, and the pesticide, strychnine, which act to increase excitation, and decrease 
inhibition, respectively, both resulting in the generation of seizures (Jett, 2012). Currently 
available treatments broadly act to equalise the imbalance within the network. Whilst this 
approach is effective, around 30% of patients are refractory to treatment, so there remains 
a clinical need for a novel pharmacological target in this disorder (Laxer et al., 2014).  
In cases of TLE where treatment is refractory, a partial temporal lobectomy is carried out 
as a last resort to remove the epileptogenic tissue. Interestingly, retrospective studies 
suggest that removal of the EC is correlated to a good postoperative outcome, and studies 
on resected tissue from patients with TLE have identified significant atrophy of the EC 
(Bonilha et al., 2007, Siegel et al., 1990). Moreover, a number of MRI studies have identified 
significant atrophy in the EC in patients with TLE (Bernasconi et al., 1999, Bernasconi et al., 
2001, Salmenperä et al., 2000).  
Many animal models of epilepsy (see (Löscher, 2017), which are required for the 
identification of novel therapeutic agents, have also identified the EC as the site of initiation 
and maintenance of epileptiform activity (Lopantsev and Avoli, 1998, Avoli et al., 2002, Ben-
Ari et al., 1981, Walther et al., 1986, Jones and Lambert, 1990). Rat models have implicated 
both LII and LV as having an increased susceptibility to epileptiform activity, due to reduced 
inhibition and increased excitability, respectively (Kobayashi et al., 2003, Bragin et al., 2009, 
Greenhill et al., 2014).  
Although the underlying pathology of TLE is unclear, one possibility is that the brain 
recapitulates developmental processes, inappropriately, in the adult brain (Scharfman, 
2007, Ben-Ari, 1985, Represa et al., 1990, Yang et al., 2006). This could lead to changes in 
expression of proteins that control this delicate balance between excitation and inhibition, 
and even create new synaptic connections. Essentially, the resulting enhanced connectivity 




A common animal model of epilepsy uses the drug KA, a potent excitotoxin, which activates 
KARs. KARs are heavily implicated in the synchronisation of neuronal network activity and 
the pathophysiology of TLE, and will be discussed in section 1.3. 
1.2.7 The EC in development 
1.2.7.1 Embryonic development 
During early embryonic development of the human brain, three primary brain structures 
are formed: the prosencephalon (forebrain), the mesencephalon (midbrain) and the 
rhombencephalon (hindbrain). From the forebrain, two structures develop: the 
telencephalon and the diencephalon (Roxo et al., 2011). The dorsal telencephalon 
eventually develops into the cerebral cortex consisting of the more familiar cortices: 
frontal, parietal, temporal and occipital. The main functions of the cortex can be 
characterised as sensory, motor or associative. The neocortex constitutes the majority of 
the cerebral cortex, but the smaller, and phylogenetically oldest, area of the cerebral cortex 
is called the ‘allocortex’. The EC is a subdivision of the allocortex known as the 
periarchicortex, a transitional, non-neocortical zone between the allocortex and the 
neocortex. It is distinguished morphologically from the typical six layers of neurones in the 
neocortex by its lack of a true cellular layer IV (Greene, 1996). It is located in the medial 
temporal lobe and is curved around the rostral surface of the hippocampus, a structure 
that is also intricately involved in memory processing. The anterior, inferior and lateral 
surfaces of the EC are surrounded by the perirhinal cortex, which is a structure that receives 
highly processed sensory information regarding visual perception and memory (Devlin and 
Price, 2007, Murray and Richmond, 2001). Indeed, sensory information does not directly 
penetrate the allocortex, but arrives via the thalamus or neocortex.  
1.2.7.2 MEC microcircuitry development 
An eloquent study detailing a temporal profile of maturation across the EC-hippocampal 
circuit was published earlier this year (Donato et al., 2017). Using pharmacogenetic 
approaches, this study described a linear, uni-directional developmental sequence 




hippocampal network. This excitation originated in LII, and the progression of maturation 
followed, a recapitulation of information flow in adult circuits, from: LII MEC, CA3, CA1, 
dentate gyrus, subiculum, LV MEC and LEC and finally LII LEC. Remarkably, the excitation 
stemming from LII MEC originated specifically from SCs, which are the first cell type to 
develop to maturity in this region. Cell-type specific silencing of LII SCs, and not PCs, 
prevented the maturation of the rest of the EC-hippocampal circuit, indicating that 
instructive excitatory activity originates from these cells. The functional maturation of 
pyramidal neurones is delayed compared with SCs. Interestingly, the maturation of SCs 
themselves was independent of local excitation, but correlated with the birth date of the 
cell, functioning as an “autonomous” (genetic) intrinsic driver of neurogenesis at the top of 
the developmental hierarchy. These targets subsequently exert an excitatory driving force 
onto downstream areas, resulting in a stage-wise maturation of the EC-hippocampal 
network (Donato et al., 2017). The precise nature of the excitatory instructive signal is 
unknown, but is suggested to involve large-scale oscillatory calcium waves which have been 
observed in the immature cortex (Garaschuk et al., 2000, Goodman and Shatz, 1993). 
The developmental progression of neurogenesis and maturation follows a gradient along 
the dorso-ventral axis of the MEC. Microcircuits mature first in the dorsal MEC, followed by 
the ventral MEC, where smaller and larger spatial scales are represented by grid cells, either 
SC or PC with the latter presenting at around the onset of exploratory behaviour (Ray and 
Brecht, 2016). Interestingly, local inhibitory circuits in the MEC also follow a gradient along 
the dorso-ventral axis, specifically regarding inhibitory inputs onto SCs, imposing a strong 
regulatory role on these cells. It appears that the dorsal MEC (with smaller spatial scales) is 
under greater inhibitory control compared to the ventral MEC (with larger spatial scales) 
(Beed et al., 2013). Inhibitory GABAergic neurotransmission also contributes to the 
maturation of the cortex, with roles in plasticity and network activity during pre- and post-
natal development, acting to pace immature networks. Accordingly, aberrant maturation 
of inhibitory mechanisms has been implicated in the aetiology of many 
neurodevelopmental disorders, including autism and schizophrenia (Le Magueresse and 




The development of MEC microcircuits is currently receiving much attention after the 
discovery of grid cells, because this area represents one of the first examples where we can 
begin to understand how network topology directly supports higher cognitive functioning. 
This thesis will contribute to this work by carrying out a comprehensive electrophysiological 
profile of both excitatory and inhibitory neurotransmission in principal cells, during 
development, in LII - at the top of the developmental hierarchy, and LV - near the end of 
the developmental hierarchy.  
1.2.7.3 Relevance to human brain development 
Ontogenetic characteristics of brain development are shared among mammalian species. 
For example, adolescence appears to be a highly conserved developmental stage and 
species share many similar neurobehavioural and physiological characteristics. This 
supports the use of animal models as tools in studies of human brain development and 
associated diseases (Spear, 2004). In general, adolescence is the period of transition from 
childhood to adulthood, not to be confused with puberty, which refers to the attainment 
of sexual maturity. Comparing stages of development in rodents and humans can be 
variable, but generally there is a consensus that peak adolescence in rats occurs at ~4-5 
weeks old, correlating to roughly 12-18 years old age span in humans (Spear, 2004).  
The rat brain has no direct correlate to the human medial temporal lobe. As such, the rat 
EC is located at the most caudal, ventral and lateral aspects of the brain. It can be sub-
divided into the lateral EC (LEC) and MEC based upon their different functional architecture. 
For example, functional studies show that the MEC significantly contributes to spatially 
specific information, whereas neurones in the LEC are more heavily, but not strictly, 
implicated in non-spatial processes, though these aspects likely work together (Van Cauter 





1.3 Kainate Receptors 
The existence of a new type of glutamate receptor emerged from the discovery of KA, a 
potent excitotoxin. The word ‘kainic’ is derived from the word kaininso, meaning ‘the ghost 
of the sea’, as it was first isolated from the seaweed Digenea simplex in 1953. The excitatory 
and neurotoxic actions of KA were recognised by the mid-1970s, and the hypothesis that 
KA was acting on a specific set of receptors was made (J C Watkins and Evans, 1981). It was 
not until the early 1990s that KARs were shown to indisputably exist after the cloning of 
KAR subunits (Bettler et al., 1992, Hollmann and Heinemann, 1994), and the identification 
of the first KAR subunit gene (Bettler et al., 1990). These break-through discoveries formed 
the foundation upon which much progress understanding the biophysical and functional 
properties of KARs has been made over the last two decades. 
We now know KARs are expressed ubiquitously in the central nervous system (CNS) and 
respond to the endogenous agonist, glutamate. Unusually, they can act both ionotropically, 
through the action of ion channels, and metabotropically, through the action of G-proteins. 
The metabotropic mechanism of KARs is not well understood and is still somewhat 
controversial, but appears to involve the activation of G-proteins and second messenger 
pathways involving protein kinase C or phospholipase C. For example, KARs have been 
shown to downregulate GABA release from hippocampal CA1 interneurones via a pertussis 
toxin-sensitive metabotropic process (Jin and Smith, 2007). Intriguingly, a more recent 
study revealed a role for postsynaptic KARs in the induction of a type of functional and 
structural plasticity in the hippocampus, which was also attributed to a metabotropic 
action (Petrovic et al., 2017), also see (Rodrigues and Lerma, 2012) for a full review.  
However, KARs are most commonly associated with an Ionotropic mechanism. Ionotropic 
glutamate receptors (iGluRs) are ion channels that open in response to glutamate binding 
and are permeable to Na+, K+ and (depending on the receptor) Ca2+. There are three classes 
of iGluRs based on their sequence homology and preferred agonist: N-methyl-d-aspartate 
(NMDAR), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPAR), KA (Traynelis et 




paucity of good specific pharmacological tools to study them, but recent advances have 
meant that the field is catching up quickly.  
1.3.1 Structure and characterisation of KARs 
KARs have a tetrameric conformation formed from a combination of five subunits: the low 
affinity GluK1-3 and the high affinity GluK4/5. The GluK1-3 subunits can form functional 
homomeric receptors whereas the GluK4 and GluK5 subunits must co-assemble with their 
lower affinity counterparts, GluK1-3, to form functional heteromeric complexes.  
Different subunit compositions can influence glutamate sensitivity, for example, 
homomeric GluK1 or GluK2 KARs have a low affinity to glutamate (EC50 ~ 100-200 μM 
range). Addition of the high affinity subunits, GluK4/5, to form heteromeric KARs increases 
glutamate sensitivity 3-50x. A summary of the known glutamate sensitivities at 
recombinant KARs with various subunit combinations can be seen in the table below.  
 
Table 1.1 Glutamate activity at recombinant KARs. EC50 (μM) values ± SEM obtained from 
published data. Alt et al (2004) determined agonist-induced calcium influx in HEK293 cells 
expressing human KARs. Schiffer et al (1997) (Schiffer et al., 1997)determined EC50 values 
from HEK293 cells expressing rat GluK3a KARs.  
The GluK1 subunit is highly expressed in the developing brain with potential roles in the 
maturation of neurones, at least in the hippocampus (Lauri et al., 2005, Lauri et al., 2006). 
The GluK2 subunit has most commonly been associated with post-synaptic responses at 
the most fiber-CA3 synapse, also in the hippocampus. It is widely expressed in the brain, 




other hand, the GluK3 subunit often forms heteromeric complexes with GluK2 with low 
glutamate sensitivity, and are thought to contribute to presynaptic KAR activity (Pinheiro 
et al., 2007). GluK4 is expressed mainly in the hippocampus whereas GluK5 is ubiquitously 
expressed in the brain. Both subunits must form heteromers with GluK1-3, and in doing so 
they can dramatically change the functional and pharmacological properties of 
recombinant receptors, such as an increase in glutamate sensitivity and slower deactivation 
and desensitisation kinetics (Mott et al., 2010, Fisher and Mott, 2011). All subunits contain 
an agonist binding site and therefore has the ability to influence channel activation and 
gating properties (Fisher and Fisher, 2014).  
All five subunits share some sequence homology with both AMPAR (~30%) and NMDAR 
(~10%) subunits. The GluK1 KAR subunit was the first to be cloned in 1990, displaying ~40% 
sequence homology with the GluR1 AMPAR, but with a significantly increased affinity for 
KA over AMPA (Bettler et al., 1990, Sommer et al., 1992). The cDNA of the GluK2 and GluK3 
subunits were subsequently cloned, showing 75-80 % sequence homology with the GluK1. 
When expressed as homomeric receptors in Xenopus oocytes they were activated by KA, 
but not by AMPA, and also showed a higher affinity for KA than for AMPARs (Egebjerg et 
al., 1991, Bettler et al., 1992). Finally, the cDNA of two further KAR subunits were identified 
in 1992, which are now referred to as GluK4 and GluK5 (previously KA1 and KA2), and show 
68 % sequence homology to each other. Unlike GluK1-3, these subunits are unable to form 
functional homomeric structures when expressed in heterogenous systems, however, co-
expression with GluK1/2 produces channel activity with novel pharmacological properties 
(Herb et al., 1992). The GluK4/5 subunits are also unable to form heteromeric structures 





Figure 1.4: Schematic representation of the general structure of an ionotropic glutamate 
receptor subunit. The S1 and S2 domains form the ligand binding domain. 
 
The precise topology of the iGluRs in the plasma membrane was determined by two groups 
in 1994, both reporting a secondary structure distinct from that of other ligand gated-ion 
channels, with each subunit consisting of a large extracellular N-terminus, a 
transmembrane domain (TM1), re-entrant loop (TM2), another transmembrane domain 
(TM3), a large extracellular loop, and a final transmembrane domain (TM4), followed by a 
cytoplasmic C-terminal domain (Wo and Oswald, 1994, Hollmann et al., 1994). TM2 is 
composed of hydrophobic residues that dip into the membrane forming a hairpin-like 
structure. Two discontinuous segments of approximately 150 amino acid residues each, 
one before the TM1 domain (S1), and the loop between TM3 and TM4 (S2), together form 




(Stern-Bach et al., 1994). The S1 and S2 segments share sequence similarities with a 
bacterial periplasmic amino acid binding protein, which could suggest an evolutionary 
structural relationship (Kuusinen et al., 1995). More recently, native KARs were found to 
be accompanied by gain-of-function auxiliary proteins, known as Netos, which act to 
support the receptors’ extracellular loop domains by bringing them into closer proximity 
and influencing a more active conformation (Litwin et al., 2017).  
There are no full-length crystal structures of KARs reported to date, unlike the AMPAR, 
GluA2 and the NMDAR, GluN1/GluN2B (Meyerson et al., 2016, Karakas and Furukawa, 
2014). However, a full-length electron microscopic structure of a tetrameric GluK2 in its 
bound confirmation with an agonist was published in 2014 (Meyerson et al., 2014). 
Furthermore, the crystal structures of over 80 soluble constructs have since been 
identified, particularly from the GluK1-3 subunits (Mollerud et al., 2017). More work is 
needed to determine the full-length crystal structures of KARs in different conformations 
to help understand KAR functions at the molecular level.  
1.3.2 RNA editing and alternative splicing at KARs 
RNA editing is a molecular process whereby discrete alterations are made to the sequence 
of nucleotides in the RNA, encoding a KAR (for example), and can alter the characteristics 
of that receptor. One of the most important sites of mRNA editing encodes the GluK1 and 
GluK2 subunits. Editing at these sites, with an RNA deaminase, determines the alternative 
incorporation of an amino acid in the channel pore-forming P-loop (QR-site). Receptors 
with edited QR sites have functionally distinct characteristics, namely decreased divalent 
cation permeability, particularly Ca2+, and very low single channel conductance (Egebjerg 
and Heinemann, 1993, Swanson et al., 1996). Another important editing site of KARs is in 
the first transmembrane domain (TM1) of the GluK2 subunit, and influences ion selectivity 
of the receptor (Köhler et al., 1993). A considerable amount of highly controlled KAR 
subunit editing occurs throughout development, but the physiological relevance of these 
changes is still uncertain.  
Various isoforms of KARs can also be derived from alternative splicing, giving rise to further 




the extracellular N-terminal domain of the GluK1 subunit results in two variants: GluK11 
and GluK12 (Bettler et al., 1990), and the latter can be further spliced into GluK1a, GluK1b 
and GluK1c (Sommer and Seeburg, 1992). Alternative spicing can also occur at the C-
terminal of the GluK2 subunit (GluK2a/GluK2b) and the GluK3 subunit (GluK3a/Gluk3b) 
(Jaskolski et al., 2004, Schiffer et al.). Thus, KARs comprise a diverse combination of 
subunits with varying protein interactions and surface expression which influence receptor 
function.  
1.3.3 Pharmacology 
The study of KARs has been hindered by the lack of selective ligands, particularly a previous 
lack of pharmacological discrimination between KARs and the more abundant AMPAR, 
obscuring the involvement of a clear KAR mediated component. Competitive antagonists, 
such as CNQX, have shown little selectivity between KAR and AMPAR, but a related 
compound, NBQX, had ~100-fold selectivity for AMPAR than KAR. The study of KARs was 
helped further with the development of AMPAR selective non-competitive antagonists, 
such as GYKI 53655, however, many drugs have not been tested against all heteromeric 
subunit combinations of KARs, which complicates the assessment of pharmacological 
properties (Paternain et al., 1995, Wilding and Huettner, 1996, Pinheiro and Mulle, 2006). 
Agonist binding to KARs involves the N-terminus and the extracellular loop, which connects 
TM3 and TM4. Different subunits have slight differences in the residues comprising the 
binding site. This is of particular importance to the development of selective KAR agonists 
or antagonists. For example, the GluK2/3 subunit possesses a larger residue that exposes 
many ligands to steric hindrance, which is why obtaining a GluK1 selective agonist, e.g. 
UBP-310, has proven easier (Mayer, 2005, Møllerud et al., 2017). See table 1.2 and 1.3 for 










Table 1.3 KAR antagonists and subunit selectivity 
 
1.3.4 Localisation of KARs 
Due to the lack of specific antibodies for some KAR subunits, a comprehensive localisation 
at the synaptic and sub-synaptic level has not yet been established. Functional localisation 
studies have been carried out using electrophysiological approaches, which have shown 
pre-synaptic KARs modulating neurotransmitter release, and postsynaptic KARs mediating 
direct excitatory neurotransmission. Postsynaptically, KARs mediate EPSCS with 
characteristic small amplitude and slow decay kinetics (Castillo et al., 1997), which have 
more recently been attributable to the KAR auxiliary subunits, Neto1 and Neto2 (Zhang et 
al., 2009). These auxiliary proteins interact directly with KARs and modify the biophysical 




modulating gating properties (Copits et al., 2011, Fisher, 2015, Fisher and Mott, 2013). In 
the hippocampus, cortex, amygdala and EC (see below), KARs have been identified on both 
GABAergic interneurones and excitatory principal cells, particularly at hippocampal mossy 
fibre synapses on CA3 PCs (Schmitz et al., 2001a, Schmitz et al., 2000). Presynaptically, KARs 
have also been identified at both GABAergic and glutamatergic synapses where they act to 
facilitate or inhibit neurotransmitter release. At excitatory synapses, presynaptic KAR 
activation has been linked to synaptic plasticity processes (Kamiya, 2002, Contractor et al., 
2001). In particular, KARs, thought to be GluK2/3 heteromers, have been shown to act as 
autoreceptors at synapses on the mossy fibre-CA3 pathway, where they exert frequency 
dependent facilitation of glutamate release (Pinheiro et al., 2007). Activation of presynaptic 
KARs at inhibitory synapses have a dual influence on GABA release. 
In the hippocampus, activation of heteromeric GluK1/2 KARs leads to a depression of 
evoked IPSCs in CA1 PCs (Clarke et al., 1997, Mulle et al., 2000). Further to this, using paired 
recordings in at interneurone-PC synapses in the CA1 region, GluK1 KARs appear to have a 
biphasic effect, where low concentrations of KA (300 nM) facilitated GABA release at 
synapses where the release probability was low, but depressed GABA release at high 
release probability synapses at high concentrations (5 µM(Jiang et al., 2001). In this respect, 
it is thought that ambient or spillover glutamate released from excitatory synapses can 
modulate nearby presynaptic KARs at inhibitory synapses to protect over-excitation of local 
circuits. It has also been suggested that the biphasic effects could involve a metabotropic 
signalling pathway, but since the topology of the KAR is unlike that of the usual G-protein 
coupled receptors, this theory remains controversial (see (Rodríguez-Moreno and Sihra, 
2007). Nonetheless, Rozas et al. (2003) suggested that KARs containing the GluK1 (ion 
channel forming) subunit was able to signal through a second messenger cascade, 
indicating a non-canonical pathway. However, it is also important to mention that high 
concentrations (e.g. 5 µM) render KA non-specific for KAR, therefore the apparent biphasic 
effect on inhibitory neurotransmission could be due to its interactions with other 




1.3.4.1 KARs in the MEC 
In situ hydridisation studies have revealed KAR mRNA in neurones of the rat MEC, but the 
functional presence and roles of KARs in this area are only beginning to be revealed. One 
study revealed that evoked EPSCs in the superficial layers of the MEC had a slow 
component mediated by KARs, most prominently in LIII pyramidal neurones, though also 
present in SCs (West et al., 2007).  
A recent comprehensive study from this laboratory has identified the location and function 
of KARs in LIII of the MEC. Chamberlain et al. (2012) identified KARs containing the GluK1 
subunit as facilitatory autoreceptors at glutamatergic synapses on pyramidal neurones. In 
addition, the same receptors also mediated an excitatory drive at glutamatergic synapses 
on GABAergic interneurones. In contrast, a KAR, likely containing the GluK2 subunit, 
mediates a slow post-synaptic excitation at glutamatergic synapses on principal neurones, 
and is likely to also be act as a presynaptic heteroreceptor, facilitating GABA release at 
inhibitory terminals on principal neurones.  
These studies emphasise the diversity of KAR expression and function, and show KARs 
contribute to network function at multiple levels in LIII in the MEC. The role of KARs in 
synaptic and network function in other areas of the MEC is currently unknown. Thus, a 
primary aim of the experimental work in this thesis was to dissect out the localisation and 
functions of KAR in LII and LV of the rat MEC.  
The study by (Chamberlain et al., 2012), also showed that in conditions of low Mg2+ there 
was an enhancement in both GABA and glutamate release which showed rhythmic 
periodicity, dependent on KARs containing the GluK1 subunit, which has implications for 
regulation of KAR-dependent slow network oscillations and putative role for the receptors 
in oscillogenesis in the MEC. Indeed, KARs are likely to pay a major role in the generation 
and maintenance of synchronised neuronal network activity in the MEC (see below) 
particularly slow wave oscillations (SWO) and GFO. In addition, KARs have been identified 
as potential targets underlying the pathophysiology of disorders involving abnormal 





1.3.5 KAR and network synchronisation 
KARs are thought to be involved in both normal and pathological synchronisation of 
neuronal networks. The distinctive slow kinetics associated with KAR-mediated synaptic 
events enable temporal summation and the generation of oscillations at various 
frequencies. For example, oriens lacunosum moleculare (O-LM) interneurones within the 
hippocampus are tuned to operate at theta frequencies, which can be witnessed 
pharmacologically (in vitro) or locally (in vivo), but both rely on the activation of post-
synaptic KARs, in addition to the membrane properties of the O-LM cells themselves 
(Goldin et al., 2007). Further to this, EEG and single unit recordings in freely moving rats 
showed a significant decrease in the frequency of the theta modulation after bilateral 
intracerebroventricular injection of a GluK1 specific antagonist, UBP-304. Again, the root 
of the affect appeared to be due to a decrease in hippocampal interneurone discharges 
that were setting the pace for the theta oscillation (Huxter et al., 2007). This suggests GluK1 
KARs have an important role in modulating theta activity through their effects on 
interneurones.  
KARs have also been linked to SWO, spontaneous neuronal activity in the form of slow (<1 
Hz), synchronised network state transitions. Of particular interest, in an in vitro study, 
Cunningham et al (2006b) showed that activation of KARs was sufficient to induce the 
rhythmic bi-stability necessary for the generation of SWO within the network, likely due to 
the temporal summation enabled by the slow KAR-mediated excitatory events 
(Cunningham et al., 2006b). This suggests KARs could play a prominent role in the 
manifestation of SWO in the MEC.  
The most common type of oscillation associated with KAR activation is the GFO (30-80 Hz), 
thought to underlie important aspects of cognition relative to the area of the brain in which 
they occur. Importantly, these fast network oscillations can be induced in the MEC, 
independently of the hippocampus, with nanomolar doses of KA (Cunningham et al., 2003, 
Cunningham et al., 2004a). A further study showed that the generation and maintenance 
of these gamma oscillations in the MEC is critically reliant on KARs containing the GluK1 
subunit (Stanger et al., 2008), which, interestingly, is in contrast to the same oscillations in 




in the MEC. Middleton et al. (2008b) revealed two types of KA-induced GFO that differed 
in frequency with distinct underlying mechanisms defined by the type of interneurone 
recruited into the rhythm, either basket interneurones or goblet cells, which were 
dependent, or independent, on NMDAR drive, respectively (Middleton et al., 2008b).  
Despite this, more work is needed to determine the precise nature of KA-induced 
oscillations in the MEC, which was a specific aim of the work in this thesis. What is especially 
interesting about the use of KA in this model is that, whilst low concentrations induce a 
GFO, high concentrations push the network into a state of epileptogenesis, a phenomena 
which has been replicated in vivo. KAR activation is therefore a useful model of both 
oscillogenesis and epileptogenesis (Victor Nadler, 1981, Ben-Ari, 1985, Fisahn, 2005).  
1.3.6 KAR and epilepsy 
KARs have been associated with the generation of epileptogenic activity since the discovery 
of KA. It was soon realised KA is a potent analogue of glutamate with the ability to 
depolarise neurons, causing hyper-excitability and eventual cell death. It is these properties 
that make KA a viable and widely used tool for researching TLE, as they mirror 
pathophysiological aspects of the disorder in animal models. The discovery of KA actually 
pre-dated the discovery of the high affinity KARs to which it binds, which were later shown 
to distribute in areas that are susceptible to seizures, such as the hippocampus and the 
MEC (Monaghan and Cotman, 1982, Represa et al., 1987). Nowadays, it is well established 
that activation of KARs generates seizures in the limbic system (Ben-Ari, 2010). Research 
regarding KARs in the MEC is lagging behind other areas of the limbic system, so examples 
of their involvement in epileptogenesis can be drawn from these areas. Despite the delay 
in availability of pharmacologically specific agents, which has hindered research in this field, 
genetic and electrophysiological approaches have helped to identify two subunits as 
playing major roles in the context of hyperexcitability and epilepsy, namely the GluK1 and 
the GluK2 containing KARs. Firstly, transgenic GluK2 knockout mice showed a greatly 
reduced susceptibility to seizures, and hippocampal pyramidal neurones in the CA3 region 
became much less sensitive to the effects of systemic KA administration (Mulle et al., 1998). 
On the other hand, Cossart et al (1998). showed that GluK1-containing KARs were 




the excitability of principal cells due to an increase in tonic/phasic inhibition (Cossart et al., 
1998, Khalilov et al., 2002). These studies are indicative of pro- and anticonvulsive actions 
of KARs containing the GluK2- and GluK1- subunits, respectively.  
The main characteristic pathologies associated with TLE, in both animal models and human 
patients (post-mortem studies), include the reorganisation of the affected neuronal 
network, with some neurones’ fate being cell death, and others sprouting new, but 
aberrant, connections. Of significance, injection of KA in rodent models of TLE not only 
leads to the onset of recurrent seizures, but also sprouting of recurrent excitatory 
connections, specifically of mossy fibres onto CA3 pyramidal neurones and DGCs in the 
dentate gyrus. These profound rearrangements, due to activation of KARs, lead to 
increased excitation of these cell types via a form of frequency facilitation dependent on 
presynaptic KARs activation. In fact, long lasting KAR mediated synaptic currents (EPSCKA), 
originating from aberrant, recurrent mossy fibre synapses, have been recorded in 
chronically epileptic rats, which do not exist in naïve conditions. Hypothetically, the 
formation of aberrant mossy fibre synapses onto DGCs, after application of KA, leads to the 
formation of functional KAR operated synapses mediating the EPSCKA, which contributes to 
evoked, spontaneous and miniature glutamatergic synaptic transmission in chronically 
epileptic, and not naïve, rats (Sloviter et al., 2006, Stafstrom, 2006, Epsztein et al., 2005). 
Of note, dual LFP recordings in the EC and dentate gyrus of freely behaving mice showed a 
significant de-synchronisation of theta oscillatory activity after injection with KA, compared 
to controls, suggesting that on-going pathologic dynamics in epilepsy can affect 
physiological oscillations, beyond acute epileptiform activity (Froriep et al., 2012).  
Finally, autoradiography studies have also shown there to be an increase in KA binding sites 
in the CA3 region of the hippocampus of humans with TLE compared to controls, suggesting 
that this KAR mediated anatomical plasticity is not restricted to animal models (Represa et 
al., 1989). These connections have been identified due to the well-defined architecture of 
this pathway, but it is not unrealistic to suggest a similar contribution of KARs to the 
generation of seizures could be prevalent in the MEC, especially as seizure generation is 




cell loss and alterations in synaptic connectivity in the superficial layers of both human 
patients and KA-induced animal models of TLE (Tolner et al., 2007, Tolner et al., 2005).  
1.3.7 Desensitisation 
KAR-mediated synaptic responses have two main intrinsic characteristics distinguishing 
them from AMPAR-mediated currents: they are smaller in amplitude, and have slower 
deactivation kinetics. Furthermore, two distinct agonist binding affinities are apparent: 1) 
high affinity agonist binding leading to ion channel opening and 2) low affinity agonist 
binding site leading to a strong desensitisation (Mott et al., 2010). In the former 
mechanism, deactivation of the KAR commences following ligand unbinding and 
subsequent closing of the ion channel, whereas following desensitisation the agonist 
remains bound. In fact, some KAR agonists, e.g. SYM2081, induce such a fast 
desensitisation that they essentially act as an antagonist at these receptors (Zhou et al., 
1997). The relative contribution of deactivation and desensitisation rates to the time course 
kinetics of the synaptic current is related to the time course of glutamate in the synaptic 
cleft (Clements, 1996). For example, in brief (~1 ms) periods of glutamate elevation, 
deactivation kinetics will dominate, whereas after prolonged exposure to glutamate, 
desensitisation will act to limit the excitability of the receptor. The desensitisation time 
constants of KARs are approximately 10-fold slower than those of AMPARs and constitute 
a defining characteristic of this receptor. Pharmacological manipulation with concanavalin 
A relieves desensitisation of KARs containing the GluK1 and GluK2, but not the GluK3 
subunits, suggesting differences in glycosylation sites between receptor subtypes (Schiffer 
et al., 1997). Moreover, the GluK1 subunit has been associated with slower desensitisation 
responses compared with the GluK2 subunit (Swanson et al., 1996). The significant 
desensitisation and slow kinetics associated with KAR currents are critical factors 
determining the frequency and amplitude of excitatory responses, and may underlie a 
protective mechanism to prevent excitotoxicity (Jones and Westbrook, 1996).  
1.3.8 KARs and development 
A distinctive feature of a number glutamate receptors, including KAR, is a change in 




Molnar’s laboratory in Bristol has shown that GluK1 and GluK2 receptors in the 
hippocampus and other areas show a distinctive developmental profile, being low at birth 
and rising steadily during early development in juveniles but regressing to lower levels in 
full adult animals (Fig.1.6). A developmental profile of functional effects of KARs in the MEC 
has not yet been fully addressed, and is one of the main aims of this thesis. We are still 
hindered by the lack of pharmacological tools to study KAR subtypes, and so the focus is 
mainly on the GluK1-containing KARs, for which specific agonists and antagonists are 
available. The current available data on KAR expression focuses on either whole rat brain 
gene expression studies without lamina differentiation in the MEC, or functional 
electrophysiological studies on the immature rat hippocampus. In the former, the 
distribution of high-affinity KAR transcripts in the developing rat brain were examined, and 
flagged up some potentially interesting differences between expression patterns in 
embryonic and postnatal development compared with adult KAR subunit expression 
patterns, particularly regarding KARs containing the GluK1 subunit. In particular, there 
seemed to be a brief developmental increase in the expression of GluK1-containing KARs 
at around postnatal day (P) 12, which then decreased in expression into adulthood (Bahn 
et al., 1994). In support of this, immunohistochemical studies (unpublished) in the 
laboratory of Professor Elek Molnar at the University of Bristol established a differential 
developmental profile of KAR subtype expression in hippocampal areas of the rat brain, 
seeing a peak expression of the GluK1 subunit at P14 (Fig 1.6).  
Functionally, KARs have been postulated to play important roles in the development and 
maturation of neuronal circuits. Attention has focused on KAR control of glutamate release 
at immature MF-CA3 synapses. KARs on MFs are thought to act as auto-receptors that are 
tonically and constitutively activated by ambient glutamate which is present in higher 
concentrations in neonate neurones (Lauri et al., 2005, Lauri et al., 2006). Differences in 
KAR function have been identified in the hippocampus throughout development. In the 
immature hippocampus, KARs increase glutamatergic inputs to interneurones and, in doing 
so, encourage synchronised network activity. These precise mechanisms are 
developmentally downregulated in the mature hippocampus, and replaced by alternative 
modes to regulate such activity, attributed to somatodendritic KARs on interneurones 




activation and signalling of KARs during postnatal development accommodate their 
differential roles in the maturation of synapses and adult neurotransmission. These 
developmentally regulated KARs are thought to reside presynaptically, and act to fine tune 
neuronal circuitry by influencing what synapses are strengthened or eliminated in an 
activity dependent manner (for review see (Lauri and Taira, 2012)). Of course, this research 
has been conducted in the hippocampus, but it is not unrealistic to hypothesise a similar 
role for KARs in the MEC given their expression and role in network synchrony in this region. 
Clearly, there is a gap in the research vis-à-vis the function of KAR during development, 
especially lamina differences in the MEC, which this thesis will aim to address. 
Understanding KARs at a synaptic and network level will provide a basis for possibilities of 
pharmacological manipulations to control hyper-excitability and pathological 
synchronisation within brain circuits.  
To assess the state of functional activity at KARs in the EC we have taken advantage of the 
ability of KAR activation to induce GFO when applied at low concentrations, as described 
previously in a number of preparations (Cunningham et al., 2003, Hormuzdi et al., 2001, 
Cunningham et al., 2004a). This allows us to use GFO as a functional measure of overall 





Figure 1.5: Localisation of KAR subunits GluK1, GluK2, GluK2/3 and GluK5 
immunoreactivity at 8 stages of development in the rat hippocampus and MEC. Horizontal 
brain slices were immunostained with anti-GluK1, GluK2, GluK2/3 and GluK5 antibodies. 
Note the increased expression of the GluK1 subunit in the P14 MEC. Work (unpublished) 







1.4 Oscillatory Activity  
1.4.1 The EEG 
Synchronised rhythmic electrical activity in populations of neurones is known as oscillation. 
The electrical nature of the brain was discovered by Richard Caton in 1875, when he 
observed electrical currents from the skulls of living rabbits and monkeys (Caton, 1875). 
This pioneering observation laid the groundwork for psychiatrist, Hans Berger, to discover 
and record “brain waves” in humans, after his invention of the electroencephalogram 
(EEG), which is a method of recording electrical activity in the brain by placing electrodes 
on the scalp. The EEG is regarded as one of the most remarkable and momentous 
developments in the history of neurobiology and, along with magnetoencephalography 
(MEG) recordings, have empowered the detection of neuronal oscillations at different 
frequencies, namely: SWO, theta (θ), alpha (α), beta (β) and gamma (γ). Rhythmic activity 
within the brain is on-going, yet transient, and different frequencies often exist in parallel, 
with some rhythms being nested within others through relations between their amplitudes 
and phases. In these instances, the EEG signal can be filtered to focus on the desired 
oscillation, to gain information on the functional significance of that particular frequency 
of activity. Generally, states of sleep give rise to large amplitude but low frequency 
rhythmic activity, whereas states of attentiveness are characterised by low amplitude, high 
frequency rhythms. Essentially, it is thought that neuronal oscillations enable the brain to 
generate and sense temporal information, which acts as a prerequisite for ensuing actions 
and cognition.  
1.4.2 Neuronal oscillations 
Neuronal oscillations are coordinated electrical activity within a group of neurones and are 
thought to underlie important aspects of cognition and behavioural states across multiple 
systems (Whittington et al., 2011). The underlying mechanisms of these rhythms are 
therefore of great importance to understand the physiological basis of cognition. Dissecting 
out these mechanisms is not possible in humans using EEG, but the development of both 
in vivo and in vitro rodent models has allowed us to gain information about aspects of the 




electrophysiology allows for the reproduction of EEG-like oscillations in small, isolated 
sections of brain, which can be pharmacologically manipulated and observed at both a 
cellular and local network level. In general, endogenous oscillations enable the precise 
timing of neuronal action potentials, which is important for coding information specific to 
different brain regions and frequencies. 
The EC-hippocampal system is critically important for the formation and storage of 
memories, but this system is also fundamental in spatial navigation (Sasaki et al., 2015). 
The underlying mechanisms of both memory and spatial navigation have been separately 
associated with neuronal oscillations. An emerging idea is that this common mechanism 
could in fact converge these disparate directions and provide an overarching, coherent and 
functional picture of the MEC-hippocampal system. Whilst many frequencies of neuronal 
oscillations co-exist, the ones of particular importance to the MEC are SWO, theta, beta 
and gamma.  
1.4.3 Slow wave oscillations 
SWOs are forms of slow (<1 Hz), synchronous network state transitions expressed in the 
thalamus and the cortex, including the MEC, and are conserved between species (Zhu et 
al., 2006). These state transitions fluctuate between periods of intense, large amplitude 
neuronal activity (up-states), and almost complete silence (down-states). It is the cycling 
between these states that constitute the slow oscillation. SWOs are a prominent feature of 
deep sleep, in the absence of sensory stimulation, that occur as a consequence of recurrent 
excitation and local inhibitory connections in the areas they reside, which initiate and 
support patterned network activity (Neske, 2015). At the cellular level, up and down states 
have been attributed to fluctuations between depolarisation and hyperpolarisation of the 
membrane potential, and they have been identified in the MEC, in vitro. (Cunningham et 
al., 2006b). SWOs in the MEC have been linked with slow EPSPs mediated by KARs, were 
unaffected by NMDAR blockade in adult rat MEC, and were influenced by metabolic 
demand via the fluctuations in membrane potential mediated by ATP-modulated 
potassium channels (Cunningham et al., 2006b). Previous work by this research group has 
also investigated SWO in the MEC at the cellular level in immature animals (P9-13). Using 




MEC exhibited spontaneous synaptic activity that often summated into large depolarising 
events, similar to the ‘up-states’ described in the MEC much later (Jones and Heinemann, 
1989). In the immature EC, the synaptic events were abolished by NMDAR blocker, AP5, an 
effect that has been confirmed by work in this thesis, and also in similar network activity 
recorded from the neighbouring neocortex (Castro-Alamancos and Favero, 2015). 
Interestingly, the presence of these large NMDAR dependent events was inversely 
correlated to the age of the rat, which could be a result of a decrease in NMDAR population 
throughout development (Sucher et al., 1995). This could explain the difference in NMDAR 
sensitivity between the studies of Jones and Heinemann and (1989) Cunningham et al. 
(2006) as they were conducted in neonatal (P9-13) and adult rats, respectively. 
Nonetheless, the presence of SWO in the MEC is indisputable. The regional and functional 
roles of such oscillations are unclear, but are thought to involve aspects of learning and 
plasticity, particularly declarative memory consolidation during sleep, as well as being 
linked to neuronal metabolism and development (Cunningham et al., 2006b). Of note, 
SWOs have also been suggested to act as a “base frequency” that groups and modulates 
other oscillations, including beta/gamma activity (see (Neske, 2015, Takeuchi et al., 2015).  
 1.4.4 Theta Oscillations 
Theta oscillations are a prominent rhythm observed in the hippocampus and its 
surrounding limbic structures, including in the MEC, during exploratory behaviour and REM 
sleep, in both humans and rodents (Lega et al., 2012, Ekstrom et al., 2005). EEG studies 
suggest that the frequency of theta rhythms in humans (1-4Hz) is slower than that of 
rodents (4-10 Hz) (see (Jacobs, 2014)). Functionally, this rhythm is believed to have roles in 
the formation and retrieval of episodic, associative and spatial memories (Stella and Treves, 
2011, Backus et al., 2016, Hanslmayr et al., 2016). Despite this, the exact relationships to 
behaviour are still being delineated, but the theta oscillation could constitute a mechanism 
that underlies and links together these behavioural states (Hasselmo, 2005).  
The theta oscillation has most commonly been recorded from place cells in the 
hippocampus, but the MEC is garnering more attention following the discovery of grid cells. 
In the MEC, it is thought that spatial information is encoded, at least partly, by the precise 




most strongly modulated by the theta rhythm, however, interneurones from all layers fire 
relatively synchronously within the theta cycle (Quilichini et al., 2010). It is becoming 
increasingly apparent that the generation of the theta rhythm involves interactions from 
multiple brain regions, especially the medial septum-diagonal band of Broca (Stewart and 
Fox, 1990). More importantly, recent studies suggest the temporal organisation of 
hippocampal neuronal activity, particularly theta cycle rhythmicity and its associated 
spatial firing, is critically dependent on inputs from the MEC (Schlesiger et al., 2015, 
Fernández-Ruiz et al., 2017). The theta phase timing is therefore likely to be comprised of 
the interactions of upstream inputs with local mechanisms, which support memory and 
spatial navigation, and so cannot be fully explained by local in vitro models (Wang, 2010). 
For this reason, the circuit mechanisms of theta oscillations in the MEC are still unclear, but 
a prominent feature is their co-ordination with GFO. Indeed, this faster gamma rhythm (30-
80 Hz) appears to be nested within, and modulated by, the slower theta rhythm. It is 
thought this allows more effective activation of downstream neuronal targets in the 
hippocampus (Fries, 2009), as well as allowing multiple ‘items’ to be encoded on each 
gamma cycle (Lisman, 2005). The mechanisms linking theta-nested GFO and grid-cell firing 
patterns are receiving increasing amounts of attention, but are still up for debate. The most 
consistent model involves local feedback inhibition between SCs, in the absence of 
recurrent excitation, that can simultaneously generate grid cell firing fields through 
network attractor states (Pastoll et al., 2013b).  
1.4.5 Gamma Oscillations 
GFO occur during both awake and sleep states throughout the cortex, hippocampus and 
striatum, and appear to be modulated by sensory input (Lowet et al., 2015, Saleem et al., 
2017). It was this observation that lead scientists in the late 1980s to postulate that GFO 
could represent a mechanism that links the activity of single neurones, which fire 
synchronously in an assembly, to the nature of a sensory stimulus. In theory,  oscillations 
can efficiently bind together outputs of neurones that encode different features of a single 
perceptual entity (see (Singer and Gray, 1995)). Donald Hebb (1950) coined the term ‘cell 
assembly’ to describe a network of neurones which are repeatedly activated, in a near-




1996). The excitatory connections will be strengthened together thereafter, a mechanism 
which has implications for many cognitive processes in general (Hebb, 1950). GFO have 
been particularly related to sensory processes linked to attention (Tallon-Baudry et al., 
2005) and working memory (Howard et al., 2003).  
Whereas theta oscillations appear to have a large input dependence from other structures, 
the faster gamma rhythm can be generated in local circuits. This means that in vitro models 
of gamma generation can be transferred to different brain structures, e.g. the hippocampus 
and the MEC, and the underlying and regional mechanisms maintaining the rhythm can be 
studied using pharmacological and genetic manipulations (Traub et al., 2004). Experimental 
work has also informed computational modelling, which aims to identify properties 
determining the synchronisation and frequency of such oscillations (Whittington et al., 
2000). GFO can be generated reliably in vitro. There are three main modes, which differ in 
their mechanisms of interneurone excitation, or recruitment, into the rhythm and will be 
discussed in the following sections. Of note, although it is not the whole picture, it is 
generally accepted that the type of interneurones involved in GFO are the perisomatic 
targeting parvalbumin-containing basket cells due to their fast kinetics and inputs to target 
cells close to the action potential initiation site (for review see (Whittington et al., 2011).  
1.4.5.1 Interneurone network gamma 
As suggested by its name, interneurone network gamma, or ING, relies solely on the 
excitation of inhibitory neurones. This mechanism was described when Whittington et al. 
(1995) evoked GFO in hippocampal slice preparations by applying afferent stimulation. The 
emergent IPSP oscillation was driven by activation of inhibitory neurones by a 
metabotropic mechanism. In this model, GFO are mediated by GABAARs (and possibly gap 
junctions (Traub et al., 2001)) between interneurones, which are pharmacologically 
disconnected from pyramidal neurones by blockade of ionotropic glutamate receptors 
(Whittington et al., 1995). In a network of tonically active interneurones, the IPSP impinging 
on each cell is intrinsically linked to the activity of the interneurone it is connected to. In its 
most stable model, interneurones that are mutually coupled with GABAergic synaptic input 
will rhythmically synchronise their firing to each other, and can only generate an IPSP when 




IPSP is therefore determined by the GABAAR feedback kinetics, specifically their 
conductance, decay time and the initial excitatory drive delivered to the interneurone, but 
also the GABAAR subunit composition. The maximum frequency of the gamma oscillation 
is inversely proportional to the decay time constant of the IPSP (Whittington et al., 1995). 
As this model relies on the activity of interneurones without excitation from other cells, the 
intrinsic properties of the interneurones themselves must have enough drive to fire, even 
in the presence of the reciprocal inhibition. For this to work, the natural firing rates of the 
interneurones must be greater than that of the gamma rate. Further to this, although 
synaptic input from pyramidal neurones is not required for the ING model, the network of 
interconnected interneurones can generate a GFO in PCs by entraining their firing. In this 
way, PCs fire periodically when the IPSPs have decayed to their weakest point. For this to 
occur through an ING mechanism, which, remember, has no input from pyramidal 
neurones, the drive of the latter must be high enough to fire during moments of low 
inhibition, but not so high that they fire prior to the interneurones, as this would be 
contributing to the rhythm.  
Whilst it is possible the ING mechanism contributes to gamma activity in vivo, and it 
provides conceptually useful information, it is unlikely to have physiological relevance 
existing in isolation.  
1.4.5.2 Pyramidal-interneurone network gamma 
Unlike the ING model, pyramidal-interneurone network gamma, or PING, as its name 
suggests, involves a network containing populations of excitatory, as well as inhibitory, 
neurones, which are reciprocally connected to each other (Wilson and Cowan, 1972, 
Whittington et al., 2000). This model of GFO is a more relevant approach because local 
circuits throughout the brain generally exhibit dense reciprocal connections between 
interneurones and principal cells. A single basket cell can receive inputs from over 1000 PCs 
(Andersen et al., 2006). The PING model is essentially an adaptation of ING, where the 
reciprocal interneurone connectivity remains the same, but with the addition of fast, 
AMPAR-mediated phasic excitatory projections onto the inhibitory population. This fast 
excitation of interneurones, in turn, provides fast inhibition back onto the excitatory 




synapses. This interplay influences the network into an oscillatory state, but for this cyclic 
behaviour to occur, the amount of excitation and inhibition should be balanced. The 
presence of PCs seems to increase the stability of the network, as inferred by the degree 
of frequency attenuation in each model after pharmacological manipulation of GABAARs 
(Whittington et al., 1996). Moreover, the participation of pyramidal neurones, and the 
subsequent AMPAR-mediated fast EPSPs in interneurones, can theoretically lead to 
presence of spike doublets, or bursts, which allow long range synchronisation of spatially 
separate, but interconnected, brain regions, despite long conduction delays (Whittington 
et al., 1997b, Traub et al., 1996b). Unlike the ING model, PING requires excitatory input 
from pyramidal neurones, therefore the latter must recover from inhibition faster than the 
interneurones to provide this drive. The synaptic delay and axonal conductance between 
the EPSP and the resulting IPSP spikes, determine the properties of the rhythm (Ermentrout 
and Kopell, 1998, Leung, 1982). GFO where frequency is determined by the above factors 
are a prominent feature of both in vivo and in vitro rhythms (Bragin et al., 1995, Csicsvari 
et al., 2003, Mann et al., 2005).  
Both ING and PING models are critically dependent on the action and involvement of 
reciprocally connected GABAergic interneurones. The participation of either mechanism in 
the generation and/or maintenance of GFO is likely to be region and species specific. 
However, the critical differences between these mechanisms is that the specific type of 
neurones involved possess the intrinsic properties to pace the network into either rhythm 
e.g. whether neurones exhibit sub-threshold or threshold membrane potential oscillations 
(Whittington et al., 2011, Gloveli et al., 2005). Moreover, depending on the levels of 
excitation of either population of neurones, the ING and PING mechanisms can be 
interchangeable. 
1.4.5.3 Persistent gamma 
Persistent gamma (PG) oscillations can be generated in a stable fashion in vitro, lasting for 
several hours, by bath application of appropriate pharmacological agents, including: KA 
(nanomolar concentrations), carbachol (tens of µM) and dihydroxyphenylglycine (DHPG). 
These agents induce a stable GFO via tonic activation of KAR, muscarinic and mGlu 




has since been described in other regions including: the cerebellar cortex (Middleton et al., 
2008b), the neocortex (Traub et al., 2005), the basolateral amygdala (Randall et al., 2011) 
and, most importantly for this thesis, the MEC (Cunningham et al., 2003, Cunningham et 
al., 2004a). In vivo, PG appears at first to be following a PING mechanism, where 
interneurones are not tonically active but receive stimulation via large compound phasic 
excitatory inputs from principal cells at a gamma frequency (Bragin et al., 1995). However, 
several mechanistic differences have been recognised in PG, the main one being its high 
dependency on conductance between gap junctions, the phylogenetically oldest form of 
neuronal communication (Draguhn et al., 1998, Traub and Bibbig, 2000). Indeed, bath 
application of the gap junction blocker, carbenoxolone, abolished PG rhythms (Traub et al., 
2000, Cunningham et al., 2003). The maintenance of PG therefore depends on chemical 
synapses and electrical coupling between both principal cells (axonal) and interneurones 
(dendritic) (Traub et al., 2001). Gap junctions connecting the axons of principal neurones 
form the axonal plexus, through which action potentials can propagate (Traub et al., 1999). 
As mentioned, the PG mechanism critically depends on large phasic EPSPs onto 
interneurones, however, the somatic spike rates (0-4 Hz) of principal cells converging onto 
these cells are too low to account for this amount of excitation. This discrepancy can 
perhaps be partially explained by gap junctions, because action potentials can propagate 
through gap junctions to other cells, producing activity in these cells without direct synaptic 
input. Interestingly, models of PG often have very fast oscillations, (100-200 Hz), nested 
within the gamma rhythm, including in the MEC (Cunningham et al., 2004a), which has also 
been attributed to the presence of gap junctions in computational models in other brain 
regions (Traub et al., 1999, Traub et al., 2008). 
The model of PG relevant to this thesis is induced by activation of KARs by bath application 
of nanomolar concentrations of KA to the MEC-hippocampal brain slice. A lamina profile of 
KA-induced GFO in the MEC was determined by Cunningham et al. (2003). They found a 
general increase in gamma power in the superficial compared to the deep layers, with the 
highest power residing in LIII. In all layers, the strength of the gamma power peaked in the 
medial portion of the MEC, and diminished as the electrodes were moved laterally. 
Microlesions between the MEC and the hippocampus had no effect on the gamma power, 




GFO was also determined and revealed that, as in studies in the hippocampus, GFO is highly 
dependent on the synchronised output of interneurones, and phasic excitation onto such 
interneurones (Cunningham et al., 2003). Additional studies have also shown KA-induced 
GFO in the MEC to be dependent on the GluK1-containing KAR receptor, using a subunit 
specific antagonist, UBP302 (Stanger et al., 2008). 
1.4.6 GFO and CNS disorders 
1.4.6.1 Schizophrenia 
Alterations in GFO have been associated with various CNS disorders in humans and animal 
models of disease, particularly AD and schizophrenia. Combinations of clinical 
electrophysiological, MRI-based and post-mortem studies on patients with schizophrenia 
have identified abnormal gamma band activity that has been attributed to impaired 
GABAergic neurotransmission, particularly relating to PV-containing interneurones (Gloveli 
et al., 2005, Hashimoto et al., 2003). Convergent evidence suggests impairment in GFO 
could underlie many of the symptoms and fundamental cognitive deficits witnessed in 
patients with schizophrenia (Uhlhaas and Singer, 2010). Gamma activity is thought to allow 
feature binding, whereby sensory inputs are united to perceive information correctly. To 
do this, the inputs must be discharged synchronously, but in patients with schizophrenia 
there are problems regarding integration of the sensory information, which perhaps leads 
to symptoms of hallucinations, thought disorder and disorganisation (Taylor et al., 2013).  
As well a deficit in PV-containing interneurones themselves, deficits in the glutamatergic 
input to this subset of cells have been proposed to play an upstream role in the 
pathophysiological mechanisms underlying abnormalities in GFO in schizophrenia. NMDAR 
hypofunction on inputs to PV-containing interneurones appear to mimic aspects of the 
disorder in healthy subjects, and exaggerate symptoms in schizophrenia patients (Coyle, 
1996, Krystal et al., 1994). Moreover, schizophrenia-associated genetic loci have been 
identified, and appear to be associated with glutamatergic, and not GABAergic, 
neurotransmission (Schizophrenia Working Group of the Psychiatric Genomics, 2014). In 
line with this, animal models of the disease have implicated PV-containing interneurones 




activity. In particular, a study by Cunningham et al. (2006a) found a significant reduction in 
the power of gamma activity in both a genetic (LPA1-decicient mice) and an acute (NMDAR 
antagonism) animal model of schizophrenia. What is particularly interesting about these 
models is that the observed deficits in PV-containing interneurones, and the resulting 
reduction in gamma activity, was specific to LII of the MEC, and showed no deficits in the 
hippocampus (Cunningham et al., 2006a). This suggests abnormal GFO residing in the 
superficial layers of the MEC may be involved in the network dysfunction leading to the 
onset of schizophrenia. Caution should be taken when looking at models of schizophrenia-
like symptoms, however, because they show variable effects on gamma rhythms which 
depend on the brain region studied and the source of excitation initiating the oscillation 
(Cunningham et al., 2006a, Hunt et al., 2017). Models of schizophrenia are often based on 
post-mortem markers, for example parvalbumin immunopositive cell number and GAD67, 
the latter of which is also expressed in somatostatin and calretinin-containing 
interneurones, thus calling into the reliability of such models. 
In addition, evidence for disruptions in network oscillations specifically at a gamma 
frequency is not a consistent pathology across all patients with schizophrenia, but rather 
disruptions across multiple bandwidths are evident, especially delta and theta oscillations, 
though again, not consistently. Indeed, interdependent rhythms often nested within each 
other and can dynamically and mechanistically influence each other and the co-ordinated 
activity between brain regions. It has therefore been proposed that the disruption of 
broader, pathway-specific cross-frequency oscillatory activity may more accurately link 
network dysfunction to the underlying pathology of schizophrenia. See Hunt et al. for a 
review on ‘aberrant network activity in schizophrenia’ (Hunt et al., 2017). Nevertheless, 
abnormal network synchrony is prevalent in both patients and models of schizophrenia, so 
understanding the physiological development of gamma oscillations in the cortex could 
provide region-specific insights into the development of cognition and associated diseases.  
1.4.7 Neuronal synchrony and development 
Neuronal oscillations are thought to have major roles in shaping the maturation of cortical 
networks during many stages of development by a process known as spike timing 




activity which leads to the modification of synapses. Stimulation of neurones during the 
peak or the trough of theta or GFO, for example, can determine whether a synapse is 
strengthened or weakened, respectively. Presentation of aberrant neural oscillations at 
critical points of development could, therefore, lead to imprecise STDP and the pathological 
modification of neuronal networks (Uhlhaas and Singer, 2010). 
During normal development, a significant increase in theta and gamma band activity, and 
long-range synchronisation, has been identified at the stage of early adulthood. This is 
followed by a significant decrease in beta and gamma band activity during late adulthood, 
which is thought to represent a transient destabilisation period of development occurring 
prior to the emergence of a mature cortical network (Uhlhaas et al., 2009). Perhaps then, 
in a network unable to support such changes in gamma activity, a break-down in the 
temporal dynamics of the network during these critical periods of development could lead 
to abnormal cognitive functioning, as seen in schizophrenia. Normal brain development 
relies on the dynamic interplay between developmentally directed gene expression and 
brain activity itself, either of which could be affected by intrinsic errors or even external 
factors. For example, chronic early life stress is a risk factor for many psychiatric illnesses 
including bipolar disorder, depression and schizophrenia, and has been recently correlated 
to a disruption in the maturation of GFO in the hippocampus (Dricks, 2016). Again, post-
mortem studies in chronically stressed rats, and in humans with schizophrenia, show a 
reduced number of PV-containing interneurones. Basket cells are the proposed cellular 
substrate underlying GFO, and postnatal development of such cells promotes striking 
changes in their morphological, intrinsic and synaptic properties. Most importantly, the 
maturation of basket cells leads to a conversion from slow into fast IPSCs, thus promoting 
coherent activity in the gamma frequency band (Doischer et al., 2008).  
Clearly, disruption of the excitatory-inhibitory balance will affect the precise timing of 
synchronised network activity, such as a GFO, which, if occurring at critical points during 
development, will have detrimental effects on the development of cognitive processing. 
Although there is a comprehensive developmental profile of the maturation of GFO in the 
hippocampus (Tsintsadze et al., 2015), there is currently no such profile in the MEC, and 




development of GFO in the MEC will help us understand the development of cognition, but 
also understand the roles of such rhythmic activity in structuring the development of this 
area of the brain. Furthermore, this knowledge can be applied to help understand 























2.1 General methods 
This project has investigated of role of KARs in network activity in LII and LV of the rat MEC 
in vitro using recordings from both single neurones (whole-cell patch clamp) and 
population activity (local field potentials). The focus has been on developmental changes 
and both approaches have been applied in brain slices from rats aged P8 to P27. 
2.1.1 Animals 
All experiments were performed in vitro using brain slice preparations from both male and 
female Wistar rats (aged 8-28 days old and weighing ~20-110 g) bred in the Biosciences 
Service Unit at the University of Bath. The rats were group-housed in cages on a 12-hour 
light-dark cycle (07:00-19:00 lights on) and provided with food and water ad libitum. 
Animals aged P23-27 were weaned but all animals under this age remained with the 
maternal parent until required for use, and were not cross-fostered. Careful note was taken 
of animal age, weight, sex (no conscious effort was made to select either males or females), 
and whether eyes were open or not at time of use.  
Male and female rats attain sexual maturity at approximately >P50 (Zemunik et al., 2003) 
and >P38 (Rivest, 1991). Therefore sex specific physiological influences on brain activity, 
for example the effects of neurosteroids on GABAergic neurotransmission (Gunn et al., 
2011), will not contribute to variability in this study, and justifies the use of both male and 
female rats (Becker et al., 2016, Beery and Zucker, 2011). Animals were removed from the 
animal facility and transferred in a covered cage to the experimental laboratory on the day 
required.  
2.1.2 Ethics Statement 
All experiments were performed under a home office license in accordance with the U.K. 
Animals (Scientific Procedures) Act 1986, European Communities Council Directive 1986 
(86/609/EEC) and conformed with the ethical review procedures of the University of Bath. 
Every effort was made to ensure that only the minimum number of animals was used and 




consideration of 3Rs guidelines. The use of animal tissue for research at the University of 
Bath requires a consideration of ethical implications by both the principal investigator, and 
second assessor, external to the group, plus a review and approval from the Head of 
Department, preceding further review by the a Research Ethics Officer. A report has to be 
submitted to the University Ethics Committee before experimental work is allowed to 
proceed, ensuring that ethical implications and processes for managing ethical issues and 
animal welfare have been properly considered. All experiments in this thesis were 
conducted on brain tissue removed following Schedule 1 procedures (cervical dislocation 
preceding decapitation). The experimenter was required to be trained by in-house staff in 
the animal facility and deemed competent in these procedures before engaging in animal 
usage. 
2.2 Slice preparation 
Combined MEC-hippocampal slices were obtained from either male or female Wistar rats 
(as above) using an approach described previously (Jones and Heinemann, 1988). Cervical 
dislocation was followed by decapitation and rapid removal of the brain into ice-cold (4˚C) 
oxygenated (carbogen gas - 95% O2, 5% CO2) sucrose-based ACSF (see section 2.4 for 
composition). The cerebellum was removed and the cerebral hemispheres were separated 
using a scalpel blade. A small amount of tissue was then removed from the dorsal surface 
of the two hemispheres, cutting parallel to the base of the brain, to create a flat surface 
prior to gluing the hemispheres onto a metal slicing block using cyanoacrylate glue with 
ventral side upwards. The block was then rapidly loaded into the slicing chamber of a 
Camden Vibroslice (CI7000 SMZ2) filled with chilled, oxygenated sACSF (for composition 
see Section 2.4).  
400 µM thick horizontal slices (Fig. 2.1) were cut automatically at ultra-slow advance speed 
(0.15 mm/sec) using a vibration frequency of 80 Hz and displacement of 2 mm. The slice 
thickness permits a good compromise between maintaining both the local circuitry needed 
to generate oscillatory activity and sufficient oxygenation of the tissue. The cutting 
parameters were selected on the basis of test experience to give the best tissue 




Slices were cut and discarded until the ventral portion of the hippocampus and rhinal 
fissure were visible. Slices thereafter were trimmed with a scalpel to leave the MEC-
hippocampus slice containing the following brain areas: ventral hippocampus, dentate 
gyrus, parahippocampal regions (subiculum, presubiculum, and parasubiculum), the 





Figure 2.1: The horizontal brain slice preparation. The rat brain was cut along the 





2.3 Slice maintenance and storage 
Following dissection, slices were immediately transferred to a holding chamber (BSC-PC, 
Warner Instruments) containing ACSF (see 2.4 for composition) at room temperature. The 
chamber was bubbled continuously with carbogen gas producing a circular flow of 
oxygenated ACSF to the slices, which retained excellent viability for up to 8 hours. Slices 
were left to equilibrate for at least one hour before use in the holding chamber and were 
then transferred individually to the recording chamber when required (Fig. 2.2).  
 
 
Figure 2.2: Schematic diagram of the BSC-PC slice holding chamber 
 
2.4 ACSF 
The core artificial cerebrospinal fluid (ACSF) used for recording was a Krebs bicarbonate 
buffer composed of (in mM) NaCl (126), KCl (4), MgSO4 (1.25), NaH2PO4 (1.4), NaHCO3 (24), 




taurine (1), ascorbic acid (0.57) were added to maintain cellular metabolism and increase 
cell survival and viability.  
Two variations of this recipe were used during the dissection and when storing the slices in 
the holding chamber. To store the slices, normal ACSF (above) was used with the addition 
of the anti-oxidant, n-acetyl cycsteine (6 µM) and the nonsteroidal anti-inflammatory drug 
indomethacin (45 µM), again to facilitate neuronal survival and slice viability.  
During the brain dissection and slicing procedure a modified and protective sucrose based 
ACSF (sACSF) was used, composed of (in mM) sucrose (206), KCl (2), MgSO4 (1.6), NaH2PO4 
(1.25), NaHCO3 (26), CaCl (2.25), glucose (10) and sodium pyruvate (5). In sACSF, NaCl was 
replaced by an equimolar concentration of sucrose to reduce the activity of Na+/K+ pumps, 
metabolic demand and general excitotoxic damage which leads to swelling and pyknosis. 
Additionally, n-acetyl cycsteine (6 µM), indomethacin (45 µM), the NMDAr channel blocker, 
ketamine (150 µM) and the ATP-gated P2X(7) receptor blocker, Coomassie Brilliant Blue 
(250 nM), were added as they provide notably improved neuronal preservation. We have 
previously established that the additives that we have used in our solutions facilitate 
production of viable, robust and high quality slices, but have no apparent direct effects on 
the pharmacology of glutamatergic or GABAergic transmission (Jones R.S.G. and Woodhall, 
G.L. unpublished observations). 
All ACSF solutions had osmolarities between 300-310 Osm. The ACSF solution used for 
recording had a pH of 7.3-7.4 at 31±1oC. A summary of the composition of the three ACSF 





Table 2.1: Composition of ACSF solutions 
2.5 Whole cell patch clamp recording 
2.5.1 General details and usage 
At the single cell level, the ability of KARs to modulate the release of the neurotransmitters, 
glutamate and GABA, from synaptic terminals has been determined. To monitor 
transmitter release, whole-cell voltage clamp recording of spontaneous synaptic currents 
was used (Fig. 2.3). A high resistance electrical seal is formed between the patch clamp 
pipette and the cell membrane of the neuronal cell soma. This is achieved by pressing the 
glass pipette against the cell surface and applying negative pressure to form a gigaseal. The 
membrane under the tip of the patch pipette is then ruptured by increasing the negative 




with the membrane of the neurones allowing the recording of individual synaptic currents 
across the whole surface of the cell body and dendritic tree with high resolution and low 
noise. Currents with amplitudes as small as 2-3 pA can be reliably recorded this way. 
Additionally, the neuronal cytosol and the electrolyte solution in the pipette reach a 
diffusional equilibrium.  
 
Figure 2.3: Whole-cell patch clamp. A tight contact, or gigaseal, is formed between the 
pipette and the plasma membrane (left). In whole cell configuration, negative pressure is 
applied to achieve access into the neurone and a diffusional equilibrium is reached with the 
solution in the pipette and the interior of the cell.  
In voltage clamp mode the current passing through open ion channels on the postsynaptic 
cell, as neurotransmitters spontaneously released from presynaptic terminals interact with 
postsynaptic receptors, can be recorded. In most cortical neurones these comprise both 
spontaneous excitatory postsynaptic currents (sEPSCs) and spontaneous inhibitory 
postsynaptic currents (sIPSCs) mediated by glutamate or GABA, respectively. 
Recording spontaneous synaptic currents provides a means of looking at both pre and 
postsynaptic changes at GABA and glutamate synapses. Alterations in time course and 
amplitude of spontaneous events are generally an indication that the postsynaptic 




activity is altered in the absence of an overt change in amplitude, it can be concluded that 
presynaptic release properties are being targeted.  
Spontaneous neurotransmitter release is comprised of two components. Firstly, 
spontaneous events can arise as a consequence of action potentials, generated in the soma 
or axon of the presynaptic neurone, invading the presynaptic terminal and opening voltage 
gated calcium channels (VGCC) initiating release that is usually multi-quantal. The second 
component is independent of action potentials and extracellular calcium, although there is 
still debate over how absolute the latter property is. These events reflect mono-quantal 
release of transmitter, and may depend on calcium sources inside the terminal. 
Experimentally, the action potential-dependent component can be removed by blocking 
voltage gated sodium channels (VGNC) with TTX, thus isolating the action potential-
independent events. These are usually referred to as “miniature” events, and can be seen 
at both excitatory glutamate (mEPSCs) and inhibitory GABA synapses (mIPSCs). The 
advantage of recording mPSCs is that it rules out drug effects at pre-terminal areas, 
eliminates the possibility of network driven activity, and identifies sites of action as directly 
on the synaptic terminal. 
These approaches have been used here to pharmacologically dissect out the contribution, 
location and function of KARs to modulation of neurotransmitter action at both excitatory 
and inhibitory synapses in the rat MEC. To achieve this, various agonists and antagonists 
for ligand gated ion channels were used (see section 2.7).  
2.5.2 Neurones recorded 
All experiments were conducted on neurones in layer II or layer V of the MEC. Specifically 
identifying neurones by morphology after dye injection was not attempted. However, the 
neurones were selected on the basis of roughly identifiable PC or SC morphology when 
viewed with DIC and are believed to be largely glutamatergic principal neurones. Neurones 
were selected for whole cell patch clamp based upon healthy, undamaged appearance. It 
is possible that occasional neurones recorded were interneurones, but these generally 
have very high baseline frequencies of synaptic currents, and any abnormal recordings 




2.5.3 Experimental details 
For patch clamp recordings, individual slices were transferred from the holding chamber to 
a recording chamber where they were submerged in a continuous flow (2ml/min) of 
oxygenated (95% O2, 5% CO2) ACSF re-circulated from a small reservoir. Slices were held in 
place in the chamber with a slice anchor constructed from a thin U-shaped piece of stainless 
steel with several very thin strands of nylon thread glued across it. The ACSF was 
maintained 31 ± 1 ˚C using an inline heater (SH-27B, Warner Instruments) and a feedback 
power supply (TC-324, Warner Instruments). This temperature establishes a good 
physiological environment without compromising the longevity of the tissue. The whole 
circulating volume, including the reservoir, was ~10 ml and the volume of the recording 
chamber was ~0.5-1.0 ml. Slices were allowed to equilibrate at the recording temperature 
for at least 30 minutes under these conditions before recording commenced.  
The recording chamber was mounted on an upright BX50WI Olympus microscope and 
neurones were visualised using a CCD infrared video camera (KP-M1E/K, Hitachi Kokusai 
Electric Inc.) and differential interference contrast (DIC) optics. Visual contrast was 
enhanced by use of an SP-11 video processor (Kramer Electronics Ltd; Israel). All neurones 
in this thesis were recorded in LII and LV of the MEC (unless stated otherwise) using an 
Axopatch 200B amplifier in voltage clamp configuration. A silver pellet electrode was 
placed in ACSF at the inlet to the recording chamber to act as a reference zero (‘ground’) 
current level. Whole cell patch-clamp pipettes were pulled from borosilicate glass pipettes 
(PG120, 1.2mm O.D x 0.93 mm I.D., Harvard Apparatus), with an open tip resistance of 1-4 
MΩ, using a Flaming/Brown microelectrode puller. The pipettes were filled with the 
appropriate intracellular solution optimised for the desired postsynaptic current (PSC) 
recordings (see below). The filled pipettes were then inserted onto a microelectrode 
holder, forming an electrical connection via a chlorinated silver wire, and then loaded onto 
the head stage of the amplifier. 
When a suitable neurone was identified a seal test was applied and the patch pipette was 
advanced under visual control and with positive pressure applied, to make contact with the 
surface. Negative pressure was then applied to attempt to achieve a gigaseal whilst 




before further negative pressure was applied to rupture the patch. Neurones were then 
voltage clamped at -60 mV and the recording allowed to equilibrate for 15-20 minutes 
before data was acquired. Access resistance was monitored at 5-minute intervals 
throughout recording and if it varied by greater than 15% neurones were excluded from 
analysis. Series resistance compensation was not used. Input resistances for the neurones 
recorded in these studies were of the order 500-700 MΩ.  
Drugs were added directly to the perfusion ACSF reservoir and each treatment was applied 
for at least 15-20 minutes before washing out. 
2.5.4 EPSCs 
To record sEPSCs, patch pipettes were filled with a Cs gluconate-based patch solution 
containing (in mM) D-gluconate (100), HEPES (40), QX-314 (1), ethylene glycol tetracetic 
acid (0.6), NaCl (2), MgCl2 (5), tetraethylammonium-CL (5), phosphocreatine (10), ATP-Na 
(4), GTP-Na (0.3). The pH was adjusted to pH 7.3 with CsOH and diluted to 275-295 mOsm 
before use. To improve space clamp and to allow resolution of small events generated at 
distal dendritic sites, Cs and QX-314 were included in the patch solution to block potassium 
channels and VGNC, respectively.  
In neurones clamped at -60 mV sEPSCs were recorded as inward currents. These are 
primarily mediated by sodium ions passing through AMPA receptors activated in response 
to spontaneous glutamate release from presynaptic terminals (see Berretta and Jones 
1996). Action potential-independent events, or mEPSCs, were recorded by blocking VGNC 
with bath perfusion with TTX (1 µM). 
2.5.5 IPSCs 
To record sIPSCs, patch pipettes were filled with a Cs-based patch solution containing (in 
mM): CsCl (100), HEPES (40), QX-314 (1), EGTA (0.6), TEA-Cl (10), MgCl2 (5), ATP-Na (4), and 
GTP-Na (0.3). The pH was adjusted to pH 7.3 with CsOH and diluted to 275-295 mOsm 
before use. In neurones clamped at -60 mV, IPSCs were recorded as outward currents (high 




through GABAARs consequent upon their activation by GABA, spontaneously released from 
presynaptic terminals. SYM2206 (20 µM) and DL-AP5 (40 µM) were added to the perfusion 
ACSF to block AMPAR and NMDAR receptors, respectively, and permit recording of sIPSCs 
uncontaminated by the presence of glutamatergic sEPSCs. Activity-independent mIPSCs 
were isolated by the addition of TTX (1 µM). 
2.5.6 Data acquisition and analysis 
Signals were filtered at 2 kHz and digitized at 50 kHz using a Digidata 1440A A-D converter 
(Axon Instruments). Data were recorded direct to computer hard drive using AxoScope 
software. PSCs were analysed off-line. Minianalysis software (Synaptosoft, Decatur) was 
used to detect PSCs using a threshold-crossing algorithm. Threshold varied from neurone 
to neurone but was maintained at a constant level once set for any individual neurone 
analysis. Threshold was usually set at a level around 2.5 times the baseline noise. As a 
general rule, at least 200 events were accumulated and analysed in any given situation 
(control v drug) although in neurones with low baseline rates this was not always possible. 
In these cases the number of events in control and drug situations was matched as closely 
as possible.  
Miniature and spontaneous EPSCs and IPSCs were detected using a threshold of 3-7 pA and 
all records were manually inspected to eliminate clearly or suspected non-biological events 
from analysis. The following parameters were detected: frequency, assessed as events per 
minute, amplitude (pA), decay time (ms), rise times (ms) and holding current (pA) and were 
analysed via the nonparametric Kolmogorov-Smirnov test (KS-test) of the cumulative 
probability distribution, constructed from ~200 events from each neurone. Significant 
differences from control obtained via KS-tests are represented as asterisks on histograms 
and assigned when p ≤ 0.01. EPSC/IPSC rise times were calculated as time between 10 – 90 
% of maximum current while decay times taken as time for current to decay 33.3%.  
Pooled data for each treatment group were compared using the means of each parameter 
in each neurone. Data are presented as a percentage change from control level before drug 
application. Errors represent the standard error of the mean (SEM). Statistical comparisons 




data which had been derived from the same slice or cell i.e. before and after addition of 
drugs. Two-way ANOVA analysis was used when comparing groups that were influenced by 
two different independent variables (e.g. time and age). Between slice changes were 
assessed using a Mann Whitney rank sum test. Significance was set at a level of P < 0.05 
and signified by an asterisk.  
2.6 Local field potential recordings 
2.6.1 General details and usage 
To monitor functional changes in KARs in network activity within local MEC circuitry, 
throughout development, we used KA to induce oscillatory activity in neuronal networks. 
These oscillations represent synchronous population activity in thousands of neurones and 
the electrical events reflect the extracellular voltage changes occurring as the summed, or 
‘net’, electrical current flow in multiple neurones. They were recorded extracellularly as 
local field potentials (LFP) using low resistance glass microelectrodes filled with ACSF and 
inserted into the specific areas of interest.  
2.6.2. Experimental details 
Slices were prepared and stored in exactly the same way as for the whole-cell patch clamp 
experiments. In most experiments, two slices were placed on a layer of lens paper in an 
interface-type recording chamber (BSC2, Digitimer Ltd. UK), where they were maintained 
at the interface between a continuous perfusion (1.2-1.4 ml/min) of oxygenated (95% O2, 
5% CO2) ACSF and warm humidified carbogen gas. The perfusion solution was recirculated 
from a storage reservoir (50 or 100 ml) in a water bath maintained at 25±1oC.  
Extracellular LFP recordings were made using microelectrodes pulled from borosilicate 
glass pipettes (PG120, 1.2mm O.D x 0.93 mm I.D., Harvard Apparatus) with a resistance of 
1-4 MΩ, using a Flaming/Brown microelectrode puller. The pipettes were filled with normal 
ACSF. Separate electrodes were placed in LII and LV MEC of the same slice under visual 
control using a Leica MZ8 binocular microscope (Fig. 2.4), and using Narishige 




temperature in the interface chamber before being warmed gradually to 31±1˚C using a 
PTCO3 temperature controller (Digitimer Ltd. UK) which warmed a water reservoir in the 
bottom of the recording chamber through which the perfusion ACSF was circulated. 
 
Figure 2.4: Diagrammatic representation of the combined MEC-HC brain slice. Figure 
shows the positioning of the electrodes for LFP recordings in layer II and V MEC.  
 
2.6.3 Generation of oscillatory activity 
Control recordings of baseline activity were made for at least 20 min prior to the addition 
of any pharmacological agents to ensure the oscillatory activity was a result KAR activation, 
and not spontaneous network activity. Oscillatory activity was induced by perfusion with 
KA (400 nM) bath applied via the circulating reservoir of ACSF. One-minute epochs of 
activity were recorded at 15 min intervals during the establishment and maintenance of 
oscillatory activity, and analysed immediately for amplitude and frequency. Drug 
treatments were only applied when the oscillatory activity had stabilised i.e. the amplitude 
and frequency was within 15 % variability in 3 consecutive recordings.  
2.6.4 Data acquisition and analysis 
LFPs were recorded using an EXT-02 extracellular amplifier (NPI Electronic). Signals were 
low pass filtered at 0.5 kHz and digitised at 10 kHz using a Minidigi 1B digitizer (Molecular 





LFP recordings were quantified on the amplitude of the modal peak and the peak frequency 
of the oscillation. Power spectra were created from 1-minute epochs of raw data using a 
fast Fourier transformation (FFT) algorithm, from which measurements of amplitude and 
frequency could be determined directly from the peak. FFTs convert the time domain of 
the original signal into a representation in the frequency domain by deconstructing the 
waveform of the oscillation into a series of sine and cosine functions. The phase 
information inherent in the analysis was removed, and the magnitude squared for each 
frequency component was used to determine the power distribution. The amplitude is 
expressed as the sum of the voltage squared at each frequency band (µV2/Hz), which, in 
this thesis, were theta (4-10 Hz), beta (12-30 Hz) and gamma (30-80 Hz). 
Pooled data for each treatment group were compared using the means of each parameter 
in each slice. Data are presented as a percentage of control level (before drug application). 
Error bars represent the SEM and ‘within slice’ comparisons were made using ANOVA and 
Student’s paired t-test. Comparisons made between different slices and age groups were 
made using the non-parametric Mann-Whitney test. 
2.7 Drugs and solutions 
All ingredients for patch solutions were obtained from Sigma, and ACSF salts were obtained 
from Sigma or Fisher Scientific. Ketamine was purchased from Dodge Animal Health Ltd.  
Drugs were made up as stock solutions, either distilled water (dH2O) or dimethyl sulfoxide 
(DMSO; Sigma, UK), stored in aliquots at -20 ˚C and diluted to the desired concentration 
the ACSF reservoir immediately prior to perfusion 
ATPA: ((RS)-2-Amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid), Tocris, UK. 
dH2O stock solution. Selective GluK1 agonist.  
Bicuculline: ([R-(R*,S*)]-6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-





DL-AP5: (DL-2-Amino-5-phosphonopentanoic acid), Tocris, UK. dH2O stock solution. 
Selective, competitive NMDAR antagonist. 
GYKI 52466: dihydrochloride (4-(8-Methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)-
benzenamine dihydrochloride). Tocris, UK. DMSO stock solution. Selective, non-
competitive AMPAR antagonist. 
KA: (Kainic acid), Tocris, UK. dH2O stock solution. Agonist at KAR.  
SYM 2206 ((±)-4-(4-Aminophenyl)-1,2-dihydro-1-methyl-2-propylcarbamoyl-6,7-
methylenedioxyphthalazine). DMSO stock solution. Tocris, UK. Non-competitive AMPAR 
antagonist. 
TTX (Tetrodotoxin), Alomone Labs., Israel. dH2O stock solution 
UBP-310: ((S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxy-thiophene-3-yl-methyl)-5-
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3.1 Introduction  
A surge of attention has focussed on the pathological role of the MEC in a number of 
psychiatric and neurological disorders. Neurones in LII have a selective vulnerability to 
aging and AD, showing the earliest evidence of regional atrophy which is associated with 
age-related memory dysfunction (Stranahan and Mattson, 2010). Both LI and LV are 
functionally implicated in the development of TLE in both patients and animal models (Pilli 
et al., 2012, Armstrong et al., 2016). MRI studies have shown abnormally decreased 
volumes of the EC in patients with schizophrenia, which is not apparent in the hippocampus 
or in healthy controls (Baiano et al., 2008). Enhanced understanding of the development of 
the MEC can inform the interpretation of the predisposition of MEC neurones to many 
psychiatric disorders, including AD, epilepsy and schizophrenia, which can be used to 
develop more targeted therapeutics.  
The aim of this chapter was to compare the baseline characteristics of sEPSCs in LII and LV, 
in both neonatal and juvenile Wistar rats, using whole cell patch clamp. The synaptic 
potentials mediated by spontaneous neurotransmitter release impinging on their somata 
and dendrites have two components; they can be driven by action potentials arriving at the 
terminals (activity dependent; sEPSCs), or by mono-quantal neurotransmitter release 
(activity independent; mEPSCs), and these two components can be recorded in the absence 
or presence of TTX, respectively. Spontaneous background currents, or synaptic ‘noise’, are 
important in signal detection and determine overall excitability of the network (Jones and 
Woodhall, 2005). The properties of EPSCs assessed in this chapter included the frequency 
(in events per minute), amplitude (pA), decay time (ms) and rise time (ms). 
Previous work in this laboratory conducted a study of the characteristics of EPSCs in 
principal neurones in LII and LV of adult Wistar rats (Berretta and Jones, 1996). In summary, 
the studies showed that the frequency of sEPSCs was similar in LII and LV, but that the 
events in the LV had a greater average amplitude, and this was attributed to the existence 
of a population of larger events not present in LII. sEPSCs in LV had faster rise and decay 
times. When action potential driven release was blocked, the frequency of EPSCs was 




result of blockade of the larger amplitude events), but not in LII. Finally, the majority of 
events in both layers were mediated by activation of postsynaptic AMPARs, but occasional 
events were recorded that were the result of activation of postsynaptic NMDARs, and these 
were seen relatively more frequently in LV. The animals used in these studies were 
considerably older (6-8 months) than those used in the present study (P8-28), and 
experimental parameters and conditions in this laboratory have changed considerably 
since these initial studies were published (e.g. use of neuroprotective and other additives, 
more sophisticated cutting equipment). In order to provide a baseline for the current 
studies of developmental changes in KAR activation, it was deemed necessary to repeat 
some of this comparison in the current experimental conditions and in younger animals. 
This study is concerned with early postnatal development, comparing sEPSCs in two groups 
of rats aged P8-11 and P21-28 which will be referred to as neonate and juvenile aged rats 
hereon in. The rationale for choosing these age groups stems from the preliminary 
immunohistochemical data from the lab of Prof. Elek Molner, showing a clear change in 
KAR expression between these age groups, and delineating the functional consequence of 
this was ultimately the aim of this thesis.  
A further series of experiments in this lab recorded the properties of sEPSCs in LIII 
(Chamberlain, 2009, Greenhill et al., 2014). Again, these were done in slices from Wistar 
rats that older than the animals used in the present study (P28-40), although were more 
comparable to those used here. A comparison between sEPSCs neurones in LIII and 
properties reported in older animals (Berretta and Jones, 1996; Greenhill et al 2014) 
showed the following main differences: a much higher frequency in LIII, a similar amplitude 
to events in LII, but similar rise and decay times to LV. There was a much higher contribution 
of action potential dependent release in LIII (around 60-70%), but, as in the other layers, 
the vast majority of sEPSCs were mediated by AMPARs, with occasional events mediated 
by postsynaptic NMDARs (Greenhill et al., 2014, Chamberlain, 2009). 




1. To provide a detailed picture of the properties of sEPSCs in LII and LV of juvenile animals 
(of a similar age to those used in studies in LIII; Chamberlain, 2009; Chamberlain et al., 
2012; Greenhill et al., 2014). 
2. To compare the properties of sEPSCs in LII and LV neurones during early development as 
a basis for subsequent investigations in to developmental roles for KAR in excitatory 
transmission.  
3.2 Methods  
Experiments were conducted on combined slices of EC and hippocampus, as described in 
Chapter 2, from neonatal (P8-11; 20-35 g) and juvenile (P20-28; 50-100 g) Wistar rats. 
Whole cell voltage clamp recordings of sEPSCs and mEPSCs were made from principal 
neurones in LII and LV in the MEC. Neurones were voltage clamped at -60 mV. Cells were 
selected with good access resistance that remained stable for the duration of the recording.  
Mean values for frequency, inter-event interval (IEI; inverse of frequency), amplitude, rise 
times and decay times were determined from a sample of at least 200 events during a 
continuous recording period for each neurone. EPSC/IPSC rise times were calculated as 
time between 10 – 90 % of maximum current while decay times taken as time for current 
to decay 33.3%. Statistical comparisons were made using a non-parametric (Mann 
Whitney) test and KS-tests for average mean data and cumulative probability distributions 
(constructed using 200 events from each neurone), respectively. Statistical significance was 
defined when P < 0.05, except for KS-analysis, where significance was reached if P < 0.01 
due to the sensitivity of the test. 
To facilitate comparisons between groups and gain an overall indication of integrated 
excitation we calculated an arbitrary charge transfer number for each neuronal population 
at the different age levels. This is approximately related to the area under the curve of the 
EPSC. Thus, from the mean value of parameters for the sEPSC populations we calculated 
the sum of the rise and decay times, and determined the product of this and the mean 





3.3.1 Characterisation of sEPSCs in layers II and V of the MEC in juvenile rats 
3.3.1.1 Amplitude and Frequency of sEPSCs 
Whole-cell recordings from LII (n = 32) and LV (n = 19) juvenile (P20-28) neurones, at a 
holding potential of -60 mV, exhibited continuous synaptic activity reflected as sEPSCs. 
They were mediated by primarily by activation of AMPARs as they could be blocked by 
NBQX (Fig. 3.1) 
 
Figure 3.1: Pharmacology of sEPSCs in MEC neurones. The traces show the typical response 
of neurones in the MEC before and after the addition of NBQX (10 μM). NBQX (10 μM) 




sEPSCs occurred at a significantly higher frequency in LII (195.7 ± 22.6 events/min) 
compared to LV (123.6 ± 31.2 events/min; P < 0.05). The cumulative probability plot of the 
IEI shows LII neurones have a significantly smaller IEI compared to LV (P<0.0001; KS-test), 
with no LII neurones IEI exceeding 15.5 seconds compared with a maximum of 40.4 seconds 
in LV. Berretta and Jones (1996) reported frequencies of ~85 events/min in both LII and LV, 
which is comparable to LV, but not LII, in this study.  
The mean event amplitudes of sEPSCs were similar in both LII and LV principal neurones at 
9.4 ± 0.6 pA and 10.5 ± 0.7 pA. These values were lower than in the older animals reported 
by Berretta and Jones (1996) and although there was still a slight skew towards larger 
amplitude events in LV, the difference in mean amplitude between the two layers was not 
significant. Summary data for frequency and amplitude of sEPSCs in juvenile rats are 





Figure 3.2. Comparison of sEPSC frequency and amplitude in LII and LV MEC principal 
neurones in juvenile rats.  (A) Average sEPSC frequency and (B) sEPSC amplitude data from 
32 LII (black) and 19 LV (green) principal neurones. Average frequency of sEPSCs was 
significantly greater in LII neurones (P < 0.001; Mann Whitney test). (C) Cumulative 
probability distribution of the IEI and (D) peak amplitude of events (> 30) collected and 
pooled from each neurone in LII  and LV. Cumulative probability distributions show the 
smaller IEI in LII neurones (P < 0.0001; KS-test) (E) sEPSCs recorded in a LII and sEPSCs 
recorded in a LV neurone. Three traces are consecutive recordings of spontaneous activity.  
3.3.1.2 Kinetics  
sEPSCs recorded in LII (n = 32) had an mean rise time of 3.9 ± 0.3 ms and mean decay time 
of 3.6 ± 0.2 ms, whereas in LV (n = 19) the average rise and decay time was 2.7 ± 0.3 ms 
and 2.9 ± 0.2 ms (Fig. 3.2). Both rise and decay times were significantly faster in sEPSCs of 
LV neurones compared with LII neurones (P = 0.01 and P = 0.03; Mann Whitney test), 
agreeing qualitatively with the studies of Berretta and Jones. However, the absolute values 
for rise times were faster (LII: 2.5 ± 0.1 ms and LV: 1.87 ± 0.1 ms) and the average decay 




differences noted here compared to the older studies are real in the absence of 
comparisons made under identical conditions, but they do emphasise the importance of 
comparing data within the same experimental conditions and preparation, for example, 
when comparing this data to neonatal sEPSCs. The cumulative distribution analysis clearly 
confirms that sEPSCs in juvenile LV neurones had significantly faster rise and decay times 
compared to LII neurones (P < 0.0001 for both plots C & D, KS-test).  
 
 
Figure 3.3. Comparison of sEPSC decay and rise time in LII and LV MEC principal neurones 
of juvenile rats. (A) Scatter plot of sEPSC rise time and (B) sEPSC decay time data from 32 
LII (black) and 19 LV (green) principal neurones. The average rise time of sEPSCs was 
significantly faster in LV neurones (P = 0.01; Mann Whitney test). (C) Cumulative probability 
distribution of the rise time and (D) decay time of events (>30) collected and pooled from 
each neurone in LII and LV. Cumulative probability distributions show the faster rise and 
decay times in LV neurones (P < 0.0001; KS-test, both plots). (E) Averaged sEPSCs of a LII 




3.3.1.3 Effect of TTX on sEPSCs 
mEPSCs recorded in the presence of TTX are considered to reflect the release of single 
quanta from individual release sites, independently of action potentials (Arancio et al., 
1994). Spontaneous glutamate release in the presence and absence of TTX in LII and LV 
principal neurones is summarised in Fig. 3.3 and 3.4, respectively. Pooled cumulative 
distributions of the IEIs of sEPSCs in LII and LV (Fig. 3.5) showed a slight shift to the right in 
the presence of TTX, indicating an increase in the IEI (decreased frequency) of events in 
both layers (P < 0.0001 for both plots, KS-test). TTX (1 μM) reduced the frequency of sEPSCs 
in both layers by ~28-30 %, from an average of 195.7 ± 22.6 (n = 32) to 139.7 ± 19.8 
events/min (n = 17) in LII and 123.6 ± 31.2 (n = 19) to 83.9 ± 16.1 events/min (n = 14) in LV. 
These results are comparable with the Berretta and Jones (1996) study, which showed TTX 
(0.5 μM) reduced the frequency of sEPSCs in both layers by 15-20%. This is in contrast to 
previous work on LIII, done at comparable ages and conditions to the present experiments, 
which showed that TTX had a much larger effect on sEPSCs (decrease in frequency of -85 
%), signifying the majority of events in LIII are action potential-dependent (Chamberlain, 
2009). Unlike in LIII, most of the sEPSCs in LII and LV of the MEC are therefore miniature 
events, mediated by spontaneous release of single quanta from presynaptic sites. This may 
be associated with a greater preponderance of recurrent excitatory connections between 
neurones in LIII compared to LII and LV (Dhillon and Jones, 2001) 
TTX had differential effects on the amplitude of sEPSCs. In LII, there was no change in the 
average amplitude (9.4 ± 0.6 pA vs 8.9 ± 0.6 pA) or the cumulative amplitude distribution 
(Fig. 3.3). However, in LV there was a significant decrease in the average amplitude of 
sEPSCs from 10.5 ± 0.7 pA (n = 19) to 8.3 ± 0.8 pA (n = 14) in the presence of TTX (P = 0.01, 
Mann Whitney test). The plot in Fig. 3.5 shows that the change in the amplitude distribution 
was mainly due to the loss of larger amplitude sEPSCs in LV (P < 0.0001; KS-test), whereas 
in LII the cumulative amplitude distribution was unaltered, again in accordance with the 
previous studies (Berretta and Jones, 1996).  
There was no difference between the mean kinetics of sEPSCs and mEPSCs in LII (rise time 




2.7 ± 0.3 ms vs 2.4 ± 0.2 ms and decay time 2.9 ± 0.2 ms vs 2.8 ± 0.2ms) principal neurones. 
The effects of TTX on sEPSCs in LII and LV MEC are summarised in table 3.1. 
 
 
Figure 3.4: Comparison of sEPSCs and mEPSCs in LII neurones of juvenile rats. Voltage 
clamp recordings were made from LII neurones in the absence (sEPSCs; n = 32; black) and 
presence (mEPSCs; n = 17; red) of TTX (1 μM). (A) Scatter plots comparing the (A) frequency 
(events/min), (B) rise time (ms), (C) amplitude (pA) and (D) decay time (ms) of sEPSCs and 
mEPSCs from LII principal neurones. Note no significant differences between sEPSCs and 
mEPSCs of LII neurones. (E) sEPSCs and (F) mEPSCs recorded in a LII MEC neurone, before 






Figure 3.5: Comparison of sEPSCs and mEPSCs in LV principal neurones of juvenile rats. 
Voltage clamp recordings were made from LV neurones in the absence (sEPSCs; n = 19; 
green) and presence (mEPSCs; n = 14; blue) of TTX (1 μM). (A) Scatter plots comparing the 
(A) frequency (events/min), (B) rise time (ms), (C) amplitude (pA) and (D) decay time (ms) 
of sEPSCs and mEPSCs from LV principal neurones. Note the decreased mean amplitude in 
the presence of TTX (P = 0.019; Mann Whitney test) (E) sEPSCs and (F) mEPSCs recorded in 
a LV MEC neurone, before and after the application of TTX (μM). Three traces are 








Table 3.1: Summary of the effects of TTX on SEPSCs in juvenile LII and LV neurones. 
Average frequency, amplitude, rise and decay times of sEPSCs in LII (black) and LV (green) 
neurones. * denotes statistically significant (P < 0.05) changes between sEPSCs and mEPSCs 
in the same layer. Note the smaller amplitude in LV mEPSCs compared to LV sEPSCs.  
 
3.3.2 Characterisation of sEPSCs in layers II and V of the MEC in neonatal rats 
3.3.2.1 Frequency and amplitude  
Whole cell recordings from LII (n = 16) and LV (n = 18) neonatal (P8–14) neurones, at a 
holding potential of -60 mV, like those in juvenile animals exhibited continuous sEPSCs 
manifested as spontaneously occurring inward currents. sEPSCs occurred at a much higher 
frequency in LII (137.2 ± 21.6 events/min) compared to LV (36.3 ± 7.7 events/min; P = 
0.0001, Mann Whitney test). A cumulative probability plot of IEI shows significantly shorter 
IEIs in LII neurones compared with LV (P<0.0001, KS-test), with no LII neurones exhibiting 
IEI exceeding ~15 seconds compared with a maximum of ~40 seconds in LV neonatal 
neurones.  
The mean event amplitudes of sEPSCs were similar in both LII and LV principal neurones at 
8.4 ± 0.5 pA and 9.0 ± 0.5 pA, but the cumulative distribution plots of amplitude revealed a 




0.0001; KS-test). Amplitudes of sEPSCs in LII did not exceed 50 pA, compared with a 
maximum amplitude of 130 pA in LV. The frequency and amplitude of sEPSCs in neonatal 
rats are summarised in Fig. 3.6. 
3.3.2.2 Kinetics  
There was no difference between the mean kinetics of sEPSCs from LII (rise time 5.4 ± 0.2 
ms; decay time 4.2 ± 0.3 ms, n = 18) and LV (rise time 5.0 ± 0.3 ms; decay time 4.8 ± 0.6 ms, 
n = 18) in neonatal neurones. Despite this, a skew towards faster rise times of sEPSCs in LV 
compared to LII neurones can be identified from the cumulative distribution plots in Fig. 
3.7 C (P < 0.0001, KS-test). No differences significant differences in decay time were present 








Figure 3.6: Comparison of sEPSC frequency and amplitude in LII and LV neurones of 
neonate rats. (A) Scatter plots comparing the sEPSC frequency and (B) sEPSC amplitude 
data from 16 LII (red) and 18 LV (blue) principal neurones. Average frequency of sEPSCs was 
significantly greater in LII neurones (P < 0.001; Mann Whitney test). (C) Cumulative 
probability distribution shown of the IEI and (D) peak amplitude of events (> 55) collected 
and pooled from each neurone in LII and LV. Cumulative probability distributions show the 
smaller IEI in LII neurones (P < 0.0001; KS-test), and the presence of higher amplitude events 
in LV neurones. (E) sEPSCs recorded in a LII and sEPSCs recorded in a LV neurone. Three 
traces are consecutive recordings of spontaneous activity. Note the slow frequency of LV 






Figure 3.7: Comparison of sEPSC decay and rise time in LII and LV neurones of neonate 
rats. (A) Scatter plot of sEPSC rise time and (B) sEPSC decay time data from 16 LII (red) and 
18 LV (blue) principal neurones. There were no significant differences between LII and LV 
mean rise or decay times. (C) Cumulative probability distribution shown of the rise time and 
(D) decay time of events (>55) collected and pooled from each neurone in LII  and LV. 
Cumulative probability distributions show the faster rise time in LV neurones (P < 0.0001; 
KS-test), but no differences in decay time. (E) Averaged sEPSCs of a LII (top; red) and a LV 









Table 3.2: Summary data of the baseline characteristics of sEPSCs in LII and LV of neonate 
and juvenile neurones. Scatter plots of sEPSC frequency, amplitude, rise times and decay 
times of sEPSCs in neurones from neonate LII (red, n = 16)), juvenile LII (black, n = 32), 
neonate LV (blue, n = 18) and juvenile LV (green, n = 19). * and # denote statistically 






3.3.3 Age Comparison 
3.3.3.1 Frequency and amplitude  
Whole cell recordings of sEPSCs were compared in 35 neurones recorded in slices from 
neonatal rats (P8-14) and 51 neurones from juvenile animals (P20-28). Again events were 
largely abolished by CNQX in both groups, confirming their dependence on AMPAR 
activation (not shown).  
In LII, the mean frequency of sEPSCs in neonatal (n = 16) and juvenile (n = 32) neurones was 
137.2 ± 21.6 events/min and 195.7 ± 22.6 events/mins, respectively. The mean frequencies 
were not significantly different, although the cumulative probability plot of IEI showed a 
slight shift towards longer IEIs (decreased frequency) in the neonates, which was significant 
when compared with a KS-test (P < 0.0001). In contrast, there was a marked difference in 
mean frequency of sEPSCs neurones in LV in neonatal (36.3 ± 7.7; n = 18) and juvenile (123.6 
± 31.2 events/min; n = 19) slices, which was significant (P < 0.01, Mann Whitney test). This 
is shown by the scatter plot in Fig. 3.8. The decreased frequency in neonatal LV neurones 
is reinforced by the cumulative probability distribution of IEI, showing a clear rightward 
shift towards increased IEIs in the neonatal neurone population (P < 0.0001, KS-test). 
Mean amplitudes of sEPSCs in neonatal neurones did not significantly differ from the 
amplitude of sEPSCs in juvenile neurones in either LII (8.4 ± 0.5 pA and 9.4 ± 0.6 pA) or LV 
(9.0 ± 0.5 pA and 10.5 ± 0.7 pA), the cumulative probability analyses of amplitude did show 
leftward shifts towards smaller amplitude events compared to neonates (P < 0.0001 for 
both plots, KS-test). Although there was a slight overall shift towards lower amplitude 
events in LV neonatal neurones, there were also occasional cells that showed much larger 
amplitude events in neonatal slices. sEPSC amplitude in the population of juvenile LV 
neurones did not exceed 80 pA, whereas in neonatal LV neurones amplitudes up to 130 pA 
were occasionally seen. Comparisons of frequency and amplitude of sEPSCs in juvenile and 







Figure 3.8: Comparison of sEPSC frequency and amplitude in neonatal and juvenile 
neurones in LII. (A) Scatter plots comparing the sEPSC frequency and (B) sEPSC amplitude 
data from 16 NEO (red) and 32 JUV (black) principal neurones. (C) Cumulative probability 
distribution shown of the IEI and (D) peak amplitude of events (> 55) collected and pooled 
from each neurone. Cumulative probability distributions show a slight skew towards 
increased IEI and decreased amplitude of NEO sEPSCs (P < 0.0001 both plots; KS-test).(E) 
sEPSCs recorded in a LII NEO  and sEPSCs recorded in a LII JUV principal neurone in the MEC. 





Figure 3.9: Comparison of sEPSC frequency and amplitude in neonate and juvenile 
neurones in LV. (A) Scatter plot of sEPSC rise time and (B) sEPSC decay time data from 18 
NEO (blue) and 19 JUV (green) neurones. Frequency of sEPSCs in LV neurones significantly 
increases during development. (C) Cumulative probability distribution shown of the IEI and 
(D) peak amplitude of events (> 52) collected and pooled from each neurone. Note the 
clearly increased IEI (slower frequency) in NEO compared with JUV sEPSCs (P < 0.0001, KS-
test), and the presence of higher amplitude events in juvenile sEPSCs of LV MEC. ). (E) sEPSCs 
recorded in a LV NEO and sEPSCs recorded in a LV JUV principal neurone 
 
3.3.2.2 Kinetics  
The most dramatic differences between neonatal and juvenile sEPSCs occurred in their rise 
and decay kinetics. The average rise time of sEPSCs got significantly faster with 
development in LII (from 5.4 ± 0.2 ms to 3.9 ± 0.3 ms; P = 0.003, Mann Whitney test) and 
LV (from 5.0 ± 0.3 ms to 2.7 ± 0.3 ms; P < 0.0001, Mann-Whitney test) neurones. Similarly, 
mean decay times of events were significantly slower in neonatal compared to juvenile 




(from 4.8 ± 0.6 ms to 2.9 ± 0.2 ms; P = 0.0006, Mann Whitney test) neurones. These findings 
are reinforced by the cumulative distribution analysis (Fig. 3.10) which clearly indicate 
sEPSCs in LII and LV MEC neurones had significantly faster rise and decay times in the older 
juvenile rats (P < 0.0001 for both plots, KS-test). 
Faster kinetics in the juvenile compared to neonatal sEPSCs are present in both layers, 
though developmental changes are more pronounced in LV MEC neurones. This seems to 
be due to a developmental elimination of slower sEPSCs in LV juvenile neurones, a trait not 
present in LII neurones. For example, no events in juvenile LV neurones exceed a decay 
time of 18 ms, but 2% of events in neonatal LV neurones exceed this decay time. In LII 
neurones, sEPSCs exceeding a decay time of 18 ms remains at 1 % in both neonatal and 







Figure 3.10: Comparison of sEPSC decay and rise time in neonatal and juvenile neurones 
in LII. (A) Scatter plot of sEPSC rise time and (B) sEPSC decay time data from 16 NEO (red) 
and 32 JUV (black) principal neurones. Rise and decay times were significantly faster in JUV 
II sEPSCs compared to NEO LII sEPSCs (P = 0.003 and P = 0.04, respectively, Mann Whitney 
test). (C) Cumulative probability distribution shown of the rise time and (D) decay time of 
events (>30) collected and pooled from each neurone. Cumulative probability distributions 
show the faster rise and decay time in JUV neurones compared to NEO (P < 0.0001; KS-test). 







Figure 3.11: Comparison of sEPSC decay and rise time in neonate and juvenile neurones 
in LV. (A) Scatter plot of sEPSC rise time and (B) sEPSC decay time data from 18 NEO (blue) 
and 19 JUV (green) neurones. Rise and decay times were significantly faster in JUV V sEPSCs 
compared to NEO LV sEPSCs (P = 0.0006 and P < 0.0001, respectively, Mann Whitney test). 
(C) Cumulative probability distribution shown of the rise time and (D) decay time of events 
(>52) collected and pooled from each neurone. Cumulative probability distributions clearly 
show the faster rise and decay time in JUV neurones compared to NEO (P < 0.0001 for both 
plots; KS-test). (E) Averaged sEPSCs of a NEO LV and a JUV LV neurone(s) are shown 





Table 3.3: Charge transfer values and ratios of sEPSCs. Charge transfer values are 
indicative of the overall neuronal excitation, and are calculated using the following 












3.4.1 Comparison of sEPSCs in juvenile compared to older animals 
Previous reports of sEPSC properties in the MEC (LII, LIII and LV) have come from studies in 
older animals than the juvenile group reported here (Berretta and Jones, 1996, 
Chamberlain, 2009, Greenhill et al., 2014). Attempts to make comparisons between these 
studies must involve caution, and until equivalent studies have compared all three layers 
in the same age groups it may be dangerous to draw too much inference from the 
differences in terms of developmental effects. Nevertheless, and notwithstanding 
differences in experimental approaches and procedures in different studies, it is instructive 
to consider first how the juvenile and adult sEPSCs may differ, but perhaps more 
importantly how the two age groups studied together here, may also differ. 
Despite considerable variability in sEPSC frequency from cell to cell, and within different 
studies, sEPSCs in LIII MEC seem to have the highest frequency (276 ± 60.0 events/min), 
followed by LII (195.7 ± 22.6 events/min) and LV (123.6 ± 31.2 events/min), in juvenile rats. 
Previous work (Berretta and Jones, 1996; Greenhill et al, 2014) shows little difference in 
sEPSC frequency in LII and LV, but this work was conducted on adult rats. In the studies 
presented here, sEPSC frequency is considerably higher in LII compared to LV in both 
neonatal and juvenile principal neurones.  
Other parameters of sEPSCs were qualitatively similar in the juvenile and older rats. 
Amplitudes of sEPSCs in LII and LV were approximately the same in LII and LV in juvenile 
(present study) and older rats (Berretta and Jones, 1996; Greenhill et al, 2014), but in 
juveniles they were slightly lower than those previously recorded. Again, it is difficult to 
draw inferences from this as the differences may be attributed to differences in 
experimental set up and procedures. It is noteworthy that there was a small population of 
sEPSCs with large amplitude, in LV neurones, rarely seen in LII in adult or juvenile neurones, 
which, interestingly, was also present in neonatal neurones. This may reflect a high 
preponderance of recurrent excitatory connections in LV compared to an almost complete 
absence of such connections in LII (Dhillon and Jones, 2000). Interestingly, there appeared 




development, which potentially could underlie the development of recurrent collateral 
excitation. The effect of TTX on sEPSCs suggests that the larger amplitude events in LV could 
be due to differences in the activity-dependent component of spontaneous transmitter 
release, such that the amplitude distribution of sEPSCs was unaffected by TTX in LII 
neurones, but the larger amplitude events in LV were abolished. This could indicate both 
activity-dependent and independent events in LII are mediated by the release of single 
quanta of transmitter, whereas in LV, activity dependent release can also be mediated by 
the release of multiple quanta. 
Rise times of sEPSCs in juvenile animals in this study were slower than those previously 
reported (Berretta and Jones, 1996) but the general trend of significantly faster rise times 
in LV compared to LII neurones was present in both data sets. Berretta and Jones (1996) 
attributed these differences, at least in part, to dendritic filtering in the less electronically 
compact LII neurones. Interestingly, rise times in the neonate animals (see below) were 
slower than in Juvenile animals. Speculatively, the progressive decrease in rise time seen 
in both layers from neonate through juvenile to old animals could result from increasing 
electrotonic compactness throughout development, perhaps occurring as a result of 
morphological and synaptic changes in neurones in both layers. LII principal neurones are 
either SCs with multiple spiny dendrites and wide-reaching branches towards the dentate 
gyrus, or PCs with long and thick spiny dendrites. LV neurones are generally large PCs with 
round somata and either horizontal or multidirectional sparsely spiny dendrites. These 
morphological and electrical properties characteristic of principal neurones in each layer of 
the MEC could, in part, account for the slow sEPSC kinetics in LII, relative to neurones in LIII 
and LV.  
3.4.2 Developmental changes in sEPSCs 
In these experiments we conducted equivalent examinations of sEPSCs in neonate and 
juvenile animals, so were able to directly compare changes in properties of spontaneous 
excitation over the developmental period. As noted above, and summarised in table 3.1 




Frequencies of sEPSCs were consistently higher in LII compared to LV in both neonate and 
juvenile groups. This difference was particularly marked in the younger animals where 
sEPSC frequency in LV was very low. In terms of development, the frequencies increased in 
both layers as animals got older, which could indicate that the probability of release was 
rising at synapses in both layers. Alternatively, the absolute number of synaptic contacts 
could be increasing as a result of synaptogenesis. The relative frequency increased 
markedly in LV (to about 340% of control) compared to LII (~140%) but although the 
differential sEPSC frequency between the layers decreased with development, it was still 
in favour of a higher level in LII in the juvenile animals.  
Amplitudes of sEPSCs (~8-10 pA) were fairly constant between age groups and were similar 
in each layer. One interpretation of this is that there was little change in the quantal 
content between layers, that the underlying postsynaptic AMPARs at the synapses were 
similar in number and composition in both layers, and that there was little change in these 
parameters as the rats approached adulthood. Unpublished immunocytochemical studies 
from Professor Elek Molnar’s group at the University of Bristol (personal communication) 
has shown that the expression of some AMPAR subunits (e.g. GluA1) increases 
progressively from P0 to P21 in hippocampal areas but much less markedly in 
extrahippocampal areas. In contrast, other subunits (e.g. GluA2) show little much less 
change in hippocampus and virtually no change in other areas over the same period. 
However, a definitive study of receptor expression in the EC remains to be done.  
Rise and decay times of sEPSCs were very similar in either layer, and in neonate animals, 
and, while both parameters became faster in both neuronal populations with 
development, there was no major differential apparent between layers in the two age 
groups. There is very little data available on morphological changes in EC with 
development, which could potentially help explain developing differences in kinetic 
parameters. However, information about dendritic growth and branching in the 
hippocampus is available (Dailey and Smith, 1996, McAllister, 2000). As might be expected, 
there is a developmental increase in the size and complexity of principal cell dendritic trees. 
With this in mind, it would be intuitive to think that sEPSC kinetics get slower with age due 




ramification of basilar and apical dendrites. However, both LII and LV sEPSCs displayed 
faster kinetics in juvenile compared with neonatal neurones, suggesting the contribution 
of electronic length to sEPSC kinetics during development may be over-shadowed by other 
factors, or that morphological changes in the EC may result in less dendritic filtering, for 
example, the pruning of distal dendritic synapses.  
Other factors that could influence kinetics include postsynaptic receptor composition 
(Conti and Weinberg, 1999) and affinity for the transmitter (Jones et al., 1998), as well as 
the rates and time course of desensitisation (Jones and Westbrook, 1996). Different factors 
become more or less important in defining the shape of EPSCs in immature versus mature 
neurones. For example, in immature neurones at mossy fibre-granule cell synapses, decay 
time depends primarily on the rate of receptor deactivation and glutamate clearance (Silver 
et al., 1996), however, changes to morphological complexity and the expression of 
glutamate transporters and receptors alter decay time throughout development. This 
study suggests the dominant determinant influencing faster rise and decay times of sEPSCs 
in mature neurones was an increase in synchrony of multi-vesicular transmitter release, 
and faster desensitisation, respectively. Similar developmental factors presumably play a 
role in the maturation of sEPSCs in the MEC. A striking feature of sEPSCs in the MEC from 
these results was the developmental elimination of sEPSCs with slower decay times. The 
presence of only fast decaying sEPSCs could push the network towards higher frequency 
events, with perhaps a greater potential for hyper-synchronous network activity (see 
Chapter 7).  
3.4.3 Developmental changes in overall excitation 
Whilst changes in sEPSC characteristics tell us about developmental alterations in synaptic 
properties, they do not provide real information about the overall level of persistent, on-
going excitation in neurones and, hence, in neuronal networks. It has been argued that the 
integration of spontaneous excitation and persistent spontaneous inhibition are 
determinant in the control of intrinsic neuronal excitability and, hence, network reactivity 
leading to synchronisation (Woodhall et al., 2005, Greenhill et al., 2014). To measure and 
compare overall excitation in the developing EC we calculated arbitrary charge transfer 




revealed that the levels of background excitation were highest in LII in juvenile rats. The 
ratio to LII in neonates was 1:1.3 showing an increase in overall excitation despite 
decreasing rise and decay times of individual events. However, the relative increase in 
integrated excitation with development was even more marked in LV with a ratio of 
juvenile to neonate of 1:2.3 again in the face of even bigger decrease in rise and decay 
times. 
Comparison between layers in the two age groups was instructive. In the neonates, 
background excitation was dramatically higher in LII than LV with a ratio between them of 
1:3.3. In the older animals although the differential was qualitatively maintained in favour 
of LII, quantitatively it fell to a ratio of 1:1.9, tending towards an equalisation of background 
synaptic excitation in the deep and superficial layers.  
What conclusions can be drawn from this? LII is clearly subject to higher levels of 
background excitation than LV both early in development and when approaching the more 
stable adult situation, and the relative overall change is not dramatic. Background 
excitatory influence on neuronal activity in LV climbs more rapidly towards that seen in LII 
by P20-28, but does not become equal to it. This suggests differential development of 
excitatory neuronal activity in the two populations. It should be noted that many of the 
studies here were completed in tissue from rats a little more than 3 weeks old, and it could 
be argued that these are still some way from adulthood, (rats becoming sexually mature at 
around 35-40 days, and not socially mature before 5-6 months; (Sengupta, 2013). Following 
changes over more extended time frames may well lead to a further narrowing of 
differential between layers. Indeed, back calculation of arbitrary charge transfer numbers 
from the results of Berretta and Jones (1994) in 3-4 month old animals establishes a ratio 
of excitation in LV:LII of just 1:1.2. Accepting the caveats associated with different 
experimental procedures and conditions, this does suggest that the two layers continue to 
equalise with continuing development. 
It is very relevant therefore that a recent study has shown that postnatal development and 
maturation of the MEC and its hippocampal connections occurs in a hierarchical fashion. 




hippocampal formation, with the full maturation of LV occurring at around P28 days 
(Donato et al., 2017). Thus, the delayed maturation of LV compared to LII could explain the 
decreased background excitation exerted by sEPSCs between the layers in neonatal v 
juvenile neurones, and the significantly greater influence of this excitation across layers, 
before they begin to equalise. 
3.4.4 Wider picture 
The results from this chapter show that excitatory events become faster and more 
frequently during development. The complete lack of a change in amplitude strongly 
implies the developmental changes observed are occurring specifically at the level of the 
synapse, and not a result of increased network activity. Increased synaptic ‘noise’ during 
development has been postulated to increase the range of synaptic strengths, which may 
support synchronised neuronal activity, such as gamma frequency oscillations, alongside 
multiplexed neuronal firing, such as grid cell computation (Solanka et al., 2015, Ermentrout 
et al., 2008). In a model of MEC neurones, Solanka et al. showed that increasing synaptic 
noise was beneficial to both gamma oscillations and encoding spatial locations with grid 
cell activity. Moreover, increases in intrinsic noise reduced the likelihood of seizures in this 
model, as it prevented neurones from becoming excessively synchronised (Solanka et al., 
2015). The results of this chapter provide experimental evidence that synaptic excitation 
increases during normal development in the rat MEC. It is not unreasonable to suggest that 
alterations in synaptic excitation, for reasons which could include: deficits in ambient 
neurotransmitter (e.g. glutamate), abnormal receptor (AMPAR) expression on the 
postsynaptic membrane or slower receptor kinetics due to aberrant subunit composition, 
may have serious implications in the generation of neurodevelopmental disorders 
associated with the MEC, especially TLE.  
What is missing from this discussion is of course how this background excitability is 
influenced by concurrent and persistent spontaneous inhibition and how the two integrate 
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Numerous disease states have implicated a dysfunction of the MEC in the underlying 
aetiology. For example, the MEC shows structural changes in patients with TLE and animal 
models of the disorder (Bartolomei et al., 2005, Bernasconi et al., 1999, Salmenperä et al., 
2000), and a considerable body of evidence supports changes in inhibitory synaptic 
organisation and neurotransmission in the generation and propagation of epileptiform 
activity, implicating layers II, III and V (Treiman, 2001, Bernard, 2010). Disrupted functional 
and anatomical arrangements of circuit selectivity in LII have been identified in animal 
models of TLE (Gibbs et al., 1997, Brooks-Kayal et al., 1998). Specifically, epileptic animals 
had a decreased contribution of inhibitory neurotransmission from presynaptic GABAARs, 
and an increase in direct excitatory connections between LII principal cells, leading to a net 
increase in excitability within the network (Armstrong et al., 2016). Alzheimer’s patients 
show an age-dependent loss and impaired expression of functional GABAARs (Limon et al., 
2012) and GABA transporters in the EC (Fuhrer et al., 2017). A decreased expression of PV-
containing interneurones, which co-localised with pathological markers has also been 
reported in AD (Solodkin et al., 1996). Mice specifically over-expressing tau in the MEC 
present with memory deficits which were preceded by impairments in synaptic plasticity 
and aberrant levels of inhibitory neurotransmitters (Fu et al., 2017). 
A number of disorders characterised by neurodevelopmental disturbances such as bipolar 
disorder and schizophrenia also implicate the MEC and disease specific altered intrinsic 
inhibitory networks (Fung et al., 2014) in their aetiology. For example, post-mortem studies 
show a decreased expression of PV-containing interneurones in the superficial layers of the 
MEC in patients with bipolar disorder, leading to disruptions in information integration and 
transfer (Pantazopoulos et al., 2007). 
In order to better understand the role inhibitory synaptic mechanisms in the MEC in 
neurodevelopmental disorders, it is necessary first to determine how inhibition may alter 
during normal development. In the previous chapter developmental changes in 




studies on inhibition, using characteristics of sIPSCs to monitor persistent background 
inhibition. 
Previous work in this laboratory has compared sIPSCs in LII, LV (Woodhall et al., 2005) and 
LIII (Chamberlain et al., 2012) in slices from adult rats, using whole cell patch clamp. As 
noted in the previous chapter on sEPSCs, caution should be exercised when drawing 
inferences from the previous studies in comparison to the present results, as different age 
groups were studied and experimental conditions and procedures were also different 
(particularly with regard to the use additives for neuroprotection and metabolic support). 
Nevertheless, it is worth summarising these studies here. The frequency of sIPSCs was 
greatest in LII, closely followed by LIII, and both layers displayed a very high frequency (40 
events/sec was not uncommon). The frequency of events was dramatically (4-5 fold) lower 
in LV. Interestingly, in the presence of TTX, the frequency of events in LV was almost halved, 
whereas layer II remained largely unaffected, suggesting a large majority of events in layer 
II occur independently of action potentials. LIII resembled LV, in that about 50% of sEPSCs 
were action potential driven and 50% were mIPSCs. Amplitudes of sIPSCs were similar in all 
three layers, and rise and decay kinetics were the same in LV and LIII, but slower in LII. 
Finally, another study in adult slices (Bailey et al., 2004) showed that GABA release was 
inhibited by presynaptic GABABR in both LV and LII, and this effect was tonically active in 
the former but not the latter. 
Whilst these studies have comprehensively characterised the baseline properties of sIPSCs 
in the MEC, there are no studies that have addressed the changes in inhibition during 
development. This project focused specifically on LII and LV, due to their physiological 
importance in managing synaptic inputs and outputs of the hippocampal formation, and in 
view of potential involvement in neurodevelopmental disorders noted above. The studies 
aimed to reinforce our current knowledge on the characteristics of sIPSCs in juvenile rats, 
but to also extend this characterisation to neonatal rats, allowing the definition of 
developmental changes in inhibitory neurotransmission in the MEC. This knowledge can be 
applied to help understand the development of associated neurodevelopmental or 





Thus, the aims of the current study were principally: 
1. To provide a detailed picture of the properties of sIPSCs in LII and LV of juvenile animals 
(P20-28). 
2. To compare the properties of sIPSCs in LII and LV neurones during early development 
(P8-11) as a basis for subsequent investigations in to developmental roles for KAR in 
inhibitory transmission.  
4.2 Methods  
All experiments in this chapter were conducted on combined slices of EC and hippocampus 
described in Chapter 2 from neonatal (P8-11; 20-35 g) and juvenile (P20-28; 50-100 g) 
Wistar rats. Whole cell voltage clamp recordings of sIPSCs and mIPSCs were recorded from 
principal neurones in LII and LV of the MEC. Neurones were voltage clamped at -60 mV. 
Cells were selected with good access resistance that remained stable for the duration of 
the recording. All experiments were conducted in the presence of DL-AP5 and SYM2206 to 
block NMDAr and AMPAr, respectively, and record sIPSCs, uncontaminated by sEPSCs.  
Mean values for frequency, inter-event interval (IEI; inverse of frequency), amplitude, rise 
and decay times were determined from a sample of 200 events during a continuous 
recording period for each neurone. IPSC rise times were calculated as time between 10 – 
90 % of maximum current while decay times taken as time for current to decay 33.3%. 
Statistical comparisons were made using a KS-test on cumulative probability distributions 
constructed from ~200 events from each neurone. To facilitate comparisons between 
groups and gain an overall indication of integrated inhibition we calculated an arbitrary 
charge transfer number for each neuronal population at the different age levels. This is 
approximately related to the area under the curve of the EPSC. Thus, from the mean value 
of parameters for the sIPSC populations we calculated 50% of the sum of the rise and decay 





4.3.1 Characterisation of sIPSCs in layers II and V of the MEC in juvenile rats 
4.3.1.1 Amplitude and Frequency of sIPSCs 
Whole cell recordings from principal neurones in both LII (n = 15) and LV (n = 18) in slices 
from juvenile animals revealed frequent inward currents, which pharmacological analysis 
(not shown) confirmed were sIPSCs mediated by GABAARs. These persistent events were 
similar to those described in older animals (Bailey et al., 2004; Woodhall et al., 2004). sIPSCs 
occurred at a significantly higher frequency in LII (571.0 ± 148.0 events/min; 9.5 Hz) 
compared to LV sIPSCs (150.7 ± 21.2 events/min; 2.5 Hz, P = 0.008). This was confirmed by 
the cumulative probability plot of IEI in Fig. 4.1, with no LII neurones IEI exceeding 7 seconds 
compared with a maximum of 16 seconds IEI in LV. This data is remarkably comparable to 
that reported by Woodhall et al. (2005) in adult animals (11.5 Hz and 2.5 Hz in LII and LV, 
respectively).  
The average amplitude of events was very similar in LII (20.1 ± 6.0 pA) and LV (18.7 ± 1.8 
pA) and the small difference was not significant. Again, this data is entirely consistent with 
the studies in adult animals (Woodhall et al., 2005; LII 24.0 ± 1.8 pA v LV 25.7 ± 3.9 pA). 
Although the average event amplitude was not significantly different, the cumulative 
amplitude plot, constructed from ~1000 sIPSCs from each data set, shows that there were 
more higher amplitude events in LII than in LV (P < 0.001, KS-test). Of the events sampled 
in the pooled data, 3% of events in LII exceeded 100 pA, compared to 1 % in LV, with 
maximum amplitudes of 502.5 pA and 212.4 pA in LII and LV, respectively. Frequency and 







Figure 4.1: Comparison of sIPSC frequency and amplitude in LII and LV neurones of 
juvenile rats. (A) Average sIPSC frequency and (B) sIPSC amplitude data from 15 LII (black) 
and 18 LV (green) principal neurones. Average frequency of sIPSCs was significantly 
increased in LII neurones (P < 0.01; Mann Whitney test). (C) Cumulative probability 
distribution shown of the IEI and (D) peak amplitude of events (> 55) collected and pooled 
from each neurone. Cumulative probability distributions show the smaller IEI in LII neurones 
(P < 0.0001; KS-test), and the presence of higher amplitude events in LII neurones. (E) sIPSCs 
recorded in a LII and (F) sIPSCs recorded in a LV neurone. Three traces are consecutive 
recordings of spontaneous activity.  
4.3.1.2 Kinetics  
sIPSCs in LII (n = 15) had a mean rise time of 5.7 ± 0.6 ms and average decay time of 5.4 ± 
0.9 ms, whereas in LV (n = 18) the average rise and decay time was 6.9 ± 0.7 ms and 9.9 ± 
2.2 ms (Fig. 4.2). Thus, the decay time of sIPSCs was slightly faster in LII compared with LV 
(P < 0.05, Mann Whitney test), a difference which was qualitatively similar in adult animals, 
although Woodhall et al. (2005) reported longer decay times (8.5 ± 0.6 ms in LII and 10.1 ± 
1.0 ms in LV). The cumulative distribution analysis confirms the slower decay times of 




significantly in the two layers. The rise and decay times of sIPSCs reported by Woodhall et 
al (2004) differ substantially from those in the present studies, but this may be as a result 
of different parameters of analysis so it is not worthwhile attempting to directly compare 
these studies.  
 
 
Figure 4.2: Comparison of sIPSC decay and rise time in LII and LV neurones of juvenile rats. 
(A) Scatter plot of sIPSC rise time and (B) sIPSC decay time data from 15 LII (black) and 18 
LV (green) principal neurones. The average decay time of sIPSCs was significantly faster in 
LII neurones (P < 0.05; Mann Whitney test). (C) Cumulative probability distribution shown 
of the rise time and (D) decay time of events (>55) collected and pooled from each neurone. 
Cumulative probability distributions show the faster rise and decay times in LII neurones (P 
< 0.0001; KS-test, both plots). (E) Averaged sIPSCs of a LII (top; black) and a LV (middle; 





4.3.1.3 Effect of TTX on sIPSCs 
mIPSCs recorded in the presence of TTX largely reflect the release of single quanta of GABA 
from individual release sites, independently of action potentials invading the terminals. The 
effect of TTX on spontaneous GABA release onto principal neurones in LII and LV of juvenile 
rats is summarised in Fig. 4.3 and 4.4, respectively. Marked differences were noted 
between the deep and superficial layers in response to TTX application. It was apparent 
that the frequency of sIPSCs in LII is largely unaffected by blocking action potentials, a 
finding that has been previously documented in adult slices (Woodhall et al., 2005). In fact, 
none of the other parameters of sIPSCs were significantly changed after TTX, despite a 
tendency towards faster rise and decay times. This suggests that sIPSCs, and therefore 
GABA release onto principal cells in LII MEC, arises largely independently of action 
potentials. However, these results should be treated with caution, as mIPSPs were only 
recorded in 3 neurones 
In contrast, bath application of TTX decreased the average frequency of sIPSCs in juvenile 
LV neurones by 66% from 150.7 ± 21.2 events/min (2.5 Hz) to 51.6 ± 7.6 events/min (0.9 
Hz) (P = 0.002, Mann Whitney test). Again, this is comparable to the study of Woodhall et 
al (2005), which showed a 63 % decreased in frequency of LV sIPSCs in the presence of TTX 
in adult slices. Despite the change in frequency, there was no change in the mean amplitude 
of LV sIPSCs in the absence (18.7 ± 1.8 pA) or presence (17.6 ± 1.6 pA) of TTX. mIPSCs in LV 
had a faster mean rise (6.9 ± 0.7 ms to 4.1 ± 0.3) and decay time (9.9 ± 2.2 ms to 5.7 ± 0.6) 










Figure 4.3: Comparison of sIPSCs and mIPSCs in LII neurones of juvenile rats. Voltage 
clamp recordings were in the absence (sIPSCs; n = 15, black) and presence (mEPSCs; n = 3, 
red) of TTX (1 μM). (A) Scatter plots comparing the (A) frequency (events/min), (B) rise time 
(ms), (C) amplitude (pA) and (D) decay time (ms) of sIPSCs and mIPSCs from LII principal 
neurones. Note no significant differences between sIPSCs and mIPSCs of LII MEC neurones. 
(E) sIPSCs and mIPSCs recorded in a LII MEC neurone, before and after the application of 





Figure 4.4: Comparison of sIPSCs and mIPSCs in LV neurones of juvenile rats. Voltage 
clamp recordings were made from neurones in the absence (sIPSCs; n = 18, green) and 
presence (mIPSCs; n = 9, blue) of TTX (1 μM). (A) Scatter plots comparing the (A) frequency 
(events/min), (B) rise time (ms), (C) amplitude (pA) and (D) decay time (ms) of sIPSCs and 
mIPSCs from LV principal neurones. Note the decreased mean frequency and rise time in the 
presence of TTX (P = 0.002 and P = 0.001; Mann Whitney test) (E) sIPSCs and mIPSCs 
recorded in a LV MEC neurone, before and after the application of TTX (μM). Three traces 
are consecutive recordings of spontaneous activity. 
 
4.3.2 Characterisation of sIPSCs in layers II and V in neonatal rats 
4.3.2.1 Frequency and amplitude  
There are currently no studies that have addressed lamina differences in the properties of 




al., 2004) and juvenile (above) slices, whole cell recordings from LII (n = 7) and LV (n = 12) 
neurones in neonate slices revealed sIPSCs that were abolished by GABAARs antagonists 
(not shown). Interestingly, there was no significant difference in the mean frequency 
between LII (67.2 ± 20.7 events/min, or 1.1 Hz) and LV (61.2 ± 19.8 events/min, or 1.0 Hz) 
although cumulative probability distributions of IEI (Fig. 4.5) did show a small shift towards 
longer IEIs, or a slower frequency, in LV neonatal neurones compared to LII which was 
significant when subjected to KS analysis (P < 0.0001).  
The mean amplitude of sIPSCs in LV (17.2 ± 2.4 pA) was a little larger than that in LII 
neurones (14.1 ± 2.4 pA), but this did not reach significance. However, again, subsequent 
analysis of the cumulative distribution plots did show a displacement of the amplitudes plot 
to the right in LV, indicating an increased presence of larger amplitude events in this layer 
(P < 0.0001). Despite this, LII has a much higher maximum amplitude (269.3 pA) compared 
to LV (177.2 pA), in fact, only one event from the pooled data in LV exceeded 100 pA 
(0.001%). Events exceeding 100 pA in LII were 10 fold higher than in LV. Indeed, the shift in 
the amplitude distribution was attributed to an increase in medium sized events between 
40-100 pA, such that only 0.005% (1/864) of sIPSC in LII neonatal neurones were in this 
region, compared with 6% (51/864) of pooled LV events. The increased presence of 
medium sized amplitudes in LV and the increased presence of small and large, but not 
medium, sized events would explain the lack of significant differences in the overall mean 
amplitudes between LII and LV neonatal sIPSCs. The frequency and amplitude of sIPSCs in 











Figure 4.5: Comparison of sIPSC frequency and amplitude in LII and LV MEC principal 
neurones of neonate rats. (A) Average sIPSC frequency and (B) sIPSC amplitude data from 
6 LII (red) and 12 LV (blue) principal neurones. No significant differences between LII and LV 
were noted in the average frequency or amplitude (C) Cumulative probability distribution 
shown of the IEI and (D) peak amplitude of events (> 77) collected and pooled from each 
neurone. Cumulative probability distributions show the smaller IEI in LII neurones (P < 
0.0001; KS-test), and a skew towards higher amplitude events in LV neurones. (E) sIPSCs 
recorded in a LII and sIPSCs recorded in a LV neurone. Three traces are consecutive 
recordings of spontaneous activity. 
4.3.2.2 Kinetics  
In neonatal neurones, the kinetics of sIPSCs were faster in LV (n = 12) compared to LII (n = 
7) neurones. The mean rise time of LV sIPSCs was 6.2 ± 0.5 ms compared to 7.4 ± 0.4 ms in 
LII, though this did not reach significance, seemingly due to a large spread of both fast and 
slow average rise times, perhaps reflecting GABA release from different sub-populations of 




show a clear displacement of towards faster rise times in LV compared to LII (P < 0.0001; 
KS-test). The mean decay time of sIPSC in LV (5.0 ± 0.6 ms) was clearly and significantly 
faster than in LII (9.6 ± 1.3 ms) neurones (P = 0.004, Mann Whitney test). Again, the 
dramatic leftward shift of the amplitude distribution indicate the much faster decay times 
in LV sIPSCs relative to those in LII neurones (P < 0.0001, Mann Whitney test). The kinetics 
of sIPSCs in LII and LV of neonatal rats are summarised in Fig. 4.6. 
 
 
Figure 4.6: Comparison of sIPSC decay and rise time in LII and LV neurones of neonate 
rats. (A) Scatter plot of sIPSC rise time and (B) sIPSC decay time data from 7 LII (red) and 12 
LV (blue) principal neurones. The average decay time of sIPSCs was significantly faster in LV 
neurones (P < 0.01; Mann Whitney test). (C) Cumulative probability distribution shown of 
the rise time and (D) decay time of events (>77) collected and pooled from each. Cumulative 
probability distributions show the faster rise and decay times in LV neurones (P < 0.0001; 
KS-test, both plots). (E) Averaged sIPSCs of a LII (top; red) and a LV (middle; blue) NEO 





Table 4.1: Summary data of the baseline characteristics of sIPSCs in LII and LV MEC of 
neonate and juvenile neurones. Scatter plots of sIPSC frequency, amplitude, rise times and 
decay times of sIPSCs in neurones from neonate LII MEC (red, n = 7)), juvenile LII MEC (black, 
n = 15), neonate LV MEC (blue, n = 12) and juvenile LV MEC (green, n = 18). * and # denote 






4.3.3 Age Comparison 
4.3.3.1 Frequency and amplitude 
Whole cell recordings of sIPSCs were compared in 19 neonate (P8-14) and 33 juvenile (P20-
28) neurones. At both ages and in both layers sIPSCs were abolished by bicuculline or 
gabazine, confirming their dependence on GABAARs activation (not shown). 
In LII, the mean frequency of sIPSCs was considerably faster in juvenile (571.0 ± 148.0, or 
9.5 Hz; n = 15) compared to neonatal (67.2 ± 20.7 events/min, or 1.1 Hz; n = 7) neurones (P 
= 0.004, Mann Whitney test). The developmental increase in sIPSC frequency (from 1.1 Hz 
to 9.5 Hz) in LII neurones was confirmed by cumulative distribution plots of IEI, showing a 
substantial leftward displacement of the distribution, reflecting the increased likelihood of 
GABA release within short intervals in the juvenile rats (P < 0.0001, KS-test).  
The mean amplitude of sIPSCs slightly increased during development in LII neurones, from 
14.1 ± 2.4 pA in neonatal to 20.1 ± 6.0 in juvenile neurones, but this was not statistically 
significant. The developmental changes in sIPSC frequency and amplitude of LII neurones 
are summarised in Fig. 4.7.  
Developmental changes in frequency and amplitude in LV sIPSCs follow a similar pattern to 
that seen in LII. The mean frequency of sIPSCs was considerably faster in juvenile (150.7 ± 
21.2, or 2.5 Hz; n = 18) compared to neonatal (61.5 ± 19.8 events/min, or 1.0 Hz; n = 12) 
neurones (P = 0.006, Mann Whitney test). It is clear that the frequency of sIPSCs in LV in 
neonatal neurones is very low indeed at this stage of development. The clear 
developmental increase in sIPSC frequency (from 1.0 Hz to 2.5 Hz) in LV neurones was 
reflected in the cumulative distribution plots of IEI (Fig. 4.8), showing a substantial leftward 
displacement of the juvenile sIPSC distribution, again, signifying the increased likelihood of 
GABA release at shorter intervals in the older rats (P < 0.0001, KS-test).  
Again, as in LII, the mean amplitude of sIPSCs did not significantly change during 
development, from 17.2 ± 1.5 pA in neonatal to 18.7 ± 1.8 in juvenile neurones. The 




two age groups, except for a population of high amplitude (> 100 pA) events present 10-
fold more in the pooled data from juvenile neurones (0.01% vs 0.001% in neonatal). The 
developmental increase in sIPSC frequency of LV neurones can be pictured in the raw traces 
in Fig. 4.8. 
 
 
Figure 4.7: Comparison of sIPSC frequency and amplitude in neonate and juvenile 
neurones in LII. (A) Scatter plots comparing the sIPSC frequency and (B) sIPSC amplitude 
data from 7 NEO (red) and 15 JUV (black) principal neurones. Note the significantly 
increased frequency of events in JUV rats (P = 0.002; Mann Whitney test) but no change in 
amplitude (C) Cumulative probability distribution shown of the IEI and (D) peak amplitude 
of events (> 60) collected and pooled from each neurone. Cumulative probability 
distribution plot shows the significantly shorter IEI JUV neurones (P < 0.0001; KS-test, both 
plots). (E) sIPSCs recorded in a LII NEO and a LII JUV principal neurone in the MEC. Three 







Figure 4.8: Comparison of sIPSC frequency and amplitude in neonate and juvenile 
neurones in LV. (A) Scatter plot of sIPSC rise time and (B) sIPSC decay time data from 12 
NEO (blue) and 18 JUV (green) principal neurones. The average frequency of sIPSCs in LV 
neurones significantly increases during development (P = 0.006; Mann Whitney test). (C) 
Cumulative probability distribution shown of the IEI and (D) peak amplitude of events (> 55) 
collected and pooled from each neurone. Note the clearly increased IEI (slower frequency) 
in NEO LV compared with JUV LV sIPSCs (P < 0.0001, KS-test). (E) sIPSCs recorded in a LV 





Examination of the properties of sIPSCs in both groups in both neuronal types at both ages 
showed a wide variation in both rise and decay times, and these may reflect separate 
populations of sIPSCs arising from different interneurones synapsing at specific locations 
on the postsynaptic principal neurones (cf Woodhall et al., 2005). We have not attempted 
to distinguish between such putative groupings in the analysis of the current data. 
In neonatal neurones in LII (n = 7), the mean rise time (7.4 ± 0.4 ms) and decay time of (9.6 
± 1.3 ms) of sIPSCs were significantly slower compared with juveniles (rise 5.7 ± 0.6 ms; P < 
0.05; decay 5.4 ± 0.9 ms; P < 0.01). Indeed, cumulative distribution analysis shows a clear 
leftward displacement of the pooled data from juvenile versus neonate sIPSC rise and 
decay times (P < 0.0001; KS-test, both plots). Changes to sIPSC kinetics could reflect the 
maturation or developmental changes to synaptic organisation of inputs from different 
sub-populations of interneurones (see discussion). Despite a general shift towards faster 
rise times in sIPSCs of juvenile neurones, there was also a population of much slower events 
in the juvenile sIPSCs, not present in neonatal neurones, such that the maximum rise time 
of sIPSCs in LII of juvenile neurones was 92.7 ms, compared with 15.7 ms in neonatal LII 
neurones.  
sIPSCs in LV neurones followed a different pattern to LII, such that there were no significant 
changes to the mean rise times in neonate (6.2 ± 0.5 ms) compared to juvenile (6.9 ± 0.7 
ms). However, similarly to in LII, a population of slower events were present in the juvenile 
neurones that was not apparent in neonate neurones, with a maximum rise time of 75.5 
ms and 16.3 ms from the pooled data of each age group, respectively.  
Interestingly, the average decay time was actually slower in the juvenile group of LV 
neurones (9.9 ± 2.2 ms) compared to neonatal sIPSCs (5.0 ± 0.6 ms), with a maximum decay 
time of 147.8 ms and 40.1 ms in the two groups, respectively. Cumulative analysis of decay 
times of sIPSCs of LV neurones show a clear rightward displacement of the distribution in 
the juvenile population, compared to neonatal, reflecting the presence of slower events. 




the neonatal neurones. The developmental changes to the kinetics of sIPSCs in LII and LV 
of the MEC are summarised in Fig. 4.9 and 4.10. 
 
Figure 4.9: Comparison of sIPSC decay and rise time in neonate and 15 juvenile neurones 
in LII. (A) Scatter plot of sIPSC rise time and (B) sIPSC decay time data from 7 NEO (red) and 
15 JUV (black) principal neurones. Both rise and decay times are significantly faster in 
juvenile neurones compared with neonate neurones (C) Cumulative probability distribution 
shown of the rise time and (D) decay time of events (>54) collected and pooled from each 
neurone. Cumulative probability distributions show a skew towards faster rise and decay 
times in JUV neurones compared to NEO (P < 0.0001; KS-test). (E) Averaged sIPSCs of a NEO 








Figure 4.10: Comparison of sIPSC decay and rise time in neonate and juvenile neurones in 
LV. (A) Scatter plot of sIPSC rise time and (B) sIPSC decay time data from 12 NEO and 18 
JUV principal neurones. (C) Cumulative probability distribution shown of the rise time and 
(D) decay time of events (>55) collected and pooled from each neurone. Cumulative 
probability distributions show the slower rise and decay times in JUV neurones compared 
to NEO (P < 0.0001 for both plots; KS-test). (E) Averaged sIPSCs of a NEO LV (top) and a JUV 







Table 4.2: Table showing charge transfer values and ratios inhibition in LII and LV MEC of 
neonate and juvenile neurones. Charge transfer values are indicative of the overall 
neuronal inhibition, and are calculated using the following equation: Rise time + decay time 
x amplitude x frequency. For /sec divide by 60. Note the substantial 7.9-fold increase in 












Table 4.3: Table showing the ratio of overall inhibition and excitation in LII and LV MEC 
in juvenile and neonate neurones. Note the dominance of inhibition in juvenile neurones.  
4.4 Discussion 
4.4.1 Comparison of sIPSCs in juvenile compared to older animals 
There have been previous lamina comparisons of sIPSC properties in the MEC of adult or 
older animals reported from this laboratory (Bailey et al., 2004; Woodhall et al., 2005; 
Greenhill et al., 2014). As with sEPSCs (Chapter 3) caution is needed required in assessing 
differences and similarities between these studies and the data in this thesis until 
equivalent studies have been conducted under the same conditions. Nevertheless there 
are parallels to be drawn between the two and which are worth pointing out. In adult 
animals the average frequency of sIPSCs in LII was around 11.5Hz (Woodhall et al., 2005) 
which compares well with the rate in juveniles of 9.5Hz seen here. sIPSC frequency in LV 
was the same in adult animals as in juveniles at 2.5Hz. Mean amplitudes were similar in 
both layers (~20 pA) in juvenile animals, and this was reflected in the adults (Woodhall et 




to change amplitude or frequency of IPSCs in LII of juvenile rats, where as it induced a 60% 
decrease in frequency with no change in amplitude in LV. Almost identical results were 
reported for adult animals by Woodhall et al. (2005). The marked similarities between the 
results here compared to the older animals suggest that it is likely that inhibitory 
transmission in the juvenile animal group studied here was fully mature or close to it.  
4.4.2 Developmental changes in sIPSCs 
Directly equivalent examinations of sIPSCs in neonate and juvenile animals under identical 
conditions were conducted in the current experiments, so comparison of changes in 
properties of spontaneous inhibition should reflect genuine developmental maturation of 
GABA transmission of the period studied. As noted above, and summarised in table 4.1 
there were a number of lamina specific differences within and across the two age groups.  
Frequencies of sIPSCs were markedly low and equivalent in LII and LV in neonate animals 
suggesting minimal spontaneous activity of GABAergic interneurones at this stage in 
development. There are a multitude of reasons why this might be so, and in the absence of 
specific studies on interneurone development in the EC, it is only possible to speculate on 
these. For example, principal neurones may still be awaiting the formation of a full 
complement of mature synaptic contacts from interneurones, or these may exist but 
mechanisms for vesicular release of GABA might be undeveloped. Data in Chapter 3 show 
that excitatory transmission onto principal cells is also underdeveloped at this stage, and it 
could be also that excitatory drive onto interneurones is also weak or not fully 
morphologically developed, so the stimulus to GABA release may not yet be present.  
We observed that the frequency of sIPSCs in the MEC increased substantially over the age 
range studied, but without a significant change in amplitude. Inhibitory circuitry in the MEC 
likely undergoes several transitions during post-natal development, directed by both gene 
expression and brain activity, which could influence sIPSC frequency. Such factors include 
changes to synaptic density, synaptogenesis and synaptic pruning, as well as changes to the 
expression of different receptor subunit compositions and interneurone excitability. No 
studies currently directly address these changes specifically in the MEC, but conclusions 




density or in the expression of VG-ion channels could cause an increased excitability of 
interneurones, and a concomitant increase in sIPSC frequency, as seen in the neocortex 
and hippocampus (Luhmann and Prince, 1991, Aoki and Baraban, 2000). Alternatively, 
instead of greater excitatory influences, developmental changes to membrane properties 
of GABAergic interneurones that contribute to the spontaneous activity could cause an 
increase in sIPSC frequency. The increased amplitude witnessed in both layers throughout 
development could reflect an increase in the strength of individual synapses, perhaps due 
to an increase in receptor density, or changes in receptor affinity or efficacy via expression 
of different receptor subunits.  
The increase in sIPSC frequency effect was dramatic in LII where a ~10 fold increase was 
seen. It was also substantial in LV (~3-fold), but remained relatively low in the deep layer 
compared to the superficial. This increase in spontaneous synaptic inhibition reflects a 
remarkable maturation of the inhibitory system over a short period 1-2 weeks. 
Interestingly, similar changes in spontaneous inhibition have been noted in neocortex with 
low numbers of sIPSCs in the first week of life rising markedly in the second and third weeks 
(e.g. Luhmann and Prince, 1991). Interestingly, in visual cortex, immature interneurones 
and GAD activity are evident in the first week of life (Chronwall and Wolff, 1980, Miller, 
1986, Wolff et al., 1984, McDonald et al., 1987) but increase dramatically during the next 
two weeks, increasing by about 5 fold between P8 and P20. Also, inhibitory axosomatic 
synapses only develop in large numbers from around P8 to P20 (Bahr and Wolff, 1985, 
Miller, 1986). It could be suggested, therefore, that the formation of functional synapses 
GABAergic at around this time is responsible for the big rise in spontaneous inhibition in 
both LV and LII in the EC. 
Interestingly, the data in Chapter 3 show that the elevation of inhibition is coincident with 
a developmental increase in excitation in both layers, at least in principal neurones. If the 
same was also true for inputs to the interneurones, then an increase excitatory 
glutamatergic drive could also contribute to increased GABA release. However, this should 
be tempered by the observation that sIPSCs in LII were almost entirely action potential-
independent mIPSCs. The same was not true in LV, and it may be pertinent that the 




interneurone drive could be involved in directly in increased inhibition in the deep layer. 
An alternative possibility is that increased excitation of interneurones promotes 
synaptogenesis of inhibitory connections. These possibilities await further investigation 
A recent study has looked at development of interneurones in entorhinal areas using 
immunohistochemistry (Ueno et al., 2017). Unfortunately, this was in mice, looked at LEC 
and not MEC, only studied animals at P14 and beyond (P21, 28, and 56), and did not look 
at lamina specific differences. Therefore, it is limited in use for comparison to the current 
findings. Large numbers of GAD positive cells were seen at P14 and this did not change 
dramatically throughout development (monitored at P21, 28 and 56). Studies of subtypes 
of interneurones showed differential development profiles. Parvalbumin positive cells 
were not present at P14, but had become visible by P21 and 28. A similar profile was seen 
with calretinin, although a few cells were present at P14. Substantial numbers of calbindin-
positive neurones were present at P14 and this remained stable throughout. Somatostatin-
positive cells were also present at high levels at P14, but this progressively decreased to a 
stable level at P21. The study does show that there are large numbers of GABA neurones 
present at P14 and these tend to increase with development, how this relates to the 
changes in GABA transmission we observe in rat MEC is a matter for conjecture.  
4.4.3 Implications of changes in kinetics  
There were developmental changes in sIPSC kinetics in both layers. PCs in CA1 of the 
hippocampus receive two kinetic classes of GABAARs mediated inhibition: slow dendritic, 
and fast perisomatic, IPSCs, which are likely generated by two distinct groups of 
interneurones. Banks et al. (2002) found a differential developmental regulation of the 
firing properties of the fast and slow GABA events between the ages of P10 and P35. 
Specifically, slow kinetic IPSCs increased over 70-fold between these ages. In the MEC in 
adult animals (Woodhall et al., 2005) detailed analysis of sIPSC kinetics also permitted the 
conclusion that there were different populations of events that reflect release of GABA 
from different populations of interneurones. We have not made such an analysis here, but 
the changes in mean kinetics could suggest that there were different interneurones 
contributing to the spontaneous release in juvenile versus neonate animals. This would fit 




2017). Alternatively, the change in kinetics could be associated with development of 
synapses at different morphological site on principal cells or as a result of changing 
postsynaptic neuronal morphology/electrotonic properties.  
Whatever the reason, sIPSCs become much sharper and briefer in LII reflected by much 
faster kinetics. This would fit with an increased ability of neuronal networks to generate 
higher frequency synchronous firing patterns during development, which are dependent 
on faster kinetics of IPSCs (see Introduction and Chapter 7). sIPSCs in LV actually became 
broader and slower which would be due to the increased presence of a population of 
slower events, not evident in the younger rats, reflecting inputs from different subtypes of 
interneurones or inputs at different somatodendritic locations. Increased dendritic 
synaptic connections, further away from the cell soma, and an increase in electronic length 
of neurones during development could account for the presence of slower events.  
4.4.5 Overall changes in inhibition 
Assessment of arbitrary charge transfer values showed that inhibition was slightly more 
prominent in LII than LV in neonates, although the difference was not marked. However 
when animals reached the juvenile stage, the difference was huge with a profound 
dominance of inhibition in LII despite the decrease in both rise and decay times in this layer. 
This lamina related dominance of inhibition has been noted in previous studies in this 
laboratory (Jones and Buhl, 1993, Jones, 1994, Woodhall et al., 2005, Greenhill and Jones, 
2010, Greenhill et al., 2014). Overall, this would fit with the susceptibility of the superficial 
layers to generation of oscillatory activity (Cunningham et al., 2003, Cunningham et al., 
2004a, Cunningham et al., 2006b) which is largely driven by inhibitory interneurones. This 
is investigated in some detail in Chapter 7 of this thesis.  
When looking at the overall changes in inhibition we must also take into account the 
developmental shift in GABAergic neurotransmission from depolarising to hyperpolarising 
responses (Cherubini et al., 1991). The switch occurs due to increased expression of the 
KCC2 co-transporter on neurones which alters the reversal potential of chloride ions, 
promoting fast hyperpolarising postsynaptic inhibition. In the rat hippocampus the 




age of P9 (Rivera et al., 1999). It is unknown what age the GABA shift occurs in the rat MEC, 
but it is likely that, at least in LII, the shift has also occurred by the age groups used in this 
study. As previously mentioned, however, LV MEC appears to have a slightly protracted 
development compared to both the hippocampus and superficial MEC, which may 
contribute to the reduced developmental increase in inhibition in the deeper layers 
(Donato et al., 2017). In addition, the baseline frequency of sIPSCs in neonate neurones of 
both layers was extremely low therefore we cannot rule out the depolarising action of 
GABAergic neurotransmission at this age.   
Postnatal development of GABAergic neurotransmission is also associated with changes in 
the composition of GABAa receptors, namely the upregulation of α1 and α4 and down 
regulation of α3 and α5 subunits (Laurie et al., 1992). The change in GABA receptor subunits 
is usually paralleled by a decrease in the time decay of IPSCs which, again, may indicate a 
slower development of inhibition in the deep layers of the MEC, though this is rather 
speculative.  
4.4.6 Wider picture 
Similarly to the results regarding excitatory neurotransmission, here we show that the 
increase in synaptic inhibition during development is related to activity specifically at the 
synapse, due to the lack of change to amplitude. Increased synaptic noise is important in 
increasing synaptic strength and range, and ultimately support synchronised brain activity 
such as gamma oscillations (see Chapter 3, section 3.4.4) (Ermentrout et al., 2008). In 
addition, computational models of synaptic noise inversely correlated the amount of noise 
with the likelihood of a seizure in the MEC (Solanka et al., 2015). Interestingly, the 
developmental increase in synaptic noise was much less pronounced in LV compared to LII, 
which could contribute to the susceptibility of the deep layers to seizure generation. 
A substantial difference observed between inhibitory events recorded in the deep and 
superficial layers of the MEC was their action potential dependence and independence, 
respectively. This likely reflects clear differences in the circuitry underlying inhibition in the 
two layers. For example, LV principle neurones may be subject to feedforward inhibition, 




connectivity for which there is evidence for in the MEC (Finch et al., 1988). Activation of 
KARs are known to drive network excitability/inhibition, therefore the differences in lamina 
connectivity in LII and LV MEC are examined further in these conditions in the next two 























Functional role of kainate receptors at 
glutamatergic synapses in LII and LV of 








Recent papers from this laboratory have provided a comprehensive description of the 
properties of inhibitory (GABA) and excitatory (glutamate) transmission in LIII of the MEC, 
and the role of KAR in mediating and modulating transmission at both (Chamberlain et al., 
2012; Greenhill et al., 2014; see previous chapters and below for details). In Chapters 3 and 
4 of this thesis, I provided complementary descriptions of the characteristics of 
spontaneous excitation and inhibition in LII and LV, and examined changes associated with 
development from neonate to juvenile rats’ state. In this chapter and the next I will detail 
the developing role of KAR in transmission in both layers and age groups. 
 KARs are ubiquitous in the central nervous system where they regulate excitatory 
neurotransmission at both sides of the synapse. At the postsynaptic membrane, KARs carry 
part of the synaptic charge, similarly to AMPARs and NMDARs. Indeed, in the hippocampus, 
the quantal release of glutamate can actually generate KAR-mediated EPSCs that 
contribute over half of the total excitatory current (Cossart et al., 2002). At the presynaptic 
level, KARs modulate transmitter release from both excitatory and inhibitory synapses, 
though this chapter will focus on the former. KAR mediated synaptic responses have been 
identified at various locations, including in the CA1 field of the hippocampus (Cossart et al., 
1998), the cerebellum (Bureau et al., 2000), thalamocortical synapses (Kidd and Isaac, 
1999), the basolateral amygdala (Li and Rogawski, 1998) and on principal cells in the 
superficial layers of the MEC (West et al., 2007). The postsynaptic responses in MEC are 
likely to be mediated by GluK2 KARs (West et al., 2007). From these studies, it has become 
apparent that KAR mediated synaptic transmission has characteristic kinetics that are 
different relative to those mediated by AMPARs, namely, excitatory responses are were 
smaller, with significantly slower decay time kinetics and were associated with tonic 
depolarising properties (Cossart et al., 2002).  
There is also compelling evidence to suggest KARs are located presynaptically at both 
excitatory and inhibitory synapses, where they can modulate neurotransmitter release. 
Many studies have focused on mossy fibre synapses onto CA3 neurones. Here, presynaptic 




concentrations of KA act to increase and decrease glutamate release, respectively. The 
exact mechanisms behind this two-way modulation are unknown, but may be related to 
KAR mediated depolarisation, whereby low levels increase transmitter release, and high 
levels inactivate sodium/calcium channels (Schmitz et al., 2001a, Schmitz et al., 2000). KARs 
function as presynaptic autoreceptors at these synapses, acting to boost glutamate release 
in a frequency-dependent manner, implicating these receptors in mediating some forms of 
short-term synaptic plasticity (frequency-dependent facilitation) (Delaney and Jahr, 2002). 
Previous work in this laboratory has identified a GluK1-containing autoreceptor in LIII of 
the MEC which acts to facilitate glutamate release onto principal neurones (Chamberlain 
et al., 2012).  
KARs have also been implicated in long-term plasticity, e.g. LTP at mossy fibre-CA3 
synapses. Specifically, LTP induction can be reversibly prevented after blockade of the 
GluK1-containing KAR, suggesting KARs can be an induction trigger for long-term changes 
in synaptic transmission (Bortolotto et al., 1999). The ability of KARs to modulate synaptic 
plasticity can have consequences for neuronal development. At thalamocortical synapses, 
postsynaptic KARs are involved in the induction and expression of synaptic plasticity in early 
development, because their slower kinetics increase synaptic integration from different 
inputs. During development, KAR expression is down-regulated at these synapses, 
decreasing the likelihood of summating an action potential (Kidd and Isaac, 1999). Studies 
from other brain regions, such as the sensory cortex, have reported GluK1-containing KARs 
undergo clear qualitative changes during neuronal development, thus suggesting roles for 
this receptor in developmental plasticity (Bahn et al., 1994). Other studies show changes 
to the editing of GluK1 and GluK2 KAR subunits at critical periods at late embryonic 
development and early postnatal stages in the rat brain (Bernard et al., 1999). 
Lastly, KARs have been implicated in the manifestation of spontaneous, bursting network 
activity in the neonatal rat hippocampus, an inherent property of development in this 
structure (Lauri et al., 2005, Ben-Ari et al., 1989), which have also been described in the 
immature rat MEC (Jones and Heinemann, 1989). Clearly, KARs and their associated 
functional characteristics can modulate neuronal excitation at both the pre- and post- 




synapses in an activity-dependent manner. Much of this research has focused heavily on 
the hippocampus, but research from this lab has begun to unravel the location and 
functional roles of KARs in the MEC, specifically in LIII.  
KARs have been implicated in many conditions with associated underlying pathology in the 
MEC, most prominently epilepsy (Epsztein et al., 2005, Tolner et al., 2007, Vincent and 
Mulle, 2009). In fact, KA is often used as a chemical model of epilepsy in rodents, due to its 
ability to closely resemble the physiological neuronal damage and seizure induction 
associated with the disorder (Ben-Ari, 1985, Ben-Ari and Cossart, 2000). Broadly speaking, 
epilepsy manifests as hyper-synchronous neuronal network activity as a result of an 
imbalance between excitation and inhibition within the brain. The KAR is therefore a major 
candidate for the involvement in the pathological mechanisms underlying epilepsy and for 
a new therapeutic target.  
This chapter aims to elucidate the involvement of KARs, specifically containing the GluK1 
subunit, in the modulation of spontaneous excitatory neurotransmission in LII and LV of 
the MEC. Unfortunately, time has not permitted examination of KAR contribution to 
evoked postsynaptic responses. I also aimed to determine developmental changes in the 
involvement of KAR modulation of excitatory neurotransmission. Knowledge on the 
contribution of various subunits to receptor function has been somewhat confounded by 
the lack of pharmacological specificity in the development of KAR agonists and antagonists. 
However, the recent development of UBP-310 and ATPA allow more selective antagonism 
and agonism of the GluK1 subunit, respectively, and have been used throughout this 
chapter, along with KA, to elucidate the roles of this subunit modulating excitatory 
transmission in LII and LV. 
5.2 Methods  
Recording methods were described fully in Chapter 2. All experiments in this chapter were 
conducted on combined slices of EC and hippocampus from neonatal (P8-11; 20-35 g) and 
juvenile (P20-28; 50-100 g) Wistar rats. Whole cell voltage clamp recordings of sEPSCs and 




clamped at -60 mV. Cells were selected with good access resistance that remained stable 
for the duration of the recording. To investigate the contribution of KARs to excitatory 
neurotransmission the non-specific agonist, KA, the relatively selective GluK1-containing 
KAR agonist, ATPA, and GluK1 antagonist, UBP-310 were used.  
Mean values for frequency, inter-event interval (IEI; inverse of frequency), amplitude, 
decay times and holding current were determined and compared between control and 
drug groups using either a paired t-test or a repeated measures ANOVA (rANOVA) for 
multiple comparison. Dunnett’s post-test was used if all comparisons were made to the 
control group, whereas a Bonferroni’s post-test was used when comparing selected pairs 
of columns when multiple drugs were added. The non-parametric Mann Whitney test was 
used when comparing different neuronal populations. Two-way ANOVA analysis was used 
when comparing groups which were influenced by two different independent variables 
(e.g. time and age). 
Cumulative distribution analysis used pooled data from a sample of events during a 
continuous recording period for each neurone and statistical comparisons were made using 
a Kolmogorov-Smirnov (KS) test for average mean data and cumulative probability 
distributions, respectively. Statistical significance was defined when P < 0.05, except for KS-
analysis, where significance was reached if P < 0.01 due to the sensitivity of the test. 
 
 





5.3.1 Effects of KA on LII EPSCs  
5.3.1.1 Effects of KA on Juvenile LII sEPSCs 
A summary of the effects of KA on sEPSCs in juvenile LII neurones can be seen in Fig. 5.1A-
E. The effects of non-selectively activating all KARs with KA on spontaneous glutamate 
release onto principal neurones in LII were determined. In the presence of 200 nM KA, the 
mean frequency of sEPSCs increased substantially from 113.9 ± 56.0 events/min (1.9 Hz) to 
1070 ± 448.1 events/min (17.8 Hz) and 1049.0 ± 356.8 events/min (17.5 Hz) after 10 and 
15 minutes, respectively (P = 0.02 for both, rANOVA, n = 4). The 9-fold increase in frequency 
was largely reversed by the subsequent application of UBP-310 (20 μM), which reduced the 
frequency of sEPSCs to 238.8 ± 88.5 events/min (4.0 Hz).  
KA also slightly increased the amplitude of events from 10.1 ± 2.6 pA to 12.2 ± 2.6 pA and 
13.0 ± 2.2 pA after 10 and 15 minutes application, which was reversed to 9.9 ± 1.5 pA after 
additional application of UBP-310. This suggests the increase in amplitude elicited by KA 
was due to activation of KARs containing the GluK1 subunit. It is unlikely that a change in 
amplitude distribution elicited by the agonist is mediated by a postsynaptic mechanism. It 
seems more likely that that an increase in network excitability and action potential 
generation in presynaptic axons causes increased synchronised transmitter release and 
larger amplitude events.  
A noticeable effect of KA was to considerably depolarise neurones, evidenced by the 
significant increase in holding current applied to keep the neurone clamped at -60 mV. This 
effect occurred without change in series resistance, and therefore was not a result of 
jeopardised integrity of the cell or changes to the seal between the electrode and the cell 
membrane. Moreover, the significant KA-induced increase in holding current of 77%, from 
-271.8 ± 59.6 pA to -444.9 ± 55.0 pA, was reduced after application of UBP-310 to -319.0 ± 
45.0 pA, indicating Gluk1-containing KARs maybe be responsible for positive inward current 




application of KA. A summary of the effects of KA on sEPSCs in juvenile LII principal 







Figure 5.1. Effects of KA (200 nM) and UBP-310 (20 μM) on sEPSCs in 4 juvenile and 7 
neonate LII neurones. (A/F) Average sEPSC frequency, (B/G) amplitude, (C/H) decay time 
and (D/I) % change in holding current data from principal neurones. Control groups (white) 
represent sEPSCs before application of KA (red) and UBP-310 (grey). Average frequency and 
holding current was significantly increased in the presence of KA and reversed after addition 
of UBP-310. Traces show concurrent recordings of sEPSCs recorded in control conditions 
(black), in the presence of KA (red) and UBP-310 (grey) in a (E) juvenile and a (J) neonate 




5.3.1.2 Effect of KA on juvenile LII mEPSCs  
The increased amplitude with KA might suggest activation of KAR receptors on excitatory 
neurones presynaptic to the recorded postsynaptic neurone was contributing to this effect 
by increasing excitatory drive. To examine this, the effect of KA on mEPSCs was determined. 
The effects of KA on mEPSCs are summarised in Fig. 5.2. Bath application of KA (200 nM) 
increased the mean frequency of mEPSCs from 136.6 ± 51.1 events/min (2.3 Hz) to 225.9 ± 
77.5 events/min (3.8 Hz) after 15 minutes, an effect which was reversed by subsequent 
application of UBP-310, reducing the frequency of mEPSCs to 104.6 events/min (1.7 Hz). 
The increase in mEPSCs was dramatically less than that seen with sEPSCs, and, in fact, did 
not reach statistical significance.  
Unlike with sEPSCs, there were no differences in the amplitude or decay times of mEPSCs 
after KA application. This does strongly suggest that the observed effects are due to 
enhanced glutamate release consequent on KAR activation on presynaptic excitatory 
neurones. Overall, the results support the suggestion that KARs that containing the GluK1 
subunit are present on both presynaptic excitatory neurones, such that an increased 
excitatory drive elicited by KA facilitates glutamate release onto principal neurones. 
Moreover, the Gluk1-containing KARs may be present postsynaptically on the recorded 
neurone since the increase in holding current induced by KA was still present in TTX but still 
reversed by UBP-310. An alternative explanation for the postsynaptic depolarising effects 
of KA could be due to the sheer increase in active AMPARs on the postsynaptic membrane, 
reflecting the substantial increase in glutamate release and sEPSC frequency. However, the 
change in holding current was unaffected by TTX, and if anything was more marked, 
whereas the increase in sEPSC frequency was largely abolished, so a direct activation of 
postsynaptic GluK1 receptors seems more probable. 
A likely explanation for these findings is that KA depolarises principal cells and activates 
recurrent excitatory connections in LII. However, it has been suggested that recurrent 
excitation between LII neurones is weak or non-existent in the EC (Dhillon and Jones, 2000, 
Couey et al., 2013, Pastoll et al., 2013a, Fuchs et al., 2016). This has been recently 
questioned by another study that found a connectivity of about 2.5% between stellate 




al., 2017). Additionally, there was a substantial connectivity between LIII PCs (which 
themselves are highly interconnected; (Dhillon and Jones, 2000) and LII SCs (Winterer et 
al., 2017).Thus, the massive increase in sEPSC frequency with KA in the current data could 
be due to activation of KAR on both LII and LIII pyramids that provide feed-forward 
excitation to LII stellate neurones. Slightly at odds with this is the reduction of the effect 
with UBP-310, since it has been suggested that KAR receptors on LII and LIII neurones 
appeared to be more GluK2 than GluK1 containing (Beed et al., 2013, Chamberlain et al., 
2012). However, the fact that UBP-310 only partially reversed the effect of KA on sEPSCs in 
LII might suggest that is a mixed population of receptors is being activated by KA. 
 
Figure 5.2. Effects of KA (200 nM) and UBP-310 (20 μM) on mEPSCs in juvenile LII 
neurones. (A) Average sEPSC frequency, (B) amplitude, (C) decay time and (D) % change in 
holding current data from 4 principal neurones. Control groups (white) represent mEPSCs 
before application of KA (red) and UBP-310 (grey). Average frequency and holding current 
was significantly increased in the presence of KA and reversed after addition of UBP-310.  
5.3.1.3 Effects of KA on neonate LII sEPSCs 
Unpublished immunohistochemical data made available by Professor Elek Molnar from the 
University of Bristol shows a progressive increase in expression of several KAR subtypes 
with development in the temporal lobe areas of the rat brain (see Fig. 1.6 in Chapter 1). 
Although the changes in the EC were not quantified, visual examination suggests a 
noticeable increase in GluK1 expression around P14 which appeared stable thereafter. 




upwards. It seems likely, therefore, that there may be alterations in KAR function in 
synaptic transmission with development. 
The effects of KA on sEPSCs in LII neurones in neonate slices are also shown in Fig. 5.1 (F-
J). In the presence of KA (200 nM), the mean frequency of sEPSCs increased substantially 
from 90.6 ± 19.8 events/min (1.5 Hz) to a maximum of 570.8 ± 194.2 events/min (9.5 Hz) 
after 15 minutes perfusion (P < 0.05, rANOVA; n = 7). This 6-fold increase in frequency was 
completely reversed to a level below control by the subsequent cumulative application of 
UBP-310 (20 μM), which reduced the frequency of sEPSCs to 67.4 ± 22.2 events/min (1.1 
Hz; P < 0.05, rANOVA). KA also increased the amplitude of events from 7.9 ± 1.0 pA to 10.2 
± 1.0 pA after 15 minutes application (P < 0.01, rANOVA), an effect that was also reversed 
to 7.4 ± 0.8 pA by UBP 310 (P < 0.0001, rANOVA).  
Surprisingly, the mean decay time of sEPSCs increased significantly from 4.1 ± 0.3 ms to 8.3 
± 1.8 ms after 15 minutes exposure to KA (P < 0.05, rANOVA; n = 7), again the effect was 
reversed to control levels (3.9 ± 0.3 ms) by UBP-310 (P < 0.05, rANOVA; n= 7).  
As in LII neurones in juvenile slices (Fig. 5.1 A-E), KA appeared to have a substantial 
postsynaptic depolarising effect, reflected by an increase in holding current in the recorded 
cell. KA increased holding current by 71%, from -86.4 ± 22.6 pA to -137.5 ± 30.6 pA (P < 
0.0004, rANOVA), and this was partially reduced by UBP-310 to -114 ± 29.4 pA.  
By and large, the effects of KA and subsequent addition of UBP-310 in neonate neurones 
were qualitatively similar to that seen in juvenile neurones, although the magnitude of the 
frequency increase was somewhat less. The data supports the suggestion that KA is 
activating a GluK1 containing KAR on the soma/dendrites of other principal neurones in LII 
and LIII (cf Winterer et al., 2017) to increase glutamate release at recurrent inputs to the 
recorded neurone. One noticeable difference was the increase in decay time of events in 
KA. This could suggest that the population of neurones activated by KA do not contribute 
to sEPSCs at rest, and that when activated they generate a separate population of sEPSCs 




5.3.2 Effects of ATPA on LII EPSCs  
5.3.2.1 Effect of ATPA on Juvenile LII sEPSCs 
KA, at a concentration discriminatory between AMPAR and KAR but not between different 
KARs, led to an increase in sEPSC frequency that was as least partially reversed by blocking 
the GluK1-containing KAR. However, does this mean GluK1 KARs are initiating the change 
in frequency in the first place? To investigate this further, the effects of the selective GluK1 
KAR agonist, ATPA, on sEPSC activity were determined.  
The effects of ATPA on sEPSCs are summarised in Fig. 5.3. Unexpectedly, ATPA (100 nM) 
slightly but significantly decreased the mean frequency of sEPSCs in LII juvenile neurones, 
from 276.3 ± 71.4 events/min (4.6 Hz) to 188.3 ± 38.0 events/min (3.1 Hz) after 10 minutes 
(P = 0.01, rANOVA with Dunnett’s post-test; n = 6), although the effect was small with only 
a partial recovery to 231.6 ± 52.4 events/min (3.9 Hz) after a wash-out, and ATPA had no 
effect on amplitude or decay time or on the holding current applied to maintain the 
neurone at -60 mV (although there was a trend towards an increase in it that actually 
reached significance during washout). These results are at odds with the experiments using 
KA, and would suggest the depolarisation observed with KA application was not due to 
activation of postsynaptic GluK1 KARs present on the recorded neurones. Likewise, it would 
also suggest that the increase in sEPSCs seen with KA is unlikely to be due to increased 
excitatory drive after activation of GluK1 receptors on recurrently connected neurones. 
However, what is most puzzling is that both effects of KA were substantially reversed by 
the GluK1 antagonist UBP-310. It is possible that the specificity of the drug is not as good 
as was previously thought. Indeed, previous studies have suggested that whilst UBP-310 
has little affinity for GluK2, it may substantially block GluK3 receptors as well as GluK1 
(Perrais et al., 2009, Atlason et al., 2010), so one possibility is that the effects of KA are 






Figure 5.3 Effects of ATPA (100 & 500 nM) on sEPSCs in 4 juvenile and 3 neonate LII 
neurones. (A/F) Average sEPSC frequency, (B/G) amplitude, (C/H) decay time and (D/I) % 
change in holding current data from principal neurones. Control groups (white) represent 
sEPSCs before application of ATPA (blue) and a wash-out (dotted). Average frequency of 
sEPSCs was significantly decreased in the presence of ATPA in juvenile (A) but not neonate 
slices (F). (E) Concurrent recordings of sEPSCs recorded from a juvenile neurone in control 
conditions (black), and in the presence of ATPA (blue) and after a wash-out (grey). NB: Due 
to the lack of an effect in neonate sEPSCs no traces are presented and the concentration of 




As noted, these results were unexpected, especially as we have previously shown that both 
KA and ATPA, induced a significant increase in sEPSC frequency in the adjacent LIII 
(Chamberlain et al., 2012). To check that the lack of an effect of ATPA was a true effect, I 
reconfirmed its effects on 3 principal neurones in LIII. Although not statistically significant 
due to the low n number, there was a clear increase in the average frequency of sEPSCs 
that was reversed upon wash-out of the drug (Fig. 5.4). However, it should be noted here 
that the effects of ATPA in LIII were unaffected by TTX, so were largely the result of 
activation of GluK1 receptors on excitatory synaptic terminals not somatic/dendritic 
receptors (Chamberlain et al., 2012). 
 
 
Figure 5.4: Effects of ATPA (100 nM) on sEPSCs in juvenile LIII neurones. (A) Average % 
change in sEPSC frequency, (B) amplitude, (C) decay time and (D) holding current data from 
3 principal neurones. Control (dashed line - - -) represents sEPSCs before application of ATPA 
(blue) and a wash-out (dotted). Note that in LIII neurones, ATPA increased sEPSC frequency.  
 
5.3.2.2 Effects of ATPA on juvenile LII mEPSCs 
To determine whether the reduction of sEPSCs by ATPA in juvenile slices was due to 
activation of presynaptic GluK1-containing KARs on glutamate terminals, as opposed to 
GluK1 receptors on soma/dendrites, I tested the effects of ATPA on mEPSCs. ATPA (100 
nM) had no effect on the frequency, amplitude or decay time kinetics of mEPSCs, as seen 






Figure 5.5: Effects of ATPA (100 nM) on mEPSCs in juvenile LII neurones in TTX (1 μM). (A) 
Average mEPSC frequency, (B) amplitude, (C) decay time and (D) % change in holding 
current data from 8 principal neurones. Control groups (dotted) represent mEPSCs in the 
presence of TTX, before application of ATPA (blue). ATPA had no effect on the frequency of 
events.  
 
5.3.2.3 Effects of ATPA on neonate LII sEPSCs 
Bath application of ATPA (100 nM), as in juvenile slices, appeared to slightly decrease the 
frequency of sEPSCs in neonate neurones, from 131.4 ± 22.8 events/min to 111.5 ± 8.9 
events/min, but the change was not significant. Cumulative addition of ATPA to 500 nM 
had no additional effect (108.7 events/min). ATPA also had no effect on the mean 
amplitude of sEPSCs or mean decay time. Interestingly, unlike in juvenile slices, ATPA 
appeared to induce a slight, but non-significant, decrease in the average holding current in 
neonatal LII principal cells (from -101.5 ± 25.4 pA to -82.7 ± 32.8 and -84.8 ± 38.5 after 100 
nM and 500 nM). Overall, the results generally reflect those seen with ATPA in juvenile 
slices and are summarised in Fig. 5.3 alongside the juvenile data.  
Although the decrease in sEPSC frequency with ATPA was not marked, the absence of 
marked effects on mEPSCs could suggest that the decrease in sEPSC frequency was the 
result of a decrease in network excitation. Reasons for this could include: 1) receptor 
desensitisation due to excessive receptor activation, 2) the presence of GluK1-containing 




in network activity, 3) GluK1 KAR activation with ATPA may have caused a depolarising 
block, a rate-limiting mechanism to protect neurones from excessive spiking. However, this 
is unlikely as the frequency of sEPSCs did not increase first, unless, however, the receptor 
is already very highly tonically active. Under high levels of tonic activity, sEPSC frequency 
could have decreased if ATPA had a lower efficacy or slower receptor binding kinetics than 
ambient glutamate, leading to a decrease in excitation relative to the tonic conditions. 
Tonic activation of GluK1-containing KARs was therefore investigated by testing the effect 
of UBP-310 alone. 
5.3.3 Effects of UBP-310 on LII EPSCs  
5.3.3.1 Effect of UBP-310 on Juvenile LII sEPSCs 
The effects of UBP-310 on sEPSCs are summarised in Fig. 5.6. The mean frequency of sEPSCs 
was substantially decreased after 15 minutes application of 20 μM UBP-310 from 237.6 ± 
70.9 events/min (4 Hz) to 96.1 ± 21.9 events/min (1.6 Hz) (P = 0.02, rANOVA with 
Bonferrini’s post-test; n = 6), suggesting GluK1 KARs are highly tonically activated in LII and 
contribute substantially to spontaneous glutamate release. There was no effect on the 
mean amplitude of sEPSCs (control 7.1 ± 0.7 pA vs 6.8 ±1.1 pA after UBP-310). Additional 
application of 200 nM KA on top of UBP-310 had no effect on mean amplitude, frequency, 
decay time or holding current. 
If we assume that UBP-310 may be blocking GluK1 receptors that are already tonically 
activated by ambient glutamate, this may indicate why ATPA had little effect on sEPSCs 
(Fig. 5.3), and it indeed could contribute to a reduction in the tonic effect by desensitisation 
of the GluK1 receptors. The fact that KA had virtually no effect in the presence of UBP-310 
may be a further indication that the increase in sEPSCs and other effects seen with KA alone 
is due to non-GluK1 receptors in recurrent circuits that are also affected by UBP310 (e.g. 





Figure 5.6: Effects of UBP-310 (20 μM) and KA (200 nM) on sEPSCs in 6 juvenile and 6 
neonate LII neurones. (A/F) Average sEPSC frequency, (B/G) amplitude, (C/H) decay time 
and (D/I) % change in holding current data from LII principal neurones. Control groups 
(white) represent sEPSCs before application of UBP-310 (grey) and KA (red). Average 
frequency was significantly decreased in the presence of UBP-310 and was not affected by 
the addition of KA. Concurrent recordings of sEPSCs recorded in control conditions (black), 





5.3.3.2 Effects of UBP-310 on juvenile LII mEPSCs 
To help determine the location of the tonically active GluK1-containing KAR, UBP-310 (20 
μM) was tested on mEPSCs in the presence of TTX (1 μM). Interestingly, effects on sEPSCs 
were also seen with mEPSCs, the mean frequency being significantly decreased from 157.2 
± 45.0 events/min (2.6 Hz) to 89.2 ± 417 events/min (1.5 Hz) (P = 0.01, paired t-test; n = 4). 
There was no change in mean amplitude (9.3 ± 1.1 pA vs UBP-310: 8.3 ± 1.6 pA) or the mean 
decay time (3.3 ± 0.3 ms vs 2.6 ± 0.2 ms). The effects of UBP-310 on mEPSCs in juvenile 
slices are summarised in Fig. 5.6.  
5.3.3.3 Effects of UBP-310 on neonate LII sEPSCs 
UBP-310 was applied alone to determine if the tonic activation GluK1-containing KAR 
activation seen in LII in juvenile rats was also present in neonates. The effects are also 
summarised in Fig. 5.6, alongside the effects on juvenile slices. In the presence of the 
antagonist, the mean frequency of sEPSCs was substantially and significantly decreased 
from a control of 194.6 ± 45.6 events/min (3.2 Hz) to 59.2 ± 11.5 events/min (1.0 Hz) after 
UBP-310 (P < 0.0001, rANOVA, n = 6). Cumulative application of KA had no further effect in 
the presence of UBP-310. The substantial decrease in frequency suggests tonic activation 
of GluK1 autoreceptors on synaptic terminals by ambient glutamate, which accounts for 
about 50-60% of spontaneous release. 
UBP-310 appeared to induce very small, but significant decrease in the average amplitude 
of sEPSCs, from a control of 8.6 ± 0.6 pA to 7.4 ± 0.6 pA (P = 0.0006, rANOVA; n = 6). UBP-
310 did not change the mean decay time of sEPSCs (4.6 ± 0.5 ms to 4.0 ± 0.6 ms). Addition 
of UBP-310 also appeared to induce a very small but significant increase in the amount of 
holding current which was applied to maintain the neurone at -60 mV, from a control of -
164.7 ± 49.1 pA to 195.4 ± 67.8 pA. Thus, again, the effect of UBP-310 on sEPSCs in LII of 
neonates reflects that seen in juveniles.  
The results thus far have identified that KARs have major roles in the regulation of 
glutamatergic transmission in LII. Specifically, generalised KAR activation substantially 




activation of soma/dendritic KAR in neurones that provide inter- and intra-lamina recurrent 
excitatory inputs to the recorded neurone. This is supported by depolarising effects of KA 
in the latter, and the fact that TTX largely abolished the response. This effect was partially 
reversed by UBP-310, which initially suggests that the receptor involved is GluK1-
containing. However, a GluK1 agonist did not increase the frequency sEPSCs, in fact, ATPA 
led to a small decrease in frequency. One interpretation of these results is that UBP-310 is 
not in fact specific for GluK1 receptors, and that KA is activating another receptor, possibly 
GluK3 (Perrais, 2009). Surprisingly, however, UBP-310 alone substantially reduced sEPSC 
and mEPSC frequency suggesting that GluK1-containing KARs are tonically active 
autoreceptors on glutamate terminals in LII and are activated by ambient glutamate, 
helping to maintain a high level of release. This leads to the possibility that the component 
of sEPSCs and mEPSCs reduced by UBP-310 after addition of KA is actually the tonic 
presynaptic component and that the remainder is recurrently driven release by non-GluK1 






Figure 5.7: Effects of UBP-310 (20 μM) on mEPSCs in juvenile LII neurones. (A) Average 
sEPSC frequency, (B) amplitude and (C) decay time of sEPSCs from 4 principal neurones. 
Control groups in the presence of TTX (dotted) represent mEPSCs before application of UBP-
310 (grey). Average frequency was significantly decreased in the presence of UBP-310. 
Traces show concurrent recordings of mEPSCs recorded in control conditions (black), and in 





5.3.4 Effects of KA on LV EPSCs  
5.3.4.1 Effect of KA on Juvenile LV sEPSCs 
The effects of KA on sEPSCs are summarised in Fig. 5.8. Generalised activation of KARs using 
KA caused a gradual and significant increase in sEPSC frequency from 167.8 ± 49.1 
events/min (2.8 Hz) to a maximum of 356.9 ± 49.1 events/min (5.9 Hz) after 15 minutes (P 
= 0.0002, rANOVA; n = 5). This effect was substantially less (~2 fold) than that seen in LII 
(~9 fold). Subsequent cumulative application of UBP-310 (20 μM) reversed the increase in 
frequency to 122.9 ± 38.5 events/mins, or 1.9 Hz (P < 0.001, rANOVA) and this actually fell 
slightly below control levels, perhaps indicating tonic activation of GluK1 KARs in LV. The 
increase also appeared slower in onset than in LII (cf Fig. 5.1).  
Unlike in LII, KA had no effect on the amplitude of sEPSCs in LV (control: 8.5 ± 0.4 pA vs KA: 
8.2 ± 0.2 pA), perhaps suggesting the increase in frequency did not have a large network 
driven component. KA also had no effect on sEPSC decay time (3.0 ± 0.3 ms v 3.1 ± 0.4 ms). 
KA did induce a significant increase in holding current from 148 ± 33.3 pA to -218.3 ± 29.9 
pA after 15 minutes in KA, which was similar to that seen in LII. However, this was not 
affected by UBP-310.  
Overall these results show that KAR activation can increase glutamate release in LV, but 
this effect is more restrained than that seen in LII. The lack of a change in amplitude could 
indicate that KA is having its effects directly on the presynaptic terminals rather than 
activating other principal neurones that provide recurrent input to the recorded neurone. 
If we accept that UBP-310 is fairly specific for GluK1, its effects suggest that KA is largely 
activating GluK1 receptors but that overall release levels may involve a tonic activation of 





Figure 5.8: Effects of KA (200 nM) and UBP-310 (20 μM) on sEPSCs in 5 juvenile and 8 
neonate LV neurones. (A/F) Average sEPSC frequency, (B/G) amplitude, (C/H) decay time 
and (D/I) % change in holding current data from LV principal neurones. Control groups 
(white) represent sEPSCs before application of KA (red) and UBP-310 (grey). Average 
frequency and holding current was significantly increased in the presence of KA and 
reversed after addition of UBP-310. Concurrent recordings of sEPSCs recorded in control 
conditions (black), in the presence of KA (red) and UBP-310 (grey) in a juvenile (E) and a (J) 
neonate LV principal neurone. Note the substantial increase and decrease in sEPSC 




5.3.4.2 Effects of KA on LV mEPSCs 
Bath application of KA (200 nM) did not significantly alter the average frequency of mEPSCs 
in 6 LV principal neurones from an average control of 87.5 ± 24.8 events/min (1.5 Hz) to 
79.3 ± 17.5 events/min (1.3 Hz) and 71.9 ± 25.1 events/min (1.2 Hz) after 5 and 10 minutes 
KA, respectively (Fig. 5.9). A slight increase in the frequency of mEPSCs does appear after 
15 minutes KA, however, on closer analysis this reflects a large increase in frequency in one 
cell. KA had no effect on the amplitude of mEPSCs, from an average of 7.6 ± 0.3 pA to 7.6 ± 
0.3 pA and 7.3 ± 0.4 pA after 10 and 15 minutes, respectively. No changes were detected 
in mean decay time of mEPSCs. However, the holding current was significantly increased 
after 15 minutes exposure to KA, suggesting the presence of post-synaptic KARs on the 
recording neurone.  
 
Figure 5.9: Effects of 200 nM KA on mEPSCs in juvenile LV neurones in TTX (1 μM). (A) 
Average sEPSC frequency, (B) amplitude, (C) decay time and (D) % change in holding current 
data from 6 LV principal neurones. Control groups (white) represent mEPSCs before 
application of KA (red). There were no significant changes in the presence of KA except an 




Thus, the lack of effect on mEPSCs suggests that most of the increased release induced by 
KA in LV is again largely due to activation of KAR on local input neurones recurrently 
innervating the recorded neurone. This would be supported by the similarity in direct 
depolarizing effects of KA on neurones regardless of whether TTX is present or not. The 
similarity in amplitude of sEPSCs and mEPSCs and lack of any change in amplitude of sEPSCs 
with KA, indicates that the input neurones are likely to be releasing glutamate at quantal 
levels. This would be supported by previous studies which have shown a relatively high 
degree of recurrent connectivity between neurones in LV, but very small amplitude single 
axon EPSPs in dual cell recordings (Dhillon and Jones, 2000). 
5.3.4.3 Effects of KA on neonate LV sEPSCs 
The effects of non-selectively activating KAR on sEPSCs are shown in Fig. 5.8F-J. In the 
presence of KA (200 nM), the mean frequency of sEPSCs moderately increased from 35.0 ± 
14.6 events/min (0.6 Hz) to 126.2 ± 93.3 events/min (2.1 Hz) and 106.7 ± 73.4 events/min 
(1.8 Hz) after 10 and 15 minutes KA, respectively (n = 8). However, the high degree of 
variability between individual neurones meant that this did not reach statistical 
significance. On closer analysis it became apparent there were two separate responses to 
KA in LV neonatal neurones: 1) Neurones that showed no increase in frequency of sEPSCs 
in the presence of KA, deemed ‘non-responsive’ (n = 4) and 2) neurones that increased the 
frequency of sEPSCs in response to KA (n = 4). In the non-responsive group, KA had no 
apparent effect on the frequency, amplitude or decay time of sEPSCs.  
The other 4 neonatal LV neurones examined neurones tested responded to KA. The amino 
acid increased the frequency of sEPSCs from a control of 48.7 ± 29.3 events/min (0.8 Hz) to 
228.9 ± 183.3 events/min (3.8 Hz) and 193.1 ± 142.0 events/min (3.2 Hz) after 10 and 15 
minutes KA, respectively. This effect was reversed to below control levels (23.2 ± 8.9 
events/min - 0.4 Hz) after addition of 20 μM UBP-310. Despite this, the increase in average 
frequency did not reach statistical significance in this KA responsive group mostly due to 
the large variation between neurones (n = 4). In the responsive group, the average 
amplitude was significantly increased by KA to 10.1 ± 2.0 pA after 10 minutes KA, from a 
control of 7.7 ± 1.1 pA (P = 0.01, rANOVA; n = 4), but just dropped blow significance after 




(to 7.7 ± 1.2 pA). As in the neurones in LII of neonate animals, KA appeared to increase the 
mean decay time in the LV responsive group (3.6 ± 0.4 ms to 7.7 ± 3.3 ms after 15 min KA), 
again this was non-significant, but the change did appear to be reversed (4.7 ± 0.8 ms) by 
UBP-310. In the neurones that responded to KA, holding current increased from -56.4 ± 
18.4 pA to 87.1 ± 26.5 pA after 15 minutes in KA (P = 0.02, rANOVA; n = 4), partially reversed 
to -77.1 ± 28.7 pA by UBP-310, again. These effects are summarised in Fig. 5.10. 
 
 
Figure 5.10: Effects of KA and UBP-310 on sEPSCs in neonatal LV neurones. (A) Overall 
average sEPSC frequency, amplitude, decay time and % change in holding current data from 
8 principal neurones. (B) The average sEPSC frequency, amplitude, decay time and % change 
in holding current data from a subset of 4 principal neurones that responded to KA. (C) The 
average sEPSC frequency, amplitude, decay time and % change in holding current data from 
a subset of 4 principal neurones that did not respond to KA. Note the responsive neurones 




5.3.5 Effects of ATPA on LV EPSCs  
5.3.5.1 Effect of ATPA on Juvenile LV sEPSCs 
To determine if activation of GluK1-containing KARs alone was sufficient to cause the 
increased frequency of sEPSCs, the effect of ATPA, was determined. A summary of the 
effects of ATPA on sEPSCs in principal neurones in LV MEC summarised in Fig. 5.11.  
As seen in LII, bath application of ATPA (100 nM) again appeared to weakly decrease the 
average frequency of sEPSCs in LV MEC principal neurones, from 155.5 ± 78.6 events/min 
(2.6 Hz) to a maximum decrease to 110.7 ± 37.6 events/min (1.8 Hz) after 5 minutes 
application, although the difference did not reach significance (n = 8) and continued 
application of ATPA actually saw a return to close to baseline levels.  
ATPA also had no effect on the amplitude or decay time of sEPSCs. The holding current 
weakly increased from an average of -50.7 ± 12.3 pA to -72.5 ± 19.5 pA after 15 minutes 
ATPA. This could suggests that GluK1 KARs are present on the membrane of the recorded 
neurones, but it was a weak effect and may be simply gradual drift in the recording 
conditions, especially as it did not reverse with washout of ATPA.  
Overall these results indicate that as in LII the effects of KA on sEPSCs are likely to be 
mediated by a receptor other that GluK1, or that the receptors may be occupied close to 





Figure 5.11: Effects of ATPA (100 & 500 nM) on sEPSCs in 8 juvenile and 4 neonate LV 
neurones. (A/D) Average sEPSC frequency, (B/E) amplitude and (C/F) decay time of sEPSCs 
from LV principal neurones from juvenile (left) and neonate (middle) slices. Control groups 
(white) represent sEPSCs before application of ATPA (blue) and a wash-out (dotted). ATPA 
had no effect on sEPSCs. (G) Concurrent recordings of sEPSCs recorded from a neonate 
neurone in control conditions (black), in the presence of 100 nM ATPA (blue) and 500 nM 





5.3.5.2 Effects of ATPA on LV juvenile mEPSCs 
Next, the effect of ATPA was determined in the presence of TTX (1 μM) to see if a 
presynaptic mechanism was the cause of the slight decrease in frequency of sEPSCs. A 
summary of the effects of ATPA can be observed in table 5.2 and in Fig. 5.11. As with 
sEPSCs, ATPA had only very weak and non-significant effect mEPSCs in LV neurones.  
 
 
Figure 5.12: Effects of ATPA on mEPSCs in juvenile LV neurones. (A) Average sEPSC 
frequency, (B) amplitude, (C) decay time and (D) % change in holding current data from 8 
principal neurones. Control groups in TTX (dotted) represent sEPSCs before application of 
ATPA (blue). 
 
5.3.5.3 Effects of ATPA on LV neonate sEPSCs 
ATPA, as in all the previous cell groups detailed in this chapter, elicited a slight and non-
significant decrease in sEPSC frequency in neonate sEPSCs from a low baseline frequency 
of 30.0 ± 7.2 events/min (0.5 Hz) to 25.1 ± 6.8 events/min (0.4 Hz) after 100 nM, with no 
further change (22.1 ± 4.8 events/min (0.4 Hz) with 500 nM. Although the decrease in 
frequency was small, it did appear to reverse (33.2 ± 12.8 events/min) after wash-out, 
suggesting it was an effect of the drug. There were no significant changes in amplitude and 
although the mean decay time appeared to increase slightly (from 3.9 ± 0.6 ms to 4.5 ± 1.7 




change was reversed (3.9 ± 0.7 ms) on wash-out so the effect could have been induced by 
the drug. ATPA did not affect holding current at either concentration. The effects of ATPA 
on LV neonate sEPSCs are summarised in Fig. 5.11.  
5.3.6 Effects of UBP-310 on LV EPSCs  
5.3.6.1 Effect of UBP-310 on Juvenile LV sEPSCs 
To determine if GluK1-containing KAR were tonically activated in LV, UBP-310, was applied 
during recording of sEPSCs. The results are summarised in Fig. 5.13. The mean frequency 
of sEPSCs was noticeably and significantly decreased from 112.3 ± 4.7 events/min (1.9 Hz) 
to 46.7 ± 12.5 events/min (0.8 Hz) in the presence UBP-310 (P = 0.0002, rANOVA; n = 4). 
Thus, as in LII, GluK1 KARs appear to be tonically activated by ambient glutamate in LV, 
which then helps to maintain on-going spontaneous glutamate release. This could indicate 
that a failure of ATPA to affect release could be because the GluK1 receptors on the 
terminals are already saturated by glutamate, and that the small decrease induced by the 
agonist could reflect a level of desensitisation of the receptors. Addition of KA cumulatively 
with UBP-310 had no further effect on the average frequency (45.7 ± 11.1 events/min (0.8 
Hz). Application of UBP-310 alone had no effect on the amplitude of sEPSCs (control 7.1 ± 
0.2 pA vs 6.7 ± 0.4 pA after UBP-310) and further application of KA also had no effect on 
the average amplitude (6.6 ± 0.5 pA). 
The decay time of sEPSCs was unaffected by the addition of UBP-310 (from 1.7 ± 0.1 ms to 
2.7 ± 0.1 ms). Strangely, decay time appeared to increase when KA was cumulatively 
applied, but this is likely to be a spurious result as further cumulative probability analysis 
showed very little shift in distributions (not shown). No statistically significant changes 








Figure 5.13: Effects of UBP-310 (20 μM) and KA (200 nM) on sEPSCs in 4 juvenile and 4 
neonate LV neurones. (A/F) Average sEPSC frequency, (B/G) amplitude, (C/H) decay time 
and (D/I) % change in holding current data from LII principal neurones. Control groups 
(white) represent sEPSCs before application of UBP-310 (grey) and KA (red). Average 
frequency was significantly decreased in the presence of UBP-310 and was not affected by 
the addition of KA. Concurrent recordings of sEPSCs recorded in control conditions (black), 





5.3.6.2 Effects of UBP-310 on juvenile mEPSCs 
To help determine the location of the tonically active GluK1-containing KAR, UBP-310 (20 
μM) was applied to mEPSCs in the presence of TTX (1 μM). Interestingly, the mean 
frequency of mEPSCs was still significantly decreased from 129.9 ± 27.0 events/min (2.2 Hz) 
to 63.5 ± 11.0 events/min (1.1 Hz) in the presence of UBP-310 (P < 0.05, t-test; n = 4). As 
with sEPSCs, UBP-310 did not significantly change the amplitude of mEPSCs (TTX: 6.9 ± 0.7 
pA vs UBP-310: 6.6 ± 0.2 pA).  
UBP-310 had no effect on the average decay time of mEPSCs (from 2.1 ± 0.2 ms to 2.1 ± 0.1 
ms), or on the mean holding current.  Results are summarised in Fig. 5.14. 
Accepting the potential limitations on specificity of UBP-310, these results largely confirm 
that GluK1-containing KAR reside on the presynaptic terminals of inputs to LV neurones 
and are tonically activated by ambient glutamate to maintain its on-going release.  
Thus, overall, the results suggest that KARs modulate glutamate transmission in LV, but 
their role may be more limited than in LII. Generalised KAR activation did increase 
glutamate release onto principal neurones by activating neurones with recurrent inputs to 
the recorded neurone but this is likely to be due to a receptor other than GluK1. The overall 
level of release was reversed by UBP-310, but a large component of this effect may be due 






Figure 5.14: Effects of 20 μM UBP-310 on mEPSCs in juvenile LV neurones. (A) Average 
sEPSC frequency, (B) amplitude and (C) decay time of sEPSCs from 4 principal neurones. 
Control groups in the presence of TTX (dotted) represent mEPSCs before application of UBP-
310 (grey). Average frequency was significantly decreased in the presence of UBP-310. 
Traces show concurrent recordings of mEPSCs recorded in control conditions (black), and in 







5.3.6.3 Effects of UBP-310 on neonate sEPSCs 
Potential tonic activation of GluK1-containing KAR was assessed in LV neonate neurones by 
application of UBP-310 alone. sEPSCs frequency was significantly decreased from 58.4 ± 
13.7 events/min (1.0 Hz) to 21.6 ± 13.7 (0.4 Hz) events/min by UBP-310 (P = 0.03, rANOVA; 
n = 4). Subsequent application of KA had no effect on the frequency of sEPSCs. Likewise, 
neither UBP-310 nor KA had any substantial effect on sEPSC amplitude, decay time or 
holding current. The results are summarised in Fig. 5.13(F-J). 
 It should be noted that as with the effects of KA on the LV neonatal neurones, UBP-310 
differentially affected a subset of cells. In 4/6 cells, UBP-310 decreased the frequency of 
events but in 2/6 cells, it clearly had no effect. This could suggest that the function or 
expression of the GluK1-containing KAR is still very low in LV at this stage in development 
or perhaps that ambient levels or glutamate are lower at this stage of development, and 
therefore the receptor is either not tonically activated by low levels of glutamate, or even 
expressed at levels that are functionally activated. The cells that had no response to UBP-
310 had a very low baseline frequency, which may be suggestive of a low ambient 
glutamate level. It was thought to be a worthwhile exercise to compare the baseline 
properties of the cells that did respond to either KA or UBP-310 application and those that 
did not. 
 
Figure 5.15: Comparing the baseline characteristics of UBP-310 and KA responsive 
neurones vs non-responsive neurones. (A) Average sEPSC frequency, (B) amplitude, (C) 
decay time and (D) holding current data from 8 LV responsive (circles) and 6 LV non-




increased in the subset of neurones that were responsive to KA and UBP-310 (P < 0.01, Mann 
Whitney test). 
Fig. 5.15 summarises the results. Mean frequency of sEPSCs was significantly lower in the 
non-responsive group, at 17.6 ± 3.1 events/min, or 0.3 Hz (n = 6), compared to the 
responsive group at 53.5 ± 15.1 events/min, or 0.9 Hz (n = 8) (P = 0.02, Mann Whitney test). 
However, the amplitude, although slightly larger in the non-responsive group (10.8 ± 1.0 
pA v 8.3 ± 0.6 pA) was not significantly different (P = 0.08). There were no differences 
observed in the average decay times or holding current between the two groups. Whether 
the lower frequency in the non-responsive group reflects a reduced ambient level of 
glutamate or whether the ambient level is low due to low expression of tonically active KAR 











Table 5.2: Summary of the effects of KAR agonists and antagonists on juvenile sEPSCs. 
Data shows the average amplitude and frequency of sEPSCs before (control) and after the 
application of KA (pink), ATPA (blue) and UBP-310 (grey). * denotes statistically significant 
changes from control (*: P < 0.05, **: P < 0.01, ***P < 0.001). # denotes statistically 







Table 5.3: Summary of the effects of KAR agonists and antagonists on juvenile mEPSCs. 
Data shows the average amplitude and frequency of sEPSCs before (control) and after the 
application of KA (pink), ATPA (blue) and UBP-310 (grey). * denotes statistically significant 
changes from control (*: P < 0.05, **: P < 0.01, ***P < 0.001). # denotes statistically 








Table 5.4: Summary of the effects of KAR agonists and antagonists on neonate sEPSCs. 
Data shows the average amplitude and frequency of sEPSCs before (control) and after the 
application of KA (pink), ATPA (blue) and UBP-310 (grey). * denotes statistically significant 
changes from control (*: P < 0.05, **: P < 0.01, ***P < 0.001). # denotes statistically 












The sections above detail the actual experimental findings in two different neuronal 
populations at two stages of development. There is a considerable amount of data, but by 
and large the patterns of responsiveness to KAR activation and blockade are qualitatively 
similar in the 4 groups. Despite this, there are certain clear differences both qualitative and 
quantitative. This section will now directly compare across location and age to emphasise 
where the principal differences lie. 
5.3.7.1 Developmental differences in the effects of KA  
Fig. 5.16 (A-C) compares the percentage change in the effects of KA on sEPSCs in neonatal 
versus juvenile neurones in LII. Although both age groups show a large increase in 
frequency, juvenile neurones showed a massively greater change (~200 fold) compared to 
neonatal neurones (~4 fold). It should be noted that there was a huge variability associated 
with increase in the juvenile neurones. In this group there was sometimes indications that 
KA may be induced a degree of synchronised oscillatory activity, which could elevate the 
frequency and amplitude of sEPSCs in some slices.  
Another clear difference between neonatal and juvenile sEPSCs was the effect on decay 
time. KA doubled the decay time of sEPSCs in neonatal neurones but had no apparent effect 
in juvenile neurones. 
Mean amplitudes of sEPSCs were increased by KA and the percentage increase (around 
40%) was almost identical in the two groups. Likewise an increase in holding current (by 
~50%) induced by KA was similar in both age groups.  
The ability of UBP-310 to reverse the effects of KA also showed one difference. In neonate 
neurones, the increase in frequency was reversed to a level lower than control, whereas 
the massive increase seen in juveniles was reduced but remained above control. All other 





Figure 5.16: Percentage change in sEPSC activity with KA (200 nM) and UBP-310 (20 μM) 
in neonate and juvenile neurones. (A) Average sEPSC percentage change in frequency, (B) 
decay time and (C) amplitude data from 7 neonate (pink) and 4 juvenile (red) LII principal 
neurones. KA increased the frequency of sEPSCs more in juvenile compared to neonatal 
neurones, and increased the decay time in neonate, and not juvenile, neurones. Average 
sEPSC percentage change in frequency (D), decay time (E) and amplitude (F) data from 4 
neonate (pink) and 5 juvenile (red) LV principal neurones.*, # and Ϯ denote significant 
differences between: * juvenile % change vs control (100 %, dashed line), # neonatal % 
change vs control (100 %, dashed line), Ϯ juvenile % change vs neonatal % change. 
 
Comparisons in LV (Fig. 5.16 D-F), are a little more complex as some neonatal neurones 
were clearly responsive to KA and others not. These neurones were subsequently 
subdivided into two groups: responsive and non-responsive. In contrast, all juvenile LV 
neurones responded to KA. There is little to be gained from comparing responsive neurones 
in juveniles to non-responsive neurones in neonates so the comparison has been restricted 
to responsive neurones in each group . The comparison is summarised in Fig. 5.16 (D-F). 
Like LII, KA induced an increase in frequency of sEPSCs neurones in both neonates and 
juveniles. The % changes in sEPSC frequency after KA were similar in the two age groups 
(~250-300%) . The changes were less marked than seen in either age group in LII, and 




In neonate LV neurones KA application resulted in an increase in mean amplitude of around 
25% in neonatal sEPSCs but left it paractically unaltered in juvenile neurones. Concurrently, 
as in LII, there was doubling in decay time in neonate neurones with no change in the 
juvenile LV neurones.  
UBP-310 reversed the frquency changes in both age groups, although in contrast to LII this 
was reduced below control levels in both age groups, an effect only seen in neonates in LII. 
The changes in amplitude in both groups and in and decay time in neonates were restored 
to control levels by UBP-310.  
5.3.7.2 Developmental differences in the effects of ATPA 
A comparison of the effects of ATPA in neonatal and juvenile neurones is summarised in 
Fig. 5.17. The only consistent effect of note was a slight decrease in the frequency of sEPSCs 
in both layers in both age groups, with perhaps a more prominent effect in the older rats. 
The effect was small, but the fact that it consistently disappeared with washout of the 





Figure 5.17: Percentage change in sEPSC activity in the presence of ATPA (100 & 500 nM) 
in neonate and juvenile neurones. (A) Average sEPSC percentage change in frequency, (B) 
amplitude, (C) decay time from 3 neonatal (light blue) compared to 6 juvenile (dark blue) 
principal neurones. (D) Average sEPSC percentage change in frequency, (E) amplitude, and 
(F) decay time data from 4 neonate (light blue) compared to 7 juvenile (dark blue) principal 
neurones. *, # and Ϯ denote significant differences between: * juvenile % change vs control 
(100 %, dashed line), # neonatal % change vs control (100 %, dashed line), and Ϯ juvenile % 
change vs neonatal % change. There were no significant differences in % change in response 
to ATPA between the two age groups.  
 
5.3.7.3 Developmental differences in the effects of UBP-310 
UBP-310 applied alone was remarkably consistent in its effects in both layers and age 
groups (Fig. 5.18). Unlike ATPA the effect was quite marked in all groups. Thus, the 
antagonist reduced the frequency of sEPSCs in neonate LII neurones by around 60%, and a 
comparable decrease (~50%) was recorded in juvenile LII cells. In LV the reduction in 




were no changes of note in any other parameters in any groups, other than occasional 
indications of a slight (~10-20%) decrease in amplitude. The effects of UBP-310 are strongly 
indicative that KARs containing the GluK-1 subunit are tonically activated by ambient 
glutamate release and contribute significantly to maintaining sEPSC frequency at both ages 
in both layers. 
 
Figure 5.18: Percentage change in sEPSC activity with UBP-310 (20 μM) and KA (200 nM) 
in neonate and juvenile neurones. Average sEPSC percentage change in frequency (A), 
decay time (B) and amplitude (C) data from 5 neonate (grey) and 5 juvenile (black) principal 
LII neurones. Average sEPSC percentage change in frequency (D), amplitude (E) and decay 
time (F) data from 5 neonatal (grey) and 4 juvenile (black) principal LV neurones. UBP-310 
significantly decreased the frequency of sEPSCs equally in both age groups, but UBP-310 
decreased sEPSC amplitude in neonatal neurones only. *, # and Ϯ denote significant 
differences between: * juvenile % change vs control (100 %, dashed line), # neonatal % 
change vs control (100 %, dashed line), Ϯ juvenile % change vs neonatal % change. There 








The suggested locations of KARs mediating excitatory neurotransmission in the MEC are 
summarised in Fig. 5.19. 
1) A presynaptic GluK1-containing KAR, which is tonically active in was demonstrated 
LII and LV in juvenile and neonate neurones (although TTX studies are needed to 
confirm a presynaptic location in neonate, though similarities in the effects of UBP-
310 on sEPSCs would be in favour of a similar mechanism in both ages.) 
2) A postsynaptic non GluK1-containing KAR is likely mediating the effects of KA, and 
the reversal in activity with addition of UBP-310 may be due to a reduction in tonic 
glutamate release. 
3) ATPA had no effect/slightly decreased glutamate release, which may be due to 
GluK1-containing KARs having already being tonically activated. Further receptor 
activation has no effect or may lead to desensitisation, which could account for the 





Figure 5.19: Summary of the suspected location of KARs at excitatory synapses in LII and 
LV MEC. KARs appeared to be present at similar locations in both layers and in both neonate 
and juvenile neurones, however, a significant increase in sEPSC amplitude in LII neurones 
only suggests the presence of KAR mediated recurrent excitation. Recurrent connectivity 
has previously been shown to be present in the superficial layers of the MEC (Winterer et 





5.5.1 Pre- and post-synaptic KARs facilitate glutamate release at excitatory synapses in 
LII and LV MEC of juvenile MEC 
The working hypothesis to interpret these results would suggest the presence of KARs both 
pre- and postsynaptically at excitatory synapses. More specifically, experiments with UBP-
310 in the presence of TTX have confirmed a GluK1-containing KAR is present at 
glutamatergic terminals, where they are tonically active and maintain a high level of 
spontaneous background excitation onto principal neurones. 
The fact that ATPA alone generally had no effect on sEPSCs may be due to the high tonic 
activity of this receptor, such that addition of nanomolar concentrations of ATPA cannot 
further increase the activation of an already saturated receptor. Moreover, this may even 
explain the small decrease in frequency of sEPSCs witnessed in the presence of ATPA (Fig. 
5.3), as excessive activation could then lead to receptor desensitisation, which is commonly 
associated with KARs (Fisher and Mott, 2011, Mott et al., 2010) thus reducing the tonic 
facilitatory effect. In addition, some studies suggest that KAR subunits can be individually 
activated within a heteromeric complex and serve dramatically different functions, 
whereby the high affinity subunits control channel gating, and low affinity subunits have 
strong desensitising properties (Fisher and Mott, 2011). In this scenario, additional 
activation of the GluK1 subunit, in conditions of high tonic activity, could encourage 
desensitisation of the complex, and account for the slight decrease/no effect of ATPA in 
these conditions. The results from this chapter were in stark contrast to previous work 
within this lab, in the adjacent LIII MEC, which showed significant increases in sEPSC 
frequency in response to ATPA, however, there was no tonic activation of GluK1-containing 
KARs in LIII, despite their existence, which may well account for the differences observed 
in LII and LV (Chamberlain, 2009, Chamberlain et al., 2012). Alternatively, in the face of such 
high GluK1-containing KAR tonic activity, a higher concentration of ATPA may be require to 
elicit a noticeable effect. Alternatively, if ATPA has a lower efficacy at the GluK1 subunit 
than ambient glutamate, then sEPSC frequency may decrease relative to the high tonic 




and these differences are probably related to tonic activity of GluK1-containing KARs 
located at presynaptic terminals. 
Lastly, experiments with KA greatly facilitated glutamate release at excitatory synapses, as 
expected. The addition of UBP-310 appeared to reverse the actions of KA, giving the 
impression the GluK1-containing KAR was responsible for the increase in frequency. 
However, this suggestion is confounded by the lack of an effect of ATPA on its own. 
Therefore, a more likely scenario is that a KARs that do not contain the GluK1 subunit are 
responsible for the KA-induced increase in sEPSC frequency, and it seems likely that they 
are located at the soma/dendrites of neurones that provide inter- and intra-lamina 
recurrent excitatory inputs to the recorded neurone. This is supported by depolarising 
effects of KA, and the fact that TTX largely abolished the response. In this scenario, the 
reversal by UBP-310 would be due to blockade of the tonic effect of ambient glutamate at 
GluK1 autoreceptors on synaptic terminals, as we have shown this to contribute ~60% of 
ongoing spontaneous glutamate release. This would then appear as a reversal of the effect 
of KA. 
To summarise, the results from this chapter suggest the presence of a tonically active 
presynaptic GluK1-containing KAR facilitating on-going glutamate release onto principal 
cells, and a non-GluK1 containing KAR located postsynaptically at the soma/dendrites of 
neurones providing recurrent excitatory inputs to the recorded cell, in the juvenile rats.  
5.5.2 Developmental differences in KAR function at glutamatergic synapses 
The effects of KAR modulation on sEPSCs were fairly similar within the two age groups 
studied, though there were some subtle effects to note. As in juvenile neurones, there was 
a strong tonic facilitation of on-going glutamate release by KARs containing the GluK1 
subunit in neonate neurones, though further experiments in TTX are required to confirm a 
presynaptic location. Likewise, experiments with ATPA had no effect, or imposed a slight 
decrease of glutamate release onto principal neurones in both layers and ages. However, 




In LII, although the frequency was increased in both age groups, and qualitative changes 
should be viewed with caution due to the variability between experiments, the extent of 
the increase was substantially more pronounced in the juveniles (~200 fold increase) versus 
neonates (~4 fold increase). The difference in response to KA may be due to the levels of 
KAR expression themselves, or due to the stage of maturation of the MEC circuitry at this 
point in post-natal development, such as the number of excitatory synapses onto principal 
neurones. KA increased the amplitude of excitatory events in both age groups in LII, which 
may be indicative of roles of KARs in driving multi-quantal glutamate release. Another 
subtle difference was that KA increased the decay time in neonate, but not juvenile, 
neurones. This may suggest KA activates synapses that were not initially tonically releasing 
glutamate onto the recorded cell, but that KA activated a population of otherwise silent 
input interneurones, the slow decay time possibly reflecting release at more distal locations 
on the soma.  
Subtle lamina differences were also apparent. Whilst neurones in LII showed a clear 
developmental increase in the excitatory effects of KA, in LV, the effects of KA were the 
same in neonate and juvenile (+ 250-300 %) neurones. Moreover, there were no KA-
induced increases in amplitude, suggesting a lack of multi-quantal glutamate release onto 
principal neurones, unlike in LII. In accordance with LII, however, there was also an increase 
in decay time in the younger age group, which, as mentioned, may reflect the activation of 
silent neurones making synapses onto the recorded neurone at more distally located sites.  
5.5.2.1 A subset of LV neonatal neurones were insensitive to KA and UBP-310 
Upon analysis of the effects of KAR manipulation in LV neonatal principal neurones, it 
became apparent that a subset of cells (n = 6 of 14 cells) were insensitive to KA and UBP-
310. There is no experimental evidence to show the KA insensitive neurones were also 
insensitive to UBP-310, but we can perhaps assume they belong to the same population. 
What was particularly noticeable about the non-responsive population of cells was their 
extremely low baseline frequency compared with the neurones that did respond to KA and 
UBP-310. From this we can, perhaps, infer that these neurones do not have functional KARs 




One theory is that these neurones are being selected against through a synaptic pruning 
developmental process. During development, synapses are constantly generated, and 
newly formed glutamatergic synapses lack functional AMPA or KAR mediated transmission, 
known as silent synapses (Isaac et al., 1995). Many of these silent synapses are 
developmentally eliminated, though some are said to be selected for AMPAR unsilencing, 
which requires synchronised activity of pre- and post- synaptic activity. The KA-insensitive 
neurones had an extremely low baseline frequency of sEPSCs compared to sensitive 
neurones, and could reflect a population of neurones which are in the process of 
unsilencing, or conversely, they could represent immature neurones that are being 
selected against.  
A previous study showed that presynaptic KARs are upregulated at immature CA3-CA1 
synapses in an activity-dependent fashion (Clarke et al., 2014). In the KA responsive 
neurones in this study, a large proportion of the sEPSCs were dependent on the action of 
KARs containing the GluK1 subunit, which, in the juvenile neurones, was shown to be 
located presynaptically. In the non-responsive neurones, no such presynaptic GluK1 KAR is 
present. Considering that all juvenile neurones tested were responsive to both KA and UBP-
310, the presence of KARs at immature synapses could be critical in determining neuronal 
fate in developing circuitry. KARs have powerful roles in the synchronisation of neuronal 
network activity, especially in the MEC, which drives Hebbian strengthening of naïve 
synapses via a process known as STDP. Asynchronous neuronal activity, perhaps associated 
with neurones lacking KARs, may lead to a functional weakening and ultimately 
morphological elimination (Clarke et al., 2014). Moreover, the depolarisation and slow 
decay properties of synaptic KARs are thought to bring the cell closer to spike threshold 
and therefore can exaggerate the effect of a single input. In this manner, KARs can bring 
unique integrative properties to the neurones upon which they reside, which, again, could 
have implications for synaptic pruning during development.  
Overall, these results suggest that the function of KARs does not change dramatically 
between the two age groups studied (P8-11 and P20-27), though there are subtler 
differences in response to KA ,which likely reflect the ability of the MEC circuitry to drive 




containing KAR in juvenile and neonate rats. Lastly, the effects of KA appear to be driven 
by a non GluK1-containing KAR that activates neurones via recurrent excitatory inputs that 















Functional role of kainate receptors in 
GABAergic transmission in LII and LV in 





In the previous chapter I identified functional effects of KARs located both pre- and post- 
synaptically that act to facilitate glutamate release at excitatory synapses. KARs are also 
known to exist at inhibitory synapses throughout the CNS (Cossart et al., 1998, Min et al., 
1999, Aroniadou-Anderjaska et al., 2007), where they can both facilitate or depress GABA 
release. Previous work in this laboratory has made a detailed analysis of KAR function in 
both excitatory and inhibitory transmission in LIII of the MEC (Chamberlain et al., 2012). In 
GABAergic transmission this study uncovered the presence of a GluK1-containing KAR 
driving excitation at glutamatergic synapses onto interneurones. In addition, it suggested 
that a putative non-GluK1 containing KAR (possibly GluK2) may act as a presynaptic 
heteroreceptor, facilitating GABA release at inhibitory terminals onto principal neurones  
As with the previous chapter, this thesis is concerned with the function of KARs during 
development as they show patterned and dynamic changes in expression during 
maturation. For example, gene expression studies identified peak levels of the GluK1-
containing KAR at birth in the sensory cortex, CA1 hippocampal interneurones, stratum 
oriens, septum and thalamus which were thought to be down-regulated thereafter (Bahn 
et al., 1994, Bahn and Wisden, 1997). Functional electrophysiology studies have identified 
a decreased contribution of KAR mediated synaptic transmission at critical periods of 
development related to experience dependent synaptic plasticity at thalamocortical 
synapses (Kidd and Isaac, 1999). In the hippocampus, tonic activation of presynaptic 
kainate receptors that facilitates glutamate release is developmentally down-regulated, 
which, again, occurs during a period of activity-dependent maturation of the circuitry (Lauri 
et al., 2005). Moreover, developmental downregulation of the presynaptic effects of KARs 
have also been identified at inhibitory synapses in the hippocampus (Maingret et al., 2005). 
Studies addressing specifically the developmental changes of KARs in the MEC are limited. 
Preliminary data from the lab of Professor Elek Molnar, which was in support of this project 
(Figure 1.6; Chapter 1), conducted a developmental profile of KAR subtype expression in 
hippocampal areas of the rat brain. The expression of GluK1-containing KARs in the EC 




expression declined into adulthood (Molnar et al. unpublished). Only one other study has 
addressed the developmental changes of KAR expression in the EC, amongst other brain 
regions, and showed a similar increase in the expression of the GluK1 subunit at ~12 days 
old (Bahn et al., 1994). The temporal increase in KAR expression may implicate the GluK1-
containing KAR in a functional role in the development of synaptic connectivity in the MEC. 
Of course, immunohistochemical studies such as these can make no assumptions as to the 
location of the expressed receptors. Thus, any developmental changes could reside with 
receptors on interneurones and inhibitory synapses with equal probability to those on 
principal neurones and excitatory synapses. Having determined functional roles in 
excitatory transmission in Chapter 5, in this chapter I turned my attention to KAR in 
inhibitory transmission in LII and LV of the MEC, and possible changes in these roles during 
development. 
Understanding changes to KAR functioning during development is of particular importance 
with regards to their roles in the generation of synchronised neuronal network activity, 
especially in the MEC (Cunningham et al., 2003, Cunningham et al., 2004a, Stanger et al., 
2008). Furthermore, the MEC has been strongly linked to many disorders associated with 
aberrant or pathological synchrony, such as epilepsy and schizophrenia (Cunningham et al., 
2006a, Uhlhaas and Singer, 2010). Existing data strongly supports a role for KARs in 
pathological network activity, largely with the use of KA to model epileptiform activity 
(Rogawski et al., 2001), however, it is important to also understand the physiological roles 
of KARs in modulating neurotransmission, and the synaptic mechanisms underlying them. 
Thus, this chapter aims to clarify the role of KARs in modulating GABAergic 
neurotransmission. Moreover, I aim to identify changes to KAR function during 
development. Together, these experiments will aid understanding of the physiological roles 
of KARs in mediating inhibitory neurotransmission throughout development, which can 




6.2 Methods  
Recording methods were described fully in chapter 2. All experiments in this chapter were 
conducted on combined slices of EC and hippocampus, described in the methods section, 
from neonatal (P8-11; 20-35 g) and juvenile (P20-28; 50-100 g) Wistar rats. Whole cell 
voltage clamp recordings of sIPSCs and mIPSCs were recorded from principal neurones in 
LII and LV MEC. Neurones were voltage clamped at -60 mV. Cells were selected with good 
access resistance that remained stable for the duration of the recording. In all recordings 
DL-AP5 and SYM-2206 were included in the bath to block NMDARs and AMPARs, 
respectively. To investigate the contribution of KARs to inhibitory neurotransmission I used 
the general agonist, KA, a relatively selective GluK1-containing KAR agonist, ATPA, and 
antagonist, UBP-310.  
Mean values for frequency, inter-event interval (IEI; inverse of frequency), amplitude, 
decay times and holding current were determined and compared between control and 
drug groups using either a paired t-test or a repeated measures ANOVA (rANOVA) for 
multiple comparison. Dunnett’s post-test was used if all comparisons were made to the 
control group, and a Bonferroni’s post-test was used when comparing selected pairs of 
columns when multiple drugs were added. The non-parametric Mann Whitney test was 
used when comparing different neuronal populations. Two-way ANOVA analysis was used 
when comparing groups that were influenced by two different independent variables (e.g. 
time and age). 
Cumulative distribution analysis used pooled data from a sample of events during a 
continuous recording period for each neurone and statistical comparisons were made using 
a Kolmogorov-Smirnov (KS) test for mean data and cumulative probability distributions, 
respectively. Statistical significance was defined when P < 0.05, except for KS-analysis, 






Table 6.1: Table of pharmacological agents. 
6.3 Results 
6.3.1 Effects of KA on LII IPSCs  
6.3.1.1 Effects of KA on juvenile LII sIPSCs 
In the first set of experiments I determined the effects of non-selective activation of KARs 
with KA, on GABA release onto principal neurones in LII in juvenile rats. sIPSCs were 
recorded in the presence of SYM 2206 (10 μM) and DL-AP5 (40 μM) to block AMPAR and 
NMDAR, respectively. The results are summarised in Fig. 6.1. KA (200 nM) increased the 
mean frequency of sIPSCs ~3-4 fold, from 246.7 ± 111.2 events/min (4.1 Hz) to 917.7 ± 
150.8 events/min (15.3 Hz) and 727.1 ± 191.2 events/min (12.1 Hz) after 10 and 15 minutes, 
respectively (P < 0.05 and P < 0.01, rANOVA; n = 4). Subsequent addition of UBP-310 (20 
μM) decreased the frequency back to control levels (267.4 ± 68.5 events/min; 4.5 Hz) after 
15 minutes (P < 0.05; rANOVA), indicating the involvement of GluK1-containing KARs in 
eliciting the high frequency of GABA release onto principal neurones after KA application.  
The increase in frequency was concurrent with an increase in amplitude which almost 
doubled from 18.25 ± 6.2 pA to a maximum of 35.9 ± 6.3 pA after 10 minutes KA (P < 0.05, 




cumulative application of UBP-310. Changes in amplitude suggest that neurones 
presynaptic to the recorded neurone are likely to be driven to fire by activation of 
postsynaptic receptors on their cell bodies, and the effects of UBP-310 would suggest a 
KARs containing the GluK1 subunit is mediating this effect.  
The mean decay time of sIPSCs was also doubled (from 5.3 ± 0.3 ms to a maximum of 10.6 
± 2.2 ms) by KA and, again, reversed to 5.9 ± 1.5 ms by UBP-310. This probably indicates 
that the presynaptic neurones that were activated by KA were giving rise to IPSCs of slower 
time course and longer duration, and could be a separate population of neurones that were 
not spontaneously active in baseline conditions. A population of large amplitude slow time 
course events is readily visible in KA in the traces shown in Fig. 6.1. 
Lastly, the mean holding current increased by + 45.3 ± 21.2 % after 15 minutes KA (P < 0.05, 
rANOVA) with a partial recovery after UBP-310 (-22.3 ± 13.9 %). This is similar to the effect 
seen when recording sEPSCs, but since we were recording principal cells in both cases it 
would be expected. The results can be interpreted in a number of ways: 1) activation of 
GluK1-containing KARs postsynaptic to glutamate terminals are driving GABA release by 
exciting interneurones and increasing the summation of sIPSCs occurring at high frequency, 
2) GluK1-containing KARs are located pre- or postsynaptically on interneurones, acting to 
directly influence GABA release onto principal neurones, or 3) due to the depolarisation 
induced by activation of KARs on the recording neurone. This would mean the 
depolarisation is not caused by an outward current of chloride ions through GABA 
receptors, but an inward current via KARs on the postsynaptic membrane. Further 
experiments using a GABAR antagonist should be able to discriminate between these 
possibilities  
6.3.1.2 Effects of KA on neonate LII sIPSCs 
Having documented the role of KA in inhibitory transmission in juvenile rats, we next 
decided to determine the effect of KA on inhibitory neurotransmission in neonate slices. It 
is important to note that the baseline frequencies of sIPSCs in neonate neurones was very 




In the presence of KA, the mean frequency of sIPSCs weakly increased from 23.8 ± 3.6 
events/min (0.4 Hz) to 32.4 ± 11.4 event/min (0.5 Hz), but this was not statistically 
significant with rANOVA analysis. The data are illustrated in Fig. 6.1. There were no 
concurrent effects on the mean amplitude of events, or their decay time. These results 
contrast markedly with those in juvenile animals where sIPSC frequency was markedly 
elevated by KA by over 300% compared to control whilst the small increase seen here 
amounted to only ~35%. The absence of an effect on amplitude in neonates also contrast 
sharply with the 100% increase seen in juveniles 
Despite the relatively minimal increase in frequency with KA a decreased frequency of 
sIPSCs occurred with cumulative application of UBP-310, and frequency actually fell to 
below control levels (11.9 ± 5.3 events/min, or 0.2 Hz), although again, this did not reach 
statistical significance. Due to the very low baseline frequency of events, only a small 
sample could be pooled from each cell in the cumulative analysis. Nevertheless, cumulative 
probability analysis of IEIs confirmed the non-significant increase with KA on the frequency 
of sIPSCs, but showed that the effect of UBP-310 did reach significance (P < 0.0001, KS-test, 
n = 3, not shown). Thus, despite such a low baseline frequency of sIPSCs, the GluK1-
containing KAR may be tonically active and may be modulating GABA release.  
Interestingly, also unlike in juvenile neurones, KA had no effect on the holding current, and 
by implication did not depolarise neonate neurones. A larger sample size is needed to 
clarify these effects. 
Overall, these results suggest that KAR control of spontaneous GABAergic inhibition is not 
well developed in neonates at P8-11. This could be for several reasons. It may simply be 
that KAR receptors are poorly expressed or have a reduced intrinsic function at this age. 
Certainly the immunohistochemical data that we have been given access to by Professor 
Elek Molnar (Fig. 1.6, introduction) suggest that there is substantially increased expression 
around P14. Therefore it may be that the GABA neurones themselves are poorly functional 
at this age. The low baseline frequency of sIPSCs would indicate that GABAergic 
synaptogenesis is not fully developed, that interneurones are not spontaneously active or 





Figure 6.1: Effects of KA (200 nM) and UBP-310 (20 μM) on sIPSCs in 4 juvenile and 3 
neonate LII neurones. (A/F) Average sIPSC frequency, (B/G) amplitude, (C/H) decay time 
and (D/I) % change in holding current data from LII principal neurones. Control groups 
(white) represent sEPSCs before application of KA (red) and UBP-310 (grey). Average 
frequency, amplitude and holding current were significantly increased in the presence of KA 
and reversed after addition of UBP-310. (E) Concurrent recordings of sEPSCs recorded in 
control conditions (black), in the presence of KA (red) and UBP-310 (grey) in a juvenile and 




6.3.2 Effects of ATPA on LII IPSCs  
6.3.2.1 Effects of KA on juvenile LII sIPSCs 
In contrast to KA, ATPA at either 100 or 500 nM had no detectable effect on the mean 
frequency, amplitude, decay time or holding current of sIPSCs in LII juvenile neurones. Data 
are summarised in Fig. 6.2 (A-E).  
This was a surprising result given the powerful effect of KA and it’s reversal by UBP-310. As 
noted in the previous chapter, it may call into question the specificity of the antagonist for 
GluK1 receptors (Perrais et al., 2009, Atlason et al., 2010). It also contrasts markedly with 
the strong increase in sIPSC frequency seen with ATPA in previous studies from this 
laboratory in LIII (Chamberlain et al., 2012). 
6.3.2.2 Effects of ATPA on neonate LII sIPSCs 
The effects of ATPA (100 nM and 500 nM) were assessed on 3 neurones in LII and the results 
are illustrated in Fig. 6.2 (F-J). Whilst ATPA (100 nM) had little effect on the mean frequency 
(it actually fell non-significantly from 95.7 ± 35.9 events/min to 69.8 ± 46.6 events/min), 
cumulative addition to 500 nM substantially increased the frequency to 415.1 ± 135.5 
events/min, although this did not reach significance due to the low sample size. 
Percentage-wise, this was a similar change (~400%) to that seen with KA in the juvenile 
animals, although the absolute increase was less.  
Similarly, the mean amplitude was unaffected by 100 nM ATPA (14.6 ± 5.6 pA vs 14.5 ± 5.1 
pA), but with 500 nM it increased to 21.8 ± 6.7 pA. The increase did not reach significance 
with rANOVA analysis, but KS-analysis confirmed a clear and significant rightward 
displacement in the amplitude distribution, reflecting the increase in amplitude (P < 0.0001, 
KS-test, not shown). The mean decay time was also increased, almost doubling from 7.9 ± 
2.2 ms to 14.9 ± 3.5 ms in the presence of ATPA.  
One interpretation of these results is that activation of the GluK1-containing KAR may 
increase synchronised multi-quantal release of GABA from the interneurone terminals that 




entirely separate population of interneurones that are innervating the recorded cell, but 
are not driven to fire and release GABA until excited by ATPA acting at receptors on their 
soma/dendrites. The much longer mean decay times of the sIPSCs seen in ATPA could 
support this possibility. However, such a scenario is very difficult to reconcile with the lack 
of effect of KA in the neonate neurones and the lack of effect of ATPA on the frequency of 
sIPSCs in juvenile LII neurones. It is possible that the receptor subunit composition/variant 
present at P8-11 has a high affinity for ATPA but a low affinity for KA, and with development 
this switches to an isoform with the reverse affinities. Nevertheless, the results are exciting 
because they are quite different in the different age groups and implicate the GluK1-
containing KAR as having a developmental role in the regulation of GABA release. Amongst 
other scenarios, this could reflect the dominance of a sub-type of interneurone that is 
modulated by the GluK1-containing KAR in neonatal neurones relative to juvenile, and will 





Figure 6.2: Effects of ATPA (100 nM and 500 nM) on sIPSCs in 4 juvenile and 3 neonate LII 
neurones. (A/F) Average sIPSC frequency, (B/G) amplitude, (C/H) decay time and (D/I) % 
change in holding current data from LII principal neurones. Control groups (white) represent 
sEPSCs before application of 100 nM ATPA (light blue) and 500 nM ATPA (dark blue). 
Average frequency, amplitude and decay time were increased in the presence of ATPA in 
neonate, but not juvenile, LV neurones. Traces show concurrent recordings of sEPSCs 
recorded in control conditions (black), in the presence of 100 nM ATPA (light blue) and 500 




6.3.3 Effects of UBP-310 on LII IPSCs 
6.3.3.1 Effects of UBP-310 on juvenile LII IPSCs 
The lack of effect of ATPA in these experiments surprising given previous studies in LIII 
(Chamberlain et al., 2012), but is, nevertheless, similar to its relative lack of effect on sEPSCs 
in the previous chapter. The results suggest that GluK1 receptors are not directly 
modulating transmitter release at either glutamate of GABA synapses in juvenile neurones. 
However, as noted in the previous chapter, addition of UBP-310, the putative GluK1-
containing KAR antagonist, demonstrated that these receptors are likely to be tonically 
activated at glutamate synapses, and may be saturated by ambient glutamate.  
I determined the effect of UBP-310 alone on sIPSCs in LII juvenile neurones and the data 
are summarised in Fig. 6.3. UBP-310 had no significant effect on the mean frequency, 
amplitude or decay time of sIPSCs in these neurones although there was trend towards a 
decrease in both frequency and amplitude (~15-20% in each case). This was reflected also 
in cumulative probability analysis, which did identify a small increase in IEIs of sIPSCs with 
UBP-310 (P < 0.0001, KS-test; n = 4, not shown) and a leftward displacement in the 
cumulative distribution of amplitudes (P = 0.003; KS-test).  
The decrease in frequency could reflect a small degree of tonic facilitation of GABA release 
by GluK1 receptors. A change in amplitude would normally be suggestive of a postsynaptic 
mechanism but it is difficult to see how this would happen. 
Perhaps a more probable explanation is that GluK1-containing KARs are tonically active on 
GABAergic terminals and activated by spillover from glutamate synapses, a scenario that 
has backing from studies in other areas (Jiang et al., 2001, Binns et al., 2003). This tonic 
effect may result in synchronised multi-quantal GABA release onto the principal neurones. 
When the heteroreceptors are blocked, there is decrease in multi-quantal, spontaneous 
GABA release, but the more frequent mono-quantal release is unaffected, and so the 
overall amplitude and frequency of inhibitory events is decreased. An alternative is that the 




sEPSCs on the recorded neurone, and not present on others that give rise to smaller mono-
quantal events. The end result of blocking the heteroreceptor would be the same.  
What is also interesting is that addition of KA cumulatively with UBP-310 resulted in a 
partial restoration of sIPSC frequency and amplitude. Whilst this could simply reflect 
competition between agonist and antagonist, it may also result from activation of non-
GluK1 receptors on the soma/dendrites of other interneurones providing input to the 
recorded neurone. Such a scenario actually presupposes that the large events that 
disappear in UBP-310 are probably not from the same source as those that are evident 






Figure 6.3: Effects of UBP-310 (20 μM) and KA (200 nM) on sIPSCs in juvenile LII neurones. 
(A) Mean sIPSC frequency, (B) amplitude, (C) decay time and (D) % change in holding current 
of sIPSCs from 4 principal neurones. Control groups (white) represent sIPSCs before 
application of UBP-310 (grey) and KA (red). (E) Traces show concurrent recordings of sIPSCs 
recorded in control conditions (black), in the presence of UBP-310 (grey) and KA (red). Note 
the decrease in sIPSC amplitude after exposure to UBP-310. 
6.3.4 Effects of KA on LV IPSCs  
6.3.4.1 Effects of KA on juvenile LV sIPSCs 
The effect of non-selectively activating KARs with KA on sIPSCs in juvenile LV neurones are 
shown in Fig. 6.4. The agonist significantly increased the mean frequency of sIPSCs to 
around 300% of control levels (from 166.5 ± 45.3 events/min (2.8 Hz) to 553.2 ± 158.8 
events/min (9.2 Hz) after 10 minutes; P < 0.01, rANOVA; n = 7). Again, this increase appears 
to be partially reversed by the addition of UBP-310, suggesting KAR containing the GluK1 




amplitude and decay times of sIPSCs were was significantly increased by KA and partially 
reversed by UBP-310 (Fig. 6.1). Changes in holding current followed a similar pattern.  
Thus, KA induced the appearance of much larger amplitude sIPSCs with a slower decay 
time. This is suggestive that the agonist was activating receptors directly on the 
soma/dendrites of GABAergic interneurones to increase action potential driven release 
resulting in synchronised multi-quantal sIPSCs. I next looked at the effects of KA on mIPSCs 





Figure 6.4: Effects of KA (200 nM) and UBP-310 (20 μM) on sIPSCs in 7 juvenile and 4 
neonate LV neurones. (A/F) Average sIPSC frequency, (B/G) amplitude, (C/H) decay time 
and (D/I) % change in holding current data from LV principal neurones. Control groups 
(white) represent sEPSCs before application of KA (red) and UBP-310 (grey). Average 
frequency, amplitude and holding current were significantly increased in the presence of 
KA. Traces show concurrent recordings of sEPSCs recorded in control conditions (black), in 





6.3.4.2 Effects of KA on juvenile LV mIPSCs 
To help clarify the origin of KA-induced increase in sIPSC frequency and amplitude, the 
experiments were repeated in the presence of TTX (1 µM), to remove the action potential 
dependent network driven effects. KA induced a small, but significant, increase in the mean 
frequency of mIPSCs, from a control of 42.7 ± 13.4 events/min (0.7 Hz) to 60.1 ± 20.0 
events/min (1.0 Hz) after 15 minutes (P < 0.05, rANOVA; n = 4). It has to be stressed that 
this effect was very small compared to sIPSCs (~40% v 300). In essence, apart from the 
marginal increase in frequency, the effects of KA on sIPSCs were abolished by recording in 
TTX. 
 
Figure 6.5: Effects of KA on mIPSCs in juvenile LV neurones (A) Mean sIPSC frequency, (B) 
amplitude, (C) decay time and (D) % change in holding current data from 4 principal 
neurones. Control groups (dotted) represent mEPSCs in the presence of TTX, before 
application of KA (red). TTX largely abolished the effects of KA.  
6.3.4.3 Effects of KA on neonate LV sIPSCs 
The effects of KA and UBP-310 were assessed on neonate neurones in LV. The results are 
illustrated and summarised in Fig. 6.4. KA (200 nM; n=5) increased the mean frequency of 
sIPSCs from 50.1 ± 28 events/min (0.8 Hz) to a maximum of 117.0 ± 38.4 events/min (2.0 
Hz) after 10 minutes, however, this increase was not sustained and decreased back to 58.8 
± 17.8 events/min (1.0 Hz) after 15 minutes. Addition of UPB-310 had no effect on the 
frequency of sIPSCs (46.9 ± 15.8 events/min, or 0.8 Hz). The 80% increase in frequency was 





KA modulated the amplitude of sIPSCs in a similar pattern to the frequency, such that the 
mean amplitude was increased after the initial exposure to KA, from a control of 16.7 ± 2.9 
pA to a maximum of 29.9 ± 14.7 pA after 5 minutes KA. After 15 minutes in the continued 
presence of KA, sIPSC amplitude decreased to 23.5 ± 8.4. This pattern of an initial peak 
followed by a decline in frequency was not unusual in MEC principal neurones and seen 
with sEPSCs, sIPSCs, in both layers and age groups. It was also seen previously with ATPA in 
LIII (Chamberlain S.E.L. and Jones R.S.G., unpublished findings). The effect was almost 
always marginal and in many cases not seen at all, but in the case of the neonate LV 
neurones it was particularly pronounced, and sIPSC frequency was almost restored to 
control levels after 15 min. The mean frequency was 17.9 ± 3.8 pA after additional 
application of UBP-310, though it is difficult to say if this slight decrease is due to UBP-310 
or a late continued decline with KA.  
Mean amplitude of sIPSCs increased with initial application of KA but also fell back towards 
control with continued application. The amplitude increase appeared to be due largely to 
the appearance of a population of large amplitude events that appeared initially in KA and 
then progressively disappeared. They were eliminated after addition of UBP-310, but again 
it’s not possible to say whether this was an effect of the drug. Neither KA nor UBP-310 had 
any noticeable effect on the decay time.  
Overall, the results do tend to show a small increase in GABA release with KA. This was 
considerably less pronounced than its effect in juvenile animals, and of the same order of 
the effect of KA in LII in neonates. The most interesting aspect was the lack of sustained 
effect of KA during continued application, with sIPSCs returning essentially to baseline 
levels after 15 minutes. This made it impossible to tell if UBP-310 had any effect, and so the 
initial increase cannot be ascribed to GluK1 receptors at this stage. Whatever the receptor 
involved, the rapid decline of the response suggests that in the neonate animals, it becomes 
inactivated or desensitised in the continued presence of the agonist. The increase appeared 
to reside largely with the transient appearance of a population of large amplitude events 
and this could possibly be due to facilitation of multi-quantal release from already active 
inhibitory terminals, or activation of a population of interneurones that are silent under 




6.3.5 Effects of ATPA on LV IPSCs 
6.3.5.1 Effects of ATPA on juvenile LV sIPSCs 
KA substantially increased the frequency of sIPSCs in juvenile neurones, an effect partially 
reversed by UBP-310. I investigated the role of GluK1 receptors further by examining the 
effect of ATPA. The agonist had no effect on the mean frequency, amplitude, decay time or 
holding current of sIPSCs in principal neurones tested (Fig. 6.6; n=7). However, in one 
additional cell ATPA did appear to induce a substantial increase in the frequency of sIPSCs, 
from a control of 247.8 events/min (4.13 Hz) to 561.9 events/min (9.4 Hz) and 660.4 
events/min (11.0 Hz) after 100 nM and 500 nM ATPA, respectively. Amplitude was 
unaffected but decay time was increased (not shown). This neurone had a much higher 
baseline frequency before the application of ATPA, which could suggest that it was a 
subtype of principal neurone or perhaps an interneurone. In any case it was left out of the 
group analysis. I also investigated the effects of ATPA in the presence of TTX (n=5), and as 
expected, it failed to alter any parameters of the mIPSCs. Combined group data from sIPSCs 






Figure 6.6: Effects of ATPA (100 nM and 500 nM) on sIPSCs in 7 juvenile and 4 neonate LV 
neurones. (A/F) Average sIPSC frequency, (B/G) amplitude, (C/H) decay time and (D/I) % 
change in holding current data from LV principal neurones. Control groups (white) represent 
sEPSCs before application of 100 nM ATPA (light blue) and 500 nM ATPA (dark blue). 
Average frequency, amplitude and decay time were increased in the presence of ATPA in 
neonate, but not juvenile, LV neurones. Traces show concurrent recordings of sEPSCs 
recorded in control conditions (black), in the presence of 100 nM ATPA (light blue) and 500 




6.3.5.2 Effects of ATPA on neonate LV sIPSCs 
To try to clarify a role of potential role for GluK1 receptors in the transient increase in sIPSCs 
produced by KA, the effects of ATPA were determined on LV neonatal neurones (Fig. 6.6 F-
J). Addition of 100 nM ATPA induced a small increase in mean frequency from 43.2 ± 9.9 
events/min (0.7 Hz) to 78.0 ± 42.3 events/min (1.3 Hz). With the cumulative addition of 
ATPA to 500 nM the frequency of sIPSCs fell back to control levels (48.8 ± 11.1 events/min, 
or 0.8 Hz).  
Amplitude increased slightly from a control level of 15.3 ± 1.9 pA to 18.4 ± 1.8 pA with 100 
nM ATPA, but again, even this small effect was not sustained with 500 nM ATPA (15.8 ± 1.0 
pA). The mean decay time doubled in the presence of 100 nM and although it again 
declined with 500 nM it remained well above control. Decay time did return close to control 
levels after wash-out of the drug, but it is difficult to say if this is due to the wash per se or 
the result of a time dependent decline due to ATPA.  
These results could suggest that, unlike in juvenile neurones in LV, KARs containing the 
GluK1 subunit can facilitate GABA release onto neonatal principal neurones, and this could 
also underlie the transient increase in sIPSCs induced by KA. It may even be possible to 
equate the time-dependent decline with KA with the concentration dependent decline 
seen with ATPA. In this regard the appearance of large amplitude sIPSCs with 100 nM, 
which then essentially disappeared with 500 nM, could reflect the activation of a 
population of interneurones that were initially silent under baseline conditions. The 
substantial change in decay kinetics would support this, and again the transient nature of 
this effect could be an indication that the receptor involved was rapidly desensitising in the 
presence of the agonist. 
6.3.5 Effects of UBP-310 on LV IPSCs 
6.3.5.1 Effects of UBP-310 on juvenile LV sIPSCs 
I have shown that GluK1-containing KARs act as tonically active facilitatory autoreceptors 




heteroreceptors at GABA terminals in LII (above). To determine if a similar function pertains 
in LV, the effects of UBP-310 on sIPSCs were studied. The antagonist had no effect on the 
mean frequency of sIPSCs (120.4 ± 27.9 events/min vs 118.2 ± 40.0 events/min; see Fig. 
6.7), suggesting that GluK1 KARs may not tonically modulate GABA release onto juvenile 
neurones in LV. UBP-310 decreased the mean amplitude (from 25.3 ± 1.8 pA to 20.3 ± 1.6 
pA; Fig 6.7B) and this change is also evident from the cumulative probability analysis (P < 
0.0001, KS-test, not shown). Examination of the records in Fig. 6.7 shows a similar 
phenomenon to that seen in LII i.e. UBP-310 appeared to remove a population of large but 
infrequent events, and this has influenced the population mean, without markedly 
affecting its frequency. Subsequent application of KA in the presence of UBP-310 increased 
the mean frequency of sIPSCs to 173.2 ± 31.6 event/min, although this did not reach 
statistical significance (rANOVA) analysis of the IEIs on the cumulative probability plot did 
suggest it was a real effect (P < 0.0001, KS-test; n = 5, not shown). Similar explanations to 
those proposed for LII could be advanced to account for the effect of UBP-310 and KA in 
LV. To avoid the repetition of these proposals here, the reader is referred back to section 
6.3.3.1 above (Effects of UBP-310 on juvenile LII sIPSCs).  
Taken together with previous results, a decrease in the amplitude of sIPSCs in the presence 
of UBP-310 could suggest the GluK1-containing KAR has roles in the synchronisation of 
GABA release onto principal neurones, and its blockade decreases the likelihood of multi-
quantal release. The decay time is not affected by UBP-310 (from 12.6 ± 3.8 ms to 13.6 ± 
5.2 ms), but subsequent application of KA did tend to decrease the mean decay time (not 
significant with rANOVA). This could support the proposal (Section 6.3.3.1) that the large 
sIPSCs that become evident when KA is added in the presence of UBP-310 are from a 
different interneurone source than those that disappear when UBP-310 is added. Careful 
comparison of event kinetics and subsequent experiments in the presence of TTX could 
help confirm these possibilities. 
6.3.5.2 Effects of UBP-310 on neonate LV sIPSCs 
The studies above suggest that there may be a role for GluK1 receptors in early 
development, although the transient nature of the effects seen with KA and ATPA are not 




onto LV neonatal neurones the, UBP-310, was bath applied. UBP-310 slightly and non-
significantly decreased the mean frequency of sIPSCs, from 105 ± 67.5 events/min to 74.9 
± 35.7 events/min. With subsequent addition of KA mean frequency of sIPSCs full slightly 
further but it was not really possible to determine the basis of this effect. Mean amplitude 
was largely unaltered (20.7 ± 2.7 pA to 18.9 ± 1.6 pA) in the presence of UBP-310 although 
there did appear to be an elimination of some higher amplitude events. In the pooled data 
from the control group, 6.2 % of event amplitudes exceeded 50 pA compared to 0.01 % in 
the presence of UBP-310. These results are summarised in Fig. 6.7. 
Overall the effects of UBP-310 in these studies are weak and the numbers of cells tested is 
low, so it may be dangerous to place any emphasis on the results. The only real effect of 
note is the apparent loss of some of the larger events when UBP was applied. This is 
reminiscent of the time dependent decline with KA and the concentration-dependent 
decline with ATPA noted above, which could be a result of receptor desensitisation. This 
could be equivalent to blocking the receptor with UBP-310. Interestingly, the baseline 
frequency of sIPSCs in the small sample tested here was double that in the studies with KA 
and ATPA. One possibility is that ‘silent” interneurones that become activated by the 
agonists, are now already active in the current studies, and UBP-310 by blocking somatic 
GluK1 receptors is now switching them off. This is highly speculative and much further work 






Figure 6.7: Effects of UBP-310 (20 μM) and KA (200 nM) on sIPSCs in 5 juvenile and 3 
neonate LV neurones. (A/F) Average sEPSC frequency, (B/G) amplitude, (C/H) decay time 
and (D/I) % change in holding current data from LV principal neurones. Control groups 
(white) represent sEPSCs before application of UBP-310 (grey) and KA (red). Traces show 
concurrent recordings of sIPSCs recorded in control conditions (black), and in the presence 
of UBP-310 (grey) and KA (red) from a (E) juvenile and a (J) neonate neurone. UBP-310 and 















In this section the effects of the changes in sIPSCs will be directly compared between 
neonate and juvenile neurones, to identify KAR dependent developmental changes in 
inhibitory neurotransmission in LII and LV. Effects of KAR modulation on sIPSC activity are 
compared in the two age groups in terms of percentage change from control  
6.3.5.1 Developmental differences in the effects of KA on sIPSCs 
Fig. 6.8 shows the percentage change in sIPSC frequency, amplitude and decay time with 
KA in neonatal and juvenile rats in LII. There are clear and marked differences between the 
groups. KA induced a large change in frequency to +479.2 ± 223.5 % in juvenile animals 
compared to a very weak increase in neonatal neurones (+51.1 ± 76.0 %). The effect in both 




± 71.8 % above control levels in neonates it fell below the control levels (-53.3 ± 15.7 %). 
The mean percentage change in sIPSC frequency in the presence of KA is not significantly 
different between the two age groups due to the huge variability in responses.  
Interestingly, there was also a very clear-cut difference the effect of KA on sIPSC amplitude 
in neonatal versus juvenile rats. KA increased the amplitude of events by +126% over 
control in juveniles compared to a complete lack of effect in neonates (mean remaining at 
100% of control). When UBP-310 was added in juvenile slices the amplitude fell to just 
+18.5 % above control. Interestingly, mean amplitude in neonates actual fell slightly at this 
point although the effect was very small (-15%) but was concurrent with the fall in 
frequency noted above.  
A similar pattern was evident in decay time as in the other parameters. Thus, the increased 
frequency and amplitude in juveniles with KA saw a concurrent increase in decay to nearly 
twice that (+96.5) % in control. This increase in decay time was again reversed by UBP-310. 
Neonate neurones showed no change in decay time throughout.  
These results suggest that, in juvenile LII neurones activation of KARs leads to a strong 
increase in sIPSCs with a large amplitude and slow decay compared to control events. This 
could indicate that the receptors responsible may be located on active presynaptic 
GABAergic terminals and act to provoke a high level of synchronised multi-quantal release. 
Alternatively, the receptors may reside on the soma/dendrites of interneurones that are 
presynaptic to the recorded neurone, and that these neurones are driven to fire only when 
KA is present. The shift in and amplitude distribution decay time may support the latter 
proposal and may also suggest that the population of interneurones activated may differ 
from those responsible for sIPSCs at baseline. Clearly, a combination of these effects is also 
possible and further experiments in the presence of TTX are needed to confirm this. The 
ability of UBP310 to reverse the increases suggests, at least at this stage, that the receptor 
is likely to contain the GluK1 subunit. 
In neonates, the frequency of sIPSCs was low and only a minimal increase was observed 




receptors are weakly expressed at this stage, or that GABA interneurones are poorly 
developed, connected or functional.  
 
Figure 6.8: Comparative change in sIPSCs with KA (200 nM) and UBP-310 (20 μM) in 
neonate and juvenile neurones. (A&D) Mean sIPSC percentage change in frequency, (B&E) 
amplitude, (C&F) decay time data from 3 neonate (pink) and 4 juvenile (red) principal 
neurones from LII (top) MEC, and from 3 neonate (pink) and 7 juvenile (red) principal 
neurones from LV (bottom) MEC. *, # and Ϯ denote significant differences between: * 
juvenile % change vs control (100 %, dashed line), # neonatal % change vs control (100 %, 
dashed line), and Ϯ juvenile % change vs neonatal % change. 
 
In some respects the age comparison In LV (also shown in Fig. 6.8) was qualitatively similar 
to LII although the quantitative differences between the age groups was not. Thus, KA 
maximally increased the frequency of events by ~+350% over control in juveniles, which 
was rather less than that seen in LII. In neonate LV, however, KA elicited a maximal +120% 
increase, which was greater than the effect in LII. Thus, the overall difference in increase 




It should be noted that increased frequency in juveniles was sustained throughout 
exposure to KA in juvenile neurones, but that in juvenile neurones it started to fall markedly 
after about 10 min and was actually ~5% below control by 15 min. This may suggest that 
KARs at this stage of development in LV are more susceptible to desensitisation compared 
to the older animals. Repeating the experiment in the presence of concanavalin a, a ligand 
which prevents desensitisation of glutamate receptors, could clarify this possibility.  
Interestingly, KA induced an increase in the amplitude of sIPSCs in LV, and percentage wise, 
the change was similar in neonatal (+74.9%) and juvenile (+75.3%). Likewise, the decay time 
of sIPSCs was increased in neonatal LV (+ 30%) juvenile (+88.6%) neurones but to a much 
greater extent in the latter. These effects contrast with complete lack of change in either 
parameter in LII neonates. 
In neonate LV UBP-310 substantially reversed the increased amplitude seen with KA, 
abolished the increase in amplitude but only weakly affected decay time. Similar effects 
were seen in the neonates with amplitude and decay, but because of decline in frequency 
back to baseline it was not possible to assess the effect of UBP on this parameter.  
6.3.5.2 Developmental differences in the effects of ATPA 
Comparison of changes to sIPSCs induce by ATPA in neonatal and juvenile LII neurones is 
summarised in Fig. 6.9. ATPA (100 nM) had no effect on sIPSCs in either age group. At 500 
nM it also failed to alter any parameter of sIPSCs in the juvenile animals but, in complete 
contrast, greatly increased the frequency in neonatal neurones by over +480 % of control. 
An increase in the amplitude (+57 %) of sIPSCs in neonatal neurones accompanied the 
increased frequency. Additionally, the mean decay time of sIPSCs increased by +95 % in 





Figure 6.9: Comparative change in sIPSCs with ATPA (100 &500 nM) in neonate and 
juvenile neurones. (A&D) Mean sIPSC percentage change in frequency, (B&E) amplitude 
and (C&F) decay time data from 3 neonate and 4 juvenile principal neurones from LII, and 
4 neonate and 8 juvenile principal neurones from LV, MEC. Note the different effects of 
ATPA in neonatal versus juvenile sIPSCs. *, # and Ϯ denote significant differences between: 
* juvenile % change vs control (100 %, dashed line), # neonatal % change vs control (100 %, 
dashed line), and Ϯ juvenile % change vs neonatal % change. 
These results suggest a developmental difference in the ability of ATPA to modulate GABA 
release in LII MEC. This could reflect a developmental downregulation of interneurones 
expressing KARs containing the GluK1 subunit, or of the excitatory drive onto 
interneurones, perhaps via receptor internalisation, differential expression of interneurone 
subtypes or alterations in the synaptic connectivity via pruning mechanisms. The results 
also suggest that it is possible for GluK1 receptors to activate GABA release in the neonates, 
possibly by exciting interneurones that are normally silent, but it is difficult to match this 
with the lack of effect of KA. One speculative possibility that the receptor subunit 
composition or variant present at P8-11 has a high affinity for ATPA but a low affinity for 





Fig. 6.9 also presents the comparison of the changes to sIPSC activity in neurones in LV. 
sIPSCs in juvenile animals showed no change in any parameter with ATPA at either 100 or 
500 nM. However, in neonatal neurones a +80% increase in frequency was seen with 100 
nM although this declined to +37%. This contrasts slightly with LII where in the same age 
group 100 nM was ineffective but 500 nM evoked a large response. Nevertheless, it does 
show that GluK1 receptors may be involved in modulating GABA transmission in both 
layers, albeit weakly, at an early age.  
ATPA also changed the amplitude of sIPSCs in neonatal neurones, increasing it by ~35% at 
100 nM. Like the frequency, this was not sustained with the higher concentration where it 
returned to control levels. A similar pattern was evident with decay time, with an increase 
of +108% at 100 nM and a smaller but still substantial increase at 500 nM +84%. The decline 
in effect of ATPA at high concentrations again could indicate that the receptor responsible, 
whilst likely to contain the GluK1 subunit, undergoes substantial desensitisation. This could 
be verified by additional experiments using concavanalin a.  
6.3.5.3 Developmental differences in the effects of UBP-310 
Unfortunately, due to time restaints, experiments on the effects of UBP-310 on inhibitory 
transmission in neonatal LII were not completed, so I can only compare changes in LV. 
These are summarised in Fig. 6.10. UBP-310 had no effect on the frequency, amplitude, or 
decay time in either age group, suggesting that GluK1 receptors are not involved in 
maintaining tonic GABA release in juveniles or adults. 
The responses to the additional application of KA in the presence of UBP were intriguing. 
KA actually decreased the frequency of sIPSCs in neonatal neurones by - 48.3 ± 11.2 % of 
control in the neonatal group and this was accompanied by a decline in decay time (-48.25 
± 11.2 %) but not amplitude. In complete contrast, in juvenile neurones, KA plus UBP-310 
induced a clear increase in frequency (+107.5 ± 78.7 %) with an elevation of decay time 
(+73.2 ± 31.6), but again no amplitude change. These results could suggest that a non-GluK1 
containing KAR may be acting to depress GABA release onto neonatal neurones and 
facilitate release onto juvenile principal neurones. This intriguing and exciting finding 





Figure 6.10: Comparative change in sIPSC activity with UBP-310 (20 μM) and KA (200 nM) 
in neonate and juvenile neurones. (A) Mean sIPSC percentage change in frequency, (B) 
amplitude, (C) decay time and (D) holding current of sIPSCs recorded from 4 neonate and 4 
juvenile principal neurones from LII MEC (top), and from 3 neonate and 5 juvenile principal 
neurones from LV MEC (bottom). UBP-310 had no effect on sIPSCs in both age groups, but 
addition of KA induced opposite effects. *, # and Ϯ denote significant differences between: 
* juvenile % change vs control (100 %, dashed line), # neonatal % change vs control (100 %, 







Figure 6.11: Summary of the suspected location of KARs at inhibitory synapses in LII and 
LV MEC. A clear difference in GABA release in response to ATPA was noted between neonate 
and juvenile sIPSCs. ATPA increased the frequency of sIPSCs in neonate, but had no effect 
on juvenile, sIPSCs. This would suggest a population of interneurones driven by the GluK1 
KAR are being activated in the neonate which may already be tonically active in the juvenile 
neurones. In addition, the effects of KA on sIPSCs in juvenile neurones would support the 
presence of a GluK1-containing KAR on the soma/dendrites (Frerking et al., 1999) or even 
the axon of interneurones (Semyanov and Kullmann, 2001), like in the hippocampus.  
 
6.4.3 Summary of findings 
The suggested locations of KARs mediating inhibitory neurotransmission in the MEC are 
summarised in Fig. 6.11. 
1) A presynaptic GluK1-containing KAR may be present on interneurones, acting to 
tonically facilitate GABA release onto principal neurones by activation by spillover 




2) A KAR is likely located at the soma/dendrites of interneurones, mediating multi-
quantal release of GABA onto principal neurones 
3) The interplay between KARs located on both principal cells and interneurones 
allow the generation of synchronised neuronal activity.  
6.4 Discussion 
The aim of this Chapter was to determine the roles of KARs in mediating inhibitory 
neurotransmission in LII and LV MEC, and to identify any developmental differences in this 
activity in neonate (P8-11) and juvenile (P20-27) neurones. 
As in the previous Chapter, interpretation of results are made more difficult considering 
the plethora of KARs located pre- and postsynaptically where they can both facilitate and 
depress excitatory and inhibitory neurotransmission (Cossart et al., 2001, Contractor et al., 
2001, Semyanov and Kullmann, 2001). Moreover, the current lack of pharmacological 
specificity of agonists and antagonists confounds scrutiny between KAR subunits. Together 
with data from Chapter 5 I will discuss the findings and identify potential scenarios 
accounting for KAR modulation of inhibitory neurotransmission, firstly in the juvenile MEC, 
followed by an explanation of the clear developmental differences in KAR function at 
GABAergic synapses.  
6.4.1 Presynaptic GluK1-containing KARs facilitate GABA release via spillover 
mechanisms 
From the results in Chapter 5 I suggested that a GluK1-containing KAR was present pre- 
synaptically at glutamatergic synapses onto principal neurones, which had a very high level 
of tonic activity contributing to ~50% of spontaneous glutamate release. Here, when this 
receptor is blocked, there appeared to be a consistent decrease in the amplitude of sIPSCs 
across both layers and in both age groups. This may suggest that GluK1-containing KARs 
are also tonically active on GABAergic terminals and activated by spillover from glutamate 
synapses, which has been shown to occur in other brain regions (Jiang et al., 2001, Binns et 
al., 2003). This tonic effect may result in synchronised multi-quantal GABA release onto the 




quantal, spontaneous GABA release, but the more frequent mono-quantal release is 
unaffected, and so the overall amplitude and frequency of inhibitory events is only 
decreased slightly.  
Next, KA induced a significant increase in the frequency and amplitude of sIPSCs recorded 
in LII and LV juvenile neurones, though to a much larger extent in LII, which may reflect the 
increased inhibitory tone in the superficial relative to the layers as shown in chapter 4 and 
in previous studies (Greenhill et al., 2014, Jones and Woodhall, 2005, Woodhall et al., 
2005). In Chapter 5, we suggested the presence of a postsynaptic non-GluK1 containing 
KAR mediating the effects of KA, therefore the large increase in sIPSCs may be driven by 
excitatory connections onto interneurones, which increase summation of sIPSCs. Once 
again, further addition of UBP-310 appears to somewhat reduce the effects of KA. The small 
reduction in frequency and amplitude may reflect a reduction in on-going facilitation of 
GABA release mediated by spillover glutamate to nearby inhibitory synapses. On the other 
hand, it is possible that KAR containing the GluK1 subunit are located directly on the 
soma/dendrites of interneurones, driving GABA release.  
Lastly, in juvenile neurones, ATPA had no effect on GABA release onto principal neurones, 
except for one neurone. As previously mentioned, this neurone had much higher baseline 
frequency to the other neurones in the data set, so may reflect a different type of principal 
neurone. Nevertheless, this may shine light on the developmental differences in response 
to ATPA discussed in the next section.  
Taken together, these results suggest there may be a GluK1-containing KAR facilitating 
GABA release at interneurone terminals, which can be tonically activated by spillover of 
glutamate from nearby excitatory synapses. It is probable that KARs are also located on the 
soma/dendrites of interneurones, as in other brain regions (Mulle et al., 2000, Cossart et 
al., 1998, Cossart et al., 2001), including the adjacent LIII MEC (Chamberlain, 2009, 





6.4.2 Developmental differences in KAR function at GABAergic synapses 
In LII, the effects of KA in neonate neurones was virtually non-existent (+51.1 ± 76.0%) 
compared to in juvenile neurones (+479.2 ± 223.5%). In juveniles, the huge increase in 
frequency was accompanied by increases in both amplitude and decay time, suggesting the 
increase in GABA release may be a network driven action potential dependent effect. The 
lack of such changes in the neonate neurones strongly suggests that excitatory synapses 
onto interneurones are underdeveloped, not connected or non-functional. Alternatively, 
this could reflect a reduced expression of KARs at this stage of development, though KA still 
caused a small, increase in glutamate release at excitatory synapses at the same age, 
indicating their presence, at least at excitatory synapses.  
There were also clear lamina differences in response to KA, with LV exhibiting a greater 
response to KA (+120%) compared to LII (+51%) in neonate neurones, which was 
accompanied by an increase in amplitude. This may suggest that, unlike in LII, excitatory to 
inhibitory connectivity is more established, and can provide the excitatory drive mediating 
synchronised GABA release from interneurones.  
By far the most compelling developmental difference in KAR function between the two age 
groups was the effects of ATPA, which induced a substantial increase in the frequency of 
GABA release onto principal neurones in both layers of neonatal MEC, but had no effect on 
the frequency of sIPSCs in juvenile neurones. The fact that ATPA had no effect on, or slightly 
decreased, glutamate release in the previous chapter strongly suggests the GluK1-
containing KAR mediating the increase in GABA release are located directly on 
interneurones. Indeed, KARs have been previously shown to be located on interneurones 
in the hippocampus, located at directly on the axons (Semyanov and Kullmann, 2001), at 
the terminals and the soma/dendrites (Cossart et al., 2001, Daw et al., 2010).  
These results suggest a developmental difference in the ability of ATPA to modulate GABA 
release the superficial and deep layers of the MEC. This could reflect a developmental 
downregulation of interneurones expressing KARs containing the GluK1 subunit, or in the 
excitatory drive onto interneurones, perhaps via receptor internalisation, differential 




mechanisms. The results suggest that it is possible for GluK1 receptors to activate GABA 
release in the neonates, possibly by exciting interneurones that are normally silent, but 
these results are confounded by the reduced effect of KA in neonates. One possibility is 
that the receptor subunit composition or variant present at P8-11 has a high affinity for 
ATPA but a low affinity for KA, and with development to the juvenile stage this switches to 
an isoform with the reverse affinities. Or, perhaps, the intense effects of KA lead to receptor 
desensitisation, which appears to be happening at least in LV. Moreover, previous work in 
this laboratory has observed similar desensitising effects of KA in juvenile neurones using 
a higher concentration of KA (unpublished findings). A study by Maingret et al. (2005) 
looked at the role of KARs expressed in neonatal hippocampal interneurones, and found 
they modulated GABAergic neurotransmission using two distinct and opposing 
mechanisms, which were mediated by different populations of neurones. A presynaptic 
KAR at GABAergic terminals, acted to decrease release probability, and a somatodentritic 
and axonal population of KARs powerfully up-regulated action-potential dependent sIPSCs 
(Maingret et al., 2005). A similar somatodentritic/axonally located GluK1-containing KAR 
may be mediating the effects of ATPA in neonate neurones here, especially considering the 
large increases in frequency, amplitude and decay time, which may reflect the activation 
of a population of interneurones that were previously silent. 
Either way, it is clear there are developmental differences in the GluK1-containing KAR 
function between the two age groups. As previously mentioned, preliminary work in 
Professor Elek Molnar’s lab showed changes in GluK1-containing KAR expression during 
development, and it appeared there was a peak in expression in the MEC at ~P14. Perhaps 
one way to account for these results is that there is a transient increase in the expression 
of GluK1-containing KARs, around the age of the neonate group (P8-11). The expression of 
these KARs on interneurones may still exist in juvenile neurones, but to a lesser degree, 
and may also have a degree of tonic activity so that ATPA has a reduced effect (1/7 cells 
responded to ATPA in juvenile). Perhaps KARs located on interneurones require a larger 
stimulus, considering that only 500, and not 100 nM, was effective. Indeed, KARs in other 
brain regions have a frequency dependence, such that the response of the receptor 




The mechanisms underlying the differences in GluK1-containing KAR activity are still up for 
debate, but the idea there may be a transient increase in expression of KARs located 
directly on interneurones gives potential for a developmental period in which KARs can 
mediate intense synchronised activity within the MEC. This patterned and synchronised 
activity may be critical for plasticity, and could implicate KARs in activity-dependent fine-
tuning and maturation of synapses, during which some synapses are strengthened and 











Developmental profile of kainic acid-





In the previous chapters of this thesis I have detailed the characteristics of glutamatergic 
excitatory and GABAergic inhibitory transmission in the MEC using spontaneous synaptic 
currents as a model for transmission, and compared the deep and superficial layers. I have 
examined how KAR may be involved in modulating transmission in both layers and 
determined changes in baseline activity and KAR modulation with development. In this 
chapter I want to explore the contribution of excitatory and inhibitory transmission to 
synchronised oscillatory activity, focussing on the role of KAR in initiating such activity 
during early development. 
Synchronised neuronal oscillations in the gamma frequency band (30-80 Hz) are 
fundamental for many higher order cognitive processes, and can be seen throughout the 
cortex (Singer and Gray, 1995, Fries, 2005, Whittington et al., 2011, Buzsáki and Wang, 
2012). It is thought that such activity has the ability to link the activity of single neurones 
that fire synchronously in an assembly to the nature of a sensory stimulus. The 
synchronised response to sensory input allows communication between both spatially 
distributed and regional populations of neurones, which is thought to underlie aspects of 
cognition specific to the brain region in which they reside. The MEC is critically important 
in both spatial and memory processes (Coutureau and Di Scala, 2009, Schultz et al., 2015), 
and early cortical changes in GFO have been identified in neurological disorders, such as 
AD, where deficits in these aspects of cognition is an early and severe consequence of the 
disorder (Klein et al., 2016, Verghese et al., 2017, Allison et al., 2016, Vlček, 2011, Vlcek and 
Laczo, 2014).  
Much evidence implicates inhibitory mechanisms in the generation of GFO, specifically 
through the action of fast-spiking perisomatic parvalbumin-containing basket 
interneurones (Buhl et al., 1998, Fisahn et al., 1998, Whittington et al., 2011). Basket 
interneurones provide a temporal structure that can entrain firing patterns and generate 
synchronous IPSPs in neighbouring neurones (Whittington et al., 1995, Traub et al., 1996a, 
Wang and Buzsaki, 1996). GFO have been described in many brain regions in vivo, including 




Bragin et al., 1995), striatum (Berke et al., 2004), amongst other areas, but most 
importantly, the MEC (Chrobak and Buzsaki, 1998). Common to all of these areas is the 
presence of dense inhibitory innervation and its associated GABAAR-mediated synaptic 
transmission.  
Previous work has indicated that GFO arise by two main mechanisms, although these are 
necessarily interrelated (for more detail, see Chapter 1). Interneurone network gamma, or 
ING relies solely on the excitation of inhibitory neurones. In this model, GFO are mediated 
by GABAARs and gap junctions (Traub et al., 2001) between interneurones, which are 
pharmacologically disconnected from principal neurones by blockade of ionotropic 
glutamate receptors (Whittington et al., 1995). Pyramidal-interneurone network gamma, 
or PING, as its name suggests, involves a network containing populations of excitatory, as 
well as inhibitory, neurones, which are reciprocally connected to each other (Wilson and 
Cowan, 1972, Whittington et al., 2000).  
GFO can also be reliably induced in in vitro slice preparations either transiently, via 
electrical stimulation (Traub et al., 1996a, Whittington et al., 1997a), or persistently, via 
chemical activation of muscarinic receptors (Whittington et al., 1995), the cholinergic 
pathway (Traub et al., 2000, Van Der Linden et al., 1999) or KARs (Buhl et al., 1998, 
Cunningham et al., 2003), the latter being the focus of this chapter. These models generate 
synchronised gamma activity with underlying properties that are mechanistically different 
and specific to the brain region in which they are induced, but crucially, all induction 
protocols for GFO require intact inhibitory neurotransmission. The time-course of the IPSPs 
is key to setting the frequency of GFOs (Whittington et al., 1995, Traub et al., 1996a), and 
blocking GABAARs abolishes rhythmic activity (Buhl et al., 1998, Fisahn et al., 1998).  
GFO can be generated in the MEC in vitro by KA (Cunningham et al., 2003). Computational 
and experimental studies using knock-out mice suggest that KA is able to generate 
oscillatory activity due to the interplay of KARs containing the GluK1 subunit directly on the 
axons of interneurones (Semyanov and Kullmann, 2001), and KARs containing the GluK2-
subunit, likely located in the somatodendritic region of both interneurones and pyramidal 




KA to induce KA-O are less understood in the MEC, but the GluK1-containing KAR appears 
to be critically important for GFO generation and maintenance (Stanger et al., 2008). This 
observation was not replicated in the hippocampus (Brown et al., 2006), emphasising the 
mechanisms underlying KA-O are likely influenced by the regional specific neuronal 
architecture supporting the rhythm. 
The balance between inhibitory and excitatory transmission differs across layers of the EC 
(Jones, 1993; Berretta and Jones, 1996; Woodhall et al., 2005; Woodhall and Jones, 2006; 
Greenhill et al., 2014). The data in this thesis have considerably extended this distinction 
and shown that there developmental changes to this balance and differential effects of KAR 
in modulating this balance, which also change with development. It is also the case that 
there is a lamina specific susceptibility to generation of GFO in the MEC (Cunningham et 
al., 2003) and other forms of oscillations (Cunningham et al., 2006b) with superficial layers 
(LII and LIII) being more likely to generate oscillatory activity than the deeper layers.  
In this chapter, I have used examined the characteristics of KA-O in LII and LV and used 
these oscillations to follow changes in the contribution of KAR activity to network 
synchrony during development in the MEC. Unpublished work from Professor Elek Molnar’s 
laboratory at the University of Bristol (see Fig. 1.6 in Chapter 1) has shown changes in KAR 
expression during development, particularly a distinct increase in the expression of KARs 
containing the GluK-1 containing subunit at around P14. It seems likely that changes in KAR 
expression during development will influence the ability of the network to engage in or 
generate synchronised activity. 
As mentioned, KA-O are dependent on inhibitory neurotransmission which undergoes 
significant changes during development, as addressed in Chapter 4. In LII, the overall 
inhibitory tone increases 8-fold between the neonatal (P 8-11) and juvenile (P 20-27) age 
groups, compared to a 5-fold increase in LV. In addition, in Chapter 6 I showed that KAR 
activation had a reduced effect on the modulation of inhibitory neurotransmission in 
neonate versus juvenile MEC. Therefore the balance between inhibition and excitation 




6), and the differences in the expression of KARs observed during development (Molnar et 
al. unpublished), may inform the interpretation of the developmental changes in KA-O.  
What is interesting about using KA to induce GFO is that it mimics both physiological and 
pathological manifestations of neuronal activity, such that small concentrations of KA can 
induce GFO, but high concentrations can induce epileptogenic activity. This poses a 
potential role for KARs in the generation of synchronised oscillatory activity and in the 
development of epilepsy and other disorders of synchrony. It is of great interest to 
understand the development of both GFO and the contribution of KARs to this activity. 
Therefore, the main aims of this chapter were to: 
1) Determine a developmental profile of KA-O in LII and LV, which would act as a 
reporter of KAR involvement in synchronised neuronal network activity. 
2) Identify developmental changes in the contribution of GABAergic and glutamatergic 
neurotransmission to KA-O in LII and LV.  
3) Draw conclusions about the changes in inhibitory neurotransmission in previous 
chapters and changes to KA-O during development.  
7.2 Methods  
All experiments described in this chapter were conducted using MEC-hippocampal slices 
(400 μM) obtained from male or female Wistar rats aged P8-27. Slices were maintained in 
an interface chamber as described in Chapter 2. Dual extracellular LFP recordings were 
made from LII and LV MEC of the same slice. Drugs were recirculated via a reservoir system. 
Numbers of observations (n) in these studies reflect the number of slices. Mean values for 
frequency and amplitude were determined and compared between different age groups 
using the non-parametric Mann Whitney test as data are not normally distributed. Two-
way ANOVA analysis was used when comparing groups that were influenced by two 
different independent variables (e.g. time and age). When comparing before and after 
effects of a drug on oscillatory activity, a paired t-test or a repeated measures ANOVA 




slice, a non-parametric, paired Wilcoxon signed rank test was used. Statistical significance 
was reached if P < 0.05.  
Control recordings of baseline activity were made for at least 20 min prior to the addition 
of any pharmacological agents to ensure the oscillatory activity was a result KAR activation, 
and not spontaneous network activity. Oscillatory activity was induced by perfusion with 
KA (400 nM) bath applied via the circulating reservoir of ACSF. One-minute epochs of 
activity were recorded at 15 min intervals during the establishment and maintenance of 
oscillatory activity, and analysed immediately for amplitude and frequency. Drug 
treatments were only applied when the oscillatory activity had stabilised i.e. the amplitude 
and frequency was within 15 % variability in 3 consecutive recordings.  
7.3 Results 
7.3.1 Generation of GFO in the juvenile rat MEC 
Cunningham et al. (2003) first demonstrated that that GFO could be induced by KAR 
activation in the MEC. They showed that the power of GFO peaked in LII/LIII and was 
considerably less in LV/VI. In superficial layers there was a medial vs lateral gradient with 
power falling of abruptly at the MEC-LEC border. GFO in the MEC persisted independently 
of the hippocampus (Cunningham et al., 2003). We used LFP recordings from LII and LV to 
confirm that GFO could be reliably induced in the MEC of juvenile (P24-27) rats under our 
preparation and recording conditions.  
LFP recordings were made simultaneously from LII and LV in the same slice. Bath perfusion 
of KA (400 nM) reliably generated rhythmic field activity in LII and LV in all slices studied in 
the P24-27 age group (n = 23). Activity in LII had a mean frequency of 31.7 ± 0.6 Hz and this 
was identical in LV (31.9 ± 0.6 Hz) However, the mean peak amplitude of activity in LII (0.4 
± 0.06 μV2 / Hz) was about 10-fold that seen in LV (0.05 ± 0.01 μV2 / Hz). In all slices, the 
amplitude of the GFO was greater in LII (P < 0.0001, Mann-Whitney test; n = 23), but there 
was no difference in the mean frequencies. Once initiated, KA-induced synchronised 





Figure 7.1: KA induced GFO in LII and LV of juvenile rats. 1 second example traces of 
extracellular activity (top) and example power spectra from 60 second epochs of raw data 
(bottom) before and after the application of KA (400 nM) in LII (A: black) and LV (B: green) 
of the same slice, and in the presence of 20 μM UBP-310 (red). (C) Overlay of activity in LII 
and LV. Gamma activity had a significantly larger amplitude in LII compared to LV, but the 
frequency of activity was the same activity was abolished in the presence of UBP-310.  
 
7.3.2 Involvement of GluK1-containing KARs in KA-O 
UBP-310, inhibited KA-O in both layers and at all ages (P8-27). KA-O were abolished in all 
slices tested, and there were no discernible differences at any age, therefore the data from 
all ages was grouped together. The results are shown in Fig. 7.1. UBP-310 (20 μM) 
decreased the mean amplitude of KA-Os by -94.5 % in LII. (P < 0.0001, rANOVA, n = 12). 
Likewise, in LV in the same slices, mean amplitude was decreased by 96.2 % in the presence 
of UBP-310, (P < 0.0001, rANOVA, n = 12). Although the mean frequency appears to 




Stanger et al. (2008) identified a role for the GluK1-containing KAR in KA-O in the MEC. They 
used another GluK1 antagonist (UBP-302) and the effect of this was less pronounced 
compared to the current experiments withUBP-310 (40 % reduction vs ~95 %). This may be 
related to the specificity of the antagonists used (UBP-302 vs UBP-310), or due to the age 
of the rats (adult >150g compared with neonatal and juvenile 10-100g). Unpublished 
immunohistochemical studies (Molnar, E, personal communication; see Fig. 1.6) showed a 
developmental decrease in the expression of the GluK1-containing KAR as animals 
progressed from juvenile state to adulthood. This may account for the increased sensitivity 
to blockade of this receptor in the younger rats. It should also be noted that Stanger et al., 
(2008) conducted their studies in LIII, so lamina differences in the function and expression 
of GluK1 (Greenhill et al., 2014, Chapters 5 and 6 in this thesis) could also contribute to 
differences between the results. In patch clamp studies I identified a tonic activation of the 
GluK1-containing KAR in LII and LV, which was not apparent in LIII (Chamberlain et al., 
2012). This may have implications for the generation of GFO between layers.  
7.3.3 Laminar comparison of KA-O during development 
Having established that KA-O can be reliably generated in the juvenile MEC, and that they 
are dependent on the GluK1-containing KAR, a developmental profile was conducted. Rats’ 
aged postnatal day 8 to 27 were separated into 5 age groups: P 8-11, P12-15, P16-19, P20-
23 and P24-27. In total, data on KA-O in LII and LV was gathered from 236 slices from 118 
P8-27 rats  
7.3.3.1 Age P8-11 
A summary of the results is shown in Fig. 7.2. Application of 400 nM KA induced KA-O in LII 
and LV of all slices tested (n = 39). Power spectra analysis showed KA-O in the P 8-11 group 
were characterised by mean peak frequencies in the beta range in both LII (17.8 ± 0.3 Hz) 
and LV (18.1 ± 0.4 Hz) MEC. At this stage, unlike in the juvenile P24-27 age group, the mean 
amplitude in LV (0.05 ± 0.01 μV2 / Hz) was significantly higher than in LII (0.03 ± 0.001 μV2 / 
Hz). The amplitude in LV exceeded that in LII in 82 % of slices tested (P = 0.003, Wilcoxon 






Figure 7.2: Lamina comparison of KA-O at P8-11. Mean amplitude (A) and frequency (B) of 
KA-O induced by 400 nM KA in LII (black) and LV (green) of the same slice (n = 39). (C) 1 
second example traces of LFP recordings in LII (black) and LV (green) in the presence of 400 
nM KA. (D) Example power spectra produced from 60 second epochs of extracellular data 
showing KA-O induced in LII (black) and LV (green) of the same slice. The mean amplitude 
of KA-O was significantly larger in LV vs LII (P = 0.003, Wilcoxon signed rank test), but there 







7.3.3.2 Age P12-15 
At P12-15, there was no significant difference in amplitude and LV had a slightly lower mean 
amplitude compared to LII. The mean amplitude of KA-Os in LII was 0.11 ± 0.03 μV2 / Hz 
compared to 0.08 ± 0.01 μV2 / Hz in LV. Despite this slight increase in the mean amplitude 
in LII compared to LV, the amplitude in LV still exceeded that of LII in 61 % of slices. 
Frequencies in both layers had increased slightly compared to P8-11, but there were still 
no statistically significant differences between them (LII 21.3 ± 0.7 Hz and LV 21.2 ± 0.7 Hz). 
The comparison of KA-O in P12-15 rats is summarised in figure 7.3. 
 
Figure 7.3: Lamina comparison of KA-O at P12-15. Mean amplitude (A) and frequency (B) 
of KA-O induced by 400 nM KA in LII (black) and LV (green) of the same slice (n = 18). (C) 1 
second example traces of LFP recordings in LII (black) and LV (green) in the presence of 400 
nM KA. (D) Example power spectra produced from 60 second epochs of extracellular data 
showing KA-O induced in LII (black) and LV (green) of the same slice. There were no 




7.3.3.3 Age P16-19 
Although, again, there were no lamina differences in the mean frequencies in LII (29.4 ± 0.7 
Hz) and LV (29.2 ± 0.7 Hz) in P16-19 rats, there was a noticeable increase in mean frequency 
relative to the adjacent younger age group (P12-15). What was also now very clear was 
that the mean amplitude of KA-O was substantially and significantly higher in LII (0.19 ± 
0.05 μV2 / Hz) compared to in LV (0.03 ± 0.00 μV2 / Hz) 23 slices (P < 0.0001, Wilcoxon signed 
rank test; n=23). This was reinforced by the fact that the amplitude in LII was larger than 
that in LV in 96 % (22/23) of slices. The difference between layers largely occurred through 
a substantial rise in amplitude in LII, whereas LV remained around the same level as the 
preceding age groups, regardless of the increase in frequency. The comparison of KA-O in 





Figure 7.4: Lamina comparison of KA-O at P16-19. Mean amplitude (A) and frequency (B) 
of KA-O induced by 400 nM KA in LII (black) and LV (green) of the same slice (n = 23). (C) 1 
second example traces of LFP recordings in LII (black) and LV (green) in the presence of 400 
nM KA. (D) Example power spectra produced from 60 second epochs of extracellular data 
showing KA-O induced in LII (black) and LV (green) of the same slice. The mean amplitude 
of KA-O was significantly larger in LII vs LII (P < 0.001, Wilcoxon signed rank test), but there 
was no difference in the mean frequency of KA-O between layers. 
 
7.3.3.4 Age P20-23 
At 20-23 days old, the mean amplitude was again significantly and substantially larger in LII 
than LV. The difference was made more marked still by a further incremental increase in 




unchanged from the mean amplitude in younger age groups. The amplitude in LII was now 
larger than in LV in all slices tested (n = 14). Despite this, there were again no differences 
in the mean frequencies of KA-O in LII (30.9 ± 0.7 Hz) and LV (31.6 ± 0.8 Hz). The 
characteristics of KA-O in rats aged P20-23 is summarised in figure 7.5. 
 
Figure 7.5: Lamina comparison of KA-O at P20-23. Mean amplitude (A) and frequency (B) 
of KA-O induced by 400 nM KA in LII (black) and LV (green) of the same slice (n = 14). (C) 1 
second example traces of LFP recordings in LII (black) and LV (green) in the presence of 400 
nM KA. (D) Example power spectra produced from 60 second epochs of extracellular data 
showing KA-O induced in LII (black) and LV (green) of the same slice. The mean amplitude 
of KA-O was significantly larger in LII vs LII (P < 0.001, Wilcoxon signed rank test), but there 





7.3.3.5 Age P24-27 
A comparison of KA-O in rats aged P24-27 is summarised in figure 7.6. In the oldest animals 
tested (n = 24), the mean amplitude continued to increase in LII with a slight increment in 
LV, and amplitude remained significantly larger in LII (0.4 ± 0.06 μV2 / Hz) compared to LV 
(0.05 ± 0.01 μV2 / Hz). As with previous findings, despite a clear age-dependent difference 
in amplitude, there were no statistically significant differences in the mean frequency of 
KA-O in LII (31.7 ± 0.6 Hz) and LV (31.9 ± 0.6 Hz) MEC.  
 
Figure 7.6: Lamina comparison of KA-O at P24-27. Mean amplitude (A) and frequency (B) 
of KA-O induced by 400 nM KA in LII (black) and LV (green) of the same slice (n = 23). (C) 1 
second example traces of LFP recordings in LII (black) and LV (green) in the presence of 400 
nM KA. (D) Example power spectra produced from 60 second epochs of extracellular data 
showing KA-O induced in LII (black) and LV (green) of the same slice. The mean amplitude 
of KA-O was significantly larger in LII vs LII (P < 0.001, Wilcoxon signed rank test), but there 




7.3.4 Developmental profile of KA-O 
 The full comparison of the developmental changes in amplitude and frequency of KA-Os 
can be seen in figures 7.7 and 7.8. 
When assessing the lamina differences with development it is obvious that there was a 
progressive and incremental age-dependent increase in the amplitude of KA-O generated 
in LII. This was just as clearly not seen in LV recorded in the same slices. LV followed a 
different developmental pattern. There was a small, but significant increase in the 
amplitude of KA-Os from P8-11 to P12-15 (P < 0.0001, Kruskal-Wallis test). However, this 
surge in the amplitude of KA-O in LV was a temporary change, and was reversed in the P16-
19 group and actually decreased to a slightly smaller mean amplitude than in the P8-11 
rats. It rose again marginally over the course of further development, but always remained 
at or slightly below the amplitude recorded at P8-11. It should be stressed that the 
amplitude in LV was relatively low throughout. 
Despite the marked differences in amplitude, there were no lamina differences in the mean 
frequencies of KA-O in each age group, and a parallel age-dependent change in the 
frequency of KA-O was apparent in both layers. However, this was not a progressive 
incremental change, but rather a clear step increase was apparent between P12-15 and 
P16-19 age groups in both layers (P < 0.05, Kruskal-Wallis test). At this point, the KA-O in 
both layers switched from beta frequency to low gamma. Thereafter, frequency continued 
to increment marginally in both layers, but the changes were not dramatic. 
These results show that there are clear developmental changes in KA-O in the MEC in vitro. 
An age-dependent step increase in frequency of KA-O occurs in both layers, but in LII this 
is accompanied by an incremental increase in KA-O amplitude which is not seen in LV, such 







Figure 7.7: Developmental profile of KA-O in LII and LV at P8-27. Bar charts showing the 
mean amplitude (left) and frequency (right) of KA-O in LII (A) and LV (C) from rats split into 
5 age groups. KA-O show a gradual developmental increase in amplitude in LII but not in 
LV, and a stepwise increase in frequency from between P12-15 and P16-19 in both layers. 
(B) 1 second example traces of LFP recordings in LII and (D) LV, in the presence of 400 nM 
KA, from 5 age groups. (E) Laminar comparison of KA-O amplitude (left) and frequency 





Figure 7.8: Summary of the development of KA-O. Top: Example power spectra from 60 
second epochs of raw data from each age group in LII (A) and LV (B). (C) Overlay of example 
power spectra from both layers. Note the larger amplitude in LII compared to in LV from 
P16 onwards. Bottom: Summary table of the mean amplitudes and frequencies of KA-O in 
LII and LV in all 5 age groups. 
 
7.3.5 Developmental changes to KA-O amplitude coincide with eye opening in LII  
Looking at the developmental changes in KA-O above, it is clear that the major changes are 
occurring between the P12-15 and P16-19 age groups. A major life event that occurs during 
the former period is eye-opening, so I have conducted further detailed developmental 
analysis to examine the relationship between KA-O and eye opening.  
As eye opening occurs around P13-14, initial further analysis was conducted on the P12-15 




were subdivided into groups according to whether the rat had 1) both eyes closed, 2) one 
eye open, or 3) both eyes open at the point of brain removal.  
In LII, the mean amplitude of KA-O in the eyes closed group was 0.07 ± 0.02 μV2 / Hz (n = 6) 
and this was not significantly different to the one eye open group (0.08 ± 0.02 μV2 / Hz; n = 
4). However, the mean amplitude rose to 0.18 ± 0.06 μV2 / Hz (n = 7) when both eyes were 
open, although this did not reach statistical significance with two-way ANOVA analysis. In 
LV, the mean amplitudes of KA-O in the same slices with eyes closed, one eye open and 
both eyes open were 1.0 ± 0.03 μV2 / Hz (n = 6), 0.08 ± 0.03 μV2 / Hz (n = 4) and 0.07 ± 0.02 
μV2 / Hz (n = 7), respectively. The data are summarised in Fig. 7.9. Although there were no 
significant differences between groups there was a slight decline in amplitude that 
contrasted with the increase seen in LII. Thus, the amplitude of KA-O does tend to increase 
in LII after eye opening, a phenomena not seen in LV.  
Developmental changes in the frequency of KA-Os also appeared to coincide with the onset 
of eye opening. KA-O activity flips abruptly from beta to gamma frequency between the 
P12-15 to P16-19 age groups, with little significant change before or after this point. In the 
P12-15 group the mean frequency of KA-O in LII in rats with their eyes closed was 19.2 ± 
0.6 Hz and virtually the same with one eye open (19.5 ± 0.4 Hz). However, when both eyes 
were open mean frequency rose to 23.8 ± 1.5 Hz (P < 0.05, 2-way ANOVA). Unlike the 
developmental changes in amplitude, the frequency of KA-O in LV MEC followed the same 
pattern as in LII. The mean frequencies of KA-O with eyes closed and one eye open and 
both eyes open were 20.2 ± 1.3 Hz (n = 6), 19.5 ± 0.4 μV2 / Hz (n = 4), and 23.5 ± 1.3 Hz (n = 
7), respectively (P < 0.05, 2-way ANOVA). Results are summarised in Fig. 7.10. 
These results show there is a developmental shift in the power of oscillatory activity from 
LV to LII of the MEC at the onset of eye opening, along with a marked increase in the 
frequency of synchronised activity from a beta to a gamma band in both layers. These data 
are the first to make a potential association between the development of GFO and visual 
sensory input in the MEC, which could have major implications for the development of the 





Figure 7.9: Change in KA-O amplitude before and after eye opening. (A) Individual 
amplitudes of KA-O recorded in 143 MEC slices, in LII (black) and LV (green) of the same 
slice. Note the developmental increase in amplitudes in LII and decrease in amplitudes in 
LV. (B) Paired amplitudes from LII and LV in (A) are subtracted to determine a dominating 
layer. Positive values represent a larger amplitude of KA-O in LII relative to LV of the same 
slice, and vice versa. There appears to be a switch from a larger amplitude in LV relative to 
LII at the onset of eye-opening. (C) Mean amplitude of KA-O in rats aged P12-15 only, split 
into 3 groups according to whether the rat had 1) eyes closed (green, n = 6), 2) one eye open 
(grey, n = 4), or 3) both eyes open (black, n = 7) at the point of brain removal. Mean 
amplitude of KA-O was appears to increase when both eyes were open, in both LII and LV. 






Figure 7.10: Change in KA-O frequency before and after eye opening. (A) Individual 
frequencies of KA-O recorded in 143 MEC slices, in LII (black) and LV (green) of the same 
slice. Note the developmental increase in frequency in both layers. (B) Paired frequencies 
from LII and LV in (A) are subtracted to determine a dominating layer. Positive values 
represent a larger frequency of KA-O in LII relative to LV of the same slice, and vice versa. 
Unlike with amplitude, there was no changes in activity between the two layers. (C) Mean 
frequency of KA-O in rats aged P12-15 only, split into 3 groups according to whether the rat 
had 1) eyes closed (green, n = 6), 2) one eye open (grey, n = 4), or 3) both eyes open (black, 
n = 7) at the point of brain removal. Mean frequency of KA-O was significantly increased 
when both eyes were open, in both LII and LV (P < 0.05, 2-way ANOVA). Vertical dotted line 






7.3.6 Detailed time course of changes in KA-O in relationship to eye-opening 
To look at the changing relationships between KA-O frequency and amplitude in the two 
layers around the point of eye opening I now examine the time course of changes in more 
detail by plotting data from individual slices against developmental age. The results of this 
analysis are shown in Figs 7.9 and 7.10.  
In the analysis of the P12-15 group above it was clear that there was little change in 
amplitude in LV but LII increased with eye opening. To examine this relative change in 
amplitude between the two layers further, I plotted amplitudes for the two layers at all 
ages over the entire data set. In addition, amplitudes in LII and LV of the same slice were 
subtracted from each other (LII – LV) and plotted against age. In this case, a positive value 
will denote a larger amplitude of KA-O in LII relative to LV of the same slice, and vice versa. 
The data are shown in fig 7.9. In LV, there appears to be a slightly higher amplitude in the 
2-3 days before eye opening, but thereafter it slowly declined. In contrast, eye opening 
coincided with a dramatic rise in amplitude in LII in many slices 
When eyes were shut at the point of brain removal, the amplitude of KA-O exceeded LII 
84.4 % (38/45 slices), whereas LII exceeded the amplitude in LV in 95.5 % of slices prepared 
from rats with eyes open at the point of removal. Figure 7.9 illustrates the changes in 
amplitude in the two layers before and after eye opening. This is emphasised in the 
subtraction data where many slices fall below the zero line when eyes were closed and a 
switch to predominantly positive values is marked precisely by eye opening.  
Changes in frequency are plotted against age for the whole dataset in Fig. 7.10. Whilst it is 
clear that frequencies are similar across layers at all ages, eye opening is marked by the 
abrupt shift from beta to gamma frequency. The similarity in frequency across layers at all 
ages is emphasised by subtracting LII from LV, shown in Fig 7.10B. Most slices lie around 
the zero line regardless of whether eyes are open or not. Interestingly the relative 
frequencies in the two layers showed an element of divergence somewhat in favour of 
higher values before and following eye opening, but around the time of the event, is when 




 7.3.7 Pharmacological studies 
As noted above, GFO induced by KA were highly sensitive to blockade of KAR by UBP-310 
in the adult rat MEC (Stanger et al., 2008), which was also confirmed in this thesis (Fig. 7.1), 
suggesting a strong involvement of GluK1 receptors. Studies have also confirmed KA-O in 
the adult rat were also reduced by bicuculline and could be virtually abolished if the 
concentration was high enough, showing a strong dependence on inhibitory transmission 
mediated via GABAAR activation. GFO were also sensitive to AMPAR blockade and partially 
reduced by blocking NMDAR (Cunningham et al., 2003, Middleton et al., 2008a). 
In the following studies, the contribution of GABAergic and glutamatergic transmission to 
KA-O was examined in more detail to compare neonate (P 8-11) and juvenile (P 20-27) rats 
and to identify developmental changes in the pharmacology, which could reflect 
developmental changes in amplitude and frequency observed in the previous section. 
Bicuculline (2-6 μM), GYKI52466 (10-20 μM) and DL-AP5 (40 μM) were used to determine 
the contribution of GABAARs, AMPARs and NMDARs to KA-O, respectively.  
Table 7.2 summarises these pharmacological studies. 
7.3.7.1 Involvement of GABAA receptors in KA-O 
The GABAAR antagonist, bicuculline, was cumulatively bath applied at concentrations of 2, 
4 and 6 μM in slices from neonate (P8-15) and juvenile (P20-27) rats. The results of these 
studies are shown in Fig 7.11 
In LII, bicuculline substantially decreased the amplitude of KA-O in both age groups. In the 
neonates (P8-15), the mean amplitude of KA-O in LII MEC was significantly and 
concentration dependently decreased by bicuculline from 139.6 ± 74.2 nV2 / Hz to a 
maximal reduction with 6 μM (12.5 ± 6.0 nV2 / Hz; P < 0.01, rANOVA; n = 5). In juvenile slices 
(n = 7) application of bicuculline again significantly decreased the amplitude of KA-O 





In LV, bicuculline also significantly decreased the amplitude of KA-O in both age groups. In 
the younger neonate group, KA-O amplitude was significantly decreased from 102.5 ± 49.4 
nV2 / Hz to a maximum of ~65-70% with 6µM bicuculline (36.3 ± 22.0 nV2 / Hz). In juvenile 
slices, bicuculline also concentration-dependently reduced KA-O, essentially abolishing 
them at 6 μM (control 26.4 ± 7.9 nV2 / Hz to 1.2 ± 0.7 nV2 / Hz). 
When KA-O were still present in the presence of the drug, bicuculline had no significant 
effect on the frequency in either age group or layer.  
Whilst bicuculline reduced amplitude in both layers in each age group, it was a more 
prominent effect in juvenile slices. The maximal reduction in LII neonate slices (with 6 μM), 
was -78.1 ± 16.1%, compared to -96.9 ± 1.4% in juvenile slices. Likewise, in LV, bicuculline 
reduced the amplitude by -59.6 ± 16.7% in neonate vs -95.5 ± 1.6% in juvenile slices.  
These results suggest that fast inhibition neurotransmission mediated by the GABAAR is 
critical for the maintenance of KA-O in both neonate and juvenile rats, however, the 
contribution and dependence of GABAAR activity may increase with age, inferred by the 





Figure 7.11: Effects of bicuculline on KA-O. Bars represent the percentage of control (- - -) 
of (A) amplitude LII (B) amplitude LV, (C) frequency LII and (D) frequency LV in neonate (light 
blue) and juvenile (dark blue) MEC. Dotted line represent control (100%). * = P < 0.05, ** = 
P < 0.01, *** P < 0.001. Statistical comparisons made using rANOVA analysis and represent 
statistically significant changes from control (dashed line). 
7.3.7.2 Involvement of AMPA receptors in KA-O 
Fast phasic excitation onto interneurones has been shown to be important in the 
generation of GFO in the hippocampus and LIII MEC. To investigate the involvement AMPAR 
in KA-O in LII and LV, GYKI-52466 (10 and 20 μM), a non-competitive AMPAR antagonist, 




In LII, the mean amplitude of KA-O in neonate slices (n = 10) was decreased from 36.6 ± 8.1 
nV2 / Hz 14.7 ± 4.4 nV2 / Hz by 20 μM with a smaller effect seen at the lower concentration 
(10 µM). Neither change reached statistical significance. However, in juvenile slices (n = 6), 
the reduction in amplitude was much greater, with the mean amplitude significantly 
decreased from a control of 133 ± 36.2 nV2 / Hz to 53.3 ± 36.3 nV2 / Hz with 10 μM GYKI-
52466, and a cumulative reduction to 35.7 ± 17.4 nV2 / Hz at 20 μM (P < 0.01 for both, 
rANOVA). 
Results were similar in LV. The mean amplitude of KA-O in neonate slices (n = 10) was 
decreased, from 40.4 ± 11.4 nV2 / Hz in control to maximal reduction to 16.8 ± 7.6 nV2 / Hz 
with 20 μM of GYKI52466 (not significant). On the other hand, GYKI52466 significantly 
decreased the amplitude of KA-O in juvenile slices, from 15.8 ± 5.3 nV2 / Hz to 2.2 ± 1.0 nV2 
/ Hz at 20 μM.  
The frequency of KA-O was significantly decreased in juvenile slices (in both layers), but not 
neonate, slices. In LII of neonate slices, the mean frequency of KA-O was 17.9 ± 0.9 Hz and 
this decreased slightly to 15.7 ± 1.7 Hz with GYKI52466 (20 µM). In LII of juveniles, mean 
frequency of KA-O was significantly decreased from 31.0 ± 0.3 Hz to 20.5 ± 2.7 Hz (P < 0.05, 
rANOVA) after addition of 20 μM. Percentage-wise there was not a huge difference 
between the age groups, but the change was only significant in the juveniles. 
GYKI52466 clearly had no effects on the frequency of KA-O in LV in neonate slices (control: 
18.1 ± 0.6 Hz vs 18.2 ± 0.8 Hz at 20 μM) whereas in juvenile slices a significant decrease 
from 31.0 ± 0.3 Hz to 20.3 ± 3.1 Hz was seen with 20 µM GYKI52466.  
These results suggest that KA-O may become increasingly dependent on the contribution 
of AMPARs during development. The lower frequency seen in juvenile KA-Os after AMPAR 
blockade may be due to a decreased excitatory drive onto interneurones which are setting 
the pace of the synchronised activity. In the younger rats, GYKI54266 may have had less of 
an effect on KA-O because there are fewer AMPARs are available, or fewer synapses onto 






Figure 7.12: Effects of GYKI 52466 on KA-O. Bars represent the percentage of control (- - -) 
of (A) amplitude LII (B) amplitude LV, (C) frequency LII and (D) frequency LV in neonate (light 
blue) and juvenile (dark blue) MEC. Dotted line represent control (100%). * = P < 0.05, ** = 
P < 0.01, *** P < 0.001. Statistical comparisons made using rANOVA analysis and represent 
statistically significant changes from control (dashed line). Note KA-O have an increased 





7.3.7.3 Involvement of NMDA receptors in KA-O 
Previous studies have shown that GFOs are modulated by NMDARs in the superficial layers 
of the MEC in adult rats, due to the involvement of GABAergic basket cells in this layer, 
which are highly sensitive to excitation driven by NMDARs (Middleton et al., 2008a). 
However, blocking NMDARs certainly does not abolish GFO in the MEC, but reveals a 
second gamma rhythm of a lower frequency, driven by a different type of interneurone 
(goblet cell; (Middleton et al., 2008a, Cunningham et al., 2003). This provides evidence for 
the existence of both a NMDAR-dependent and a NMDAR-independent gamma rhythm in 
the superficial layers of the MEC, which can switch, dependent on the subtype of 
interneurone recruited into the rhythm (Middleton et al., 2008a).  
Here, we determined the contribution of NMDAR activity using the competitive NMDAR 
antagonist, DL-AP5. The results are summarised in Fig 7.13.  
In LII in neonate slices (n = 14), blocking NMDARs significantly decreased the mean 
amplitude of KA-O, but had no effect on frequency. Amplitude decreased from 36.1 ± 9.3 
nV2 / Hz to 11.1 ± 3.8 at 40 μM DL-AP5 (P < 0.05, rANOVA). Concurrently, the frequency 
was unaltered. In LII of juvenile slices (n = 12), DL-AP5 also decreased the amplitude of KA-
O, but despite the effect being almost identical to that seen in neonate slices it failed to 
reach significance (see table 7.1 for raw data). In contrast to neonates, however, the 
frequency of KA-O was significantly lowered albeit only marginally, from a control of 31.5 
± 0.6 Hz to 27.8 ± 1.0 Hz (with 40 μM DL-AP5; P < 0.001) 
Very similar results were observed in LV. DL-AP5 decreased the mean amplitude of KA-O in 
neonate slices (n = 14) from 52.0 ± 13.1 nV2 / Hz 16.1 ± 6.6 nV2 / Hz (40 μM, P < 0.01, 
rANOVA). It also decreased the amplitude of KA-O in LV in juvenile slices (n = 12), from 42.2 
± 10.7 nV2 / Hz to 11.0 ± 2.8 nV2 / Hz (P < 0.001) in the presence 40 μM DL-AP5. Unlike in LII 
the change in juveniles was significant. Concurrent changes in frequency were also similar 
to LII, with no effect of NMDAR blockade in neonates, but a very small, but significant 





Figure 7.13: Effects of DL-AP5 on KA-O. Bars represent the percentage of control (- - -) of 
(A) amplitude LII (B) amplitude LV, (C) frequency LII and (D) frequency LV in neonate (light 
blue) and juvenile (dark blue) MEC. Dotted line represent control (100%). * = P < 0.05, ** = 
P < 0.01, *** P < 0.001. Statistical comparisons made using rANOVA analysis and represent 





Table 7.1: Summary table of the effects of 2-6 μM bicuculline (BIC), 10 μM GYKI 52466, 
20-40 μM DL-AP5 and 20 μM UBP-310 on KA-O in LII and LV MEC of neonate and juvenile 
rats. * = P < 0.05, ** = P < 0.01, *** P < 0.001. Statistical comparisons made using rANOVA 







7.3.8 Summary of findings 
1) An age-dependent increase in KA-O amplitude was seen in the superficial, but not 
deep, layers of the MEC. 
2) A developmental flip in the frequency of KA-O from a beta to a gamma band 
occurs shortly after eye opening. 
3) KA-O are more pronounced in the deep layers of neonate (P8-11) but become 
progressively more pronounced in the superficial layers of juvenile rats (20-27) 
with, the switch in dominance occurring at the onset of eye opening. 
4) KA-O in the MEC are dependent on fast GABAAR mediated neurotransmission, and 
are partially driven by NMDAR and AMPAR mediated excitatory drive, which 
appears to be more dominant in KA-O of older rats. 
7.4 Discussion 
7.4.1 Developmental changes in KA-O 
This chapter set out to determine how oscillatory activity, induced by KAR activation, arises 
and develops in networks of the MEC. The results of this study identified that KA-O were 
induced at all ages studied, therefore future experiments should be done to clarify exactly 
when KA-O arise. KA-Os were present in the form of beta oscillations in the youngest age 
groups (P8-11 and P12-15), in both layers. A gamma frequency was attained in a step-wise 
manner between the P12-15 to P16-19 age groups. KA-O are known to be critically 
dependent on large compound phasic excitatory inputs onto interneurones and their 
ensuing inhibitory synaptic outputs (Cunningham et al., 2004b, Gillies et al., 2002, 
Cunningham et al., 2003). The development of synchronised activity within a network of 
neurones will therefore be intrinsically linked to the development of the inhibitory 
machinery supporting the rhythm. A recent study has addressed postnatal development of 
GABAergic interneurones in the temporal cortex sub-regions, including in the MEC, and 
revealed an increase in the density of PV-interneurones between P14 and P21 (Ueno et al., 




GFO due to several distinctive features, including their ability to fire rapidly without fatigue 
(Buzsaki et al., 1983, Kawaguchi and Kubota, 1997, Traub et al., 1996a). Another study 
performed a more region specific analysis of PV-expression in single neurones, as a marker 
of interneurone maturity, in areas of the MEC-hippocampal network (Donato et al., 2017). 
They showed that LII of the MEC was the first area to upregulate PV-expression at 
approximately P17, compared with P26 in LV, suggesting inhibitory neurotransmission 
matures earlier in the superficial layers relative to the deep. It is important to note that the 
above studies (Ueno et al. 2017, Donato et al. 2017) were conducted in mice, therefore 
caution should be taken when drawing parallels with the data from this thesis, though a 
similar developmental timeline is likely in the rat temporal cortex.  
The patch clamp data from Chapter 4 nicely complements these results, showing that, 
between neonate (P8-13) and juvenile neurones (P20-27), there was a substantial surge (8-
fold increase) in inhibitory activity in LII. This also ties in well with results from the current 
chapter, showing a large, age-dependent increase in the amplitude of KA-O in LII, which 
was not apparent in LV. Within the same time-frame, patch studies in Chapter 4 showed 
that inhibition in LV also increased (4 fold), but the overall inhibition was much stronger in 
the superficial layers comparatively, and likely accounts for the greater tendency of the 
superficial layers to generate GFO in this study and others (Cunningham et al., 2003, 
Cunningham et al., 2004a, Middleton et al., 2008a). In addition, in Chapter 4 we showed 
that IPSP kinetics were faster in juvenile rats (P20-27) versus neonate (P8-13) in LII, but not 
LV, which could reflect the maturation or activation of a sub-population of fast spiking 
inhibitory interneurones. The reasons for lamina differences in KA-O likely include the 
delayed maturation of inhibitory circuits in LV versus LII (Donato et al., 2017), as well as the 
underlying neuronal architecture in each layer. For example, principal neurones are 
thought to be mainly interconnected via inhibitory interneurones in the superficial layers 
of the MEC (Couey et al., 2013, Fuchs et al., 2016), though this is a working hypothesis that 
has been recently challenged (Winterer et al., 2017). Other factors that may influence the 
development of GFO are the formation of electrical synapses between basket cells, 
increases in glutamatergic inputs onto basket cells, general increases in basket cell to 




1996, Taketo and Yoshioka, 2000, Chattopadhyaya et al., 2004, Le Magueresse and Monyer, 
2013, Traub et al., 2001, Schmitz et al., 2001b, Traub et al., 2000).  
Either way, it is clear from the results of this study, and other studies from this lab (Greenhill 
et al., 2014, Greenhill and Jones, 2010, Jones and Woodhall, 2005, Jones and Bühl, 1993), 
there is a developmental surge in the level of inhibition in the superficial layers of the MEC 
which may support the ability of the microcircuitry in this layer to generate and maintain 
oscillatory activity.  
7.4.2 GABAergic and glutamatergic pharmacology of KA-O in the neonate and juvenile rat 
MEC 
Cunningham et al. (2003) were the first to induce KA-O in the MEC of adult rats, and a full 
pharmacological profile was conducted (Cunningham et al., 2003). In agreement with these 
studies, KA-O were significantly decreased in LII and LV MEC in the presence of bicuculline, 
reinforcing that gamma rhythms generated by local neuronal circuits have a dependence 
on fast inhibitory neurotransmission.  
Cunningham et al. (2003) also determined that KA-O in the adult rat MEC required AMPARs 
and gap junctions, suggestive of a PING mechanism underlying the oscillation (see 
Introduction for explanation), however, the frequency of EPSPs invading fast spiking 
interneurones was actually lower than the frequency of these cells, implying a degree of 
tonic excitation of interneurones, a prominent feature of an ING mechanism. Therefore, 
the mechanisms underlying KA-O in the adult MEC would appear to contain components 
of both a tonic and phasic excitatory drive (Cunningham et al., 2003). In this chapter, the 
relative contribution of AMPARs to KA-O was determined in the two age groups: neonate 
(P8-13) and juvenile (P20-27). Interestingly, the results in the juvenile group were 
comparable to those of Cunningham et al. (2003), showing a clear decrease in the 
amplitude of KA-O when AMPARs are blocked, in both layers. This is accompanied by a 
slight decrease in the frequency of KA-O, again in both layers, which is likely the result of 
reduced excitatory drive onto interneurones, which are pacing the rhythm. This does not 




in amplitude, it was not statistically significant, and the effect is clearly not as prominent as 
in the juvenile group.  
This could mean the excitatory connections onto interneurones driving the rhythm are less 
dependent on AMPAR activation, or have not fully developed yet. Perhaps in the neonate 
MEC, the slower, beta oscillation may be predominantly generated by a different (slower) 
subtype of interneurone, considering that, as mentioned earlier, maturation of fast spiking 
PV-containing interneurones likely occurs after the age of the young rats (PV interneurones 
mature ~P17 in temporal cortex of mice). Indeed, Middleton et al. identified two rhythms 
within the MEC, with different frequencies (Middleton et al., 2008a), which were sustained 
by different populations of interneurones. Therefore, it is entirely possible that there is a 
shift in the dominance, or ability, of certain interneuronal subtypes to generate rhythmic 
activity at different stages of development. Middleton et al. (2008a) revealed the slower 
rhythm within the superficial layers of the MEC after blocking NMDARs with ketamine, 
implying that the output frequency of neurones in the MEC is controlled by the extent of 
NMDAR activation.  
In this chapter, a different antagonist, DL-AP5, was used to block NMDARs, and decreased 
the amplitude of KA-O in both layers and both ages. However, it is important to note that 
whilst drugs were only applied when oscillatory activity was deemed ‘stable’, after 2 
consecutive recordings of +/-20 % variability in KA-O amplitude, control data for stability 
within LV MEC was variable, therefore caution should be taken when looking at more subtle 
drug effects, especially if there was no recovery in the wash-out (see Appendix for build-up 
of KA-O in both layers and all age groups). Frequency, on the other hand, was extremely 
stable after 1 hour application of KA, in both layers and all age groups. It is entirely possible 
that the lack of stability within LV MEC is directly related to the delayed maturation of 
inhibitory neurotransmission in this layer (Donato et al., 2017). Recovery in KA-O amplitude 
after a wash-out period only occurred in the juvenile group, so we can assume that, at least 
in the older animals, NMDARs do contribute to the maintenance of KA-O in LII and LV. 
Moreover, there was a small (only 3.5 Hz), but very significant, decrease in the frequency 
of KA-O in the juvenile group only, which may reflect a decrease in NMDAR driven fast 




al., 2003). The fact DL-AP5 decreased the frequency of KA-O in juvenile, but not neonates, 
may be indicative of a protracted development of some interneuronal subtypes which are 
driven by NMDAR activation.  
7.4.3 KA-O as a reporter of KAR activity during development 
From this chapter and the patch clamp studies in chapter 6, it is clear that there are major 
differences in the action of KA in neonate (P8-11) versus juvenile (P20-27) rats. Whilst it is 
likely this reflects the maturation of neuronal connectivity as a whole, these studies also 
shed light on the role of KARs in neuronal synchrony during development. An interesting 
observation from this chapter was that, in the youngest age group, KA-O were more 
powerful in LV relative to LII. Moreover, there was a small, but significant, surge in the 
amplitude of KA-O in LV between the first two age groups, which was not maintained in the 
older animals. From the patch clamp data, although KA had minimal effects on sIPSC 
frequency in the neonate age groups, the mean increase was much more prominent in LV 
relative to LII (+25% LII vs +150% LV). In juvenile rats, KA increased the frequency of sIPSCs 
to a similar degree in LII (+273%) and LV (+230%), however, the baseline frequency in LV 
started much lower, therefore LII sIPSCs had a much higher frequency after KA compared 
to LV (15.3 Hz vs 9.2 Hz).  
The frequency of GABA release onto principal neurones in response to KA may certainly 
account for the lamina differences in KA-O observed in LII and LV during development, 
which may be a reflection on the development of synaptic contacts from interneurones, or 
the expression of KARs. Unpublished immunohistochemistry studies from the lab of 
Professor Elek Molnar showed that expression of the GluK1-containing KAR peaks at ~P14, 
followed by a steady decline into adulthood (Molnar et al. unpublished data, figure 1.6). 
Other studies have suggested a similar developmental pattern of expression of this 
receptor (Bahn et al., 1994). Interestingly, we found a significant increase in the amplitude 
of KA-O around this same stage of development (P12-15 age group) in the deep layers of 
the MEC, which decreased in older animals. Having shown that KA-O are heavily dependent 
on the GluK1 subunit (Fig.7.1), it is possible that the temporal surge in amplitude in the 
deep layers is related to the increased expression of GluK1-containing KARs at this point in 




frequency in response to activation of KARs containing the GluK1 subunit only in the 
neonate (P8-11) group, which, again, may be related to a temporal developmental increase 
in the expression of this receptor in the deep layers of the MEC.  
7.4.4 Oscillations, eye opening and wider implications 
A particularly interesting observation in this chapter was that the increased amplitude of 
KA-O in LII MEC appeared to occur at the onset of eye opening. The increase in amplitude 
of KA-O is undoubtedly linked to the maturation of the neuronal architecture underpinning 
the synchronised activity, but it is not unwarranted to suggest visual sensory input may 
influence, or indeed kick-start, this maturation process, especially given the roles of the 
MEC, and adjacent hippocampus, in spatial navigation processing (Hafting et al., 2005, 
Moser et al., 2008, Sargolini et al., 2006, O'Keefe and Dostrovsky, 1971, O'Keefe, 1976). 
Cortical plasticity is influenced by sensory input during development in other areas of the 
brain, such as the visual cortex (Espinosa and Stryker, 2012, Song and Abbott, 2001). In a 
series of ground-breaking experiments on developmental plasticity, Wiesel and Hubel 
showed that visual deprivation during development imposed life-long changes in the 
strength and organisation of inputs from the eyes to cortical cells, in kittens (Wiesel and 
Hubel, 1963b, Hubel and Wiesel, 1963, Wiesel and Hubel, 1963a). Moreover, a recent study 
looking at the early development of network oscillations in the ferret visual cortex 
concluded there was an increase in the power of gamma oscillations after eye opening 
which may influence cortical maturation (Li et al., 2017).  
Whilst the MEC does not receive direct visual sensory input, other adjacent regions, such 
as the retrosplenial cortex, do and provide a strong afferent input to the MEC (Kerr et al., 
2007, Burwell and Amaral, 1998b). Moreover, the retrosplenial cortex has fundamental 
roles in forming associations between environmental stimuli and in spatial navigation (Oess 
et al., 2017, Clark, 2017, Mao et al., 2017, Epstein, 2008). It is possible that the development 
of MEC microcircuitry is influenced by input from nearby structures receiving direct visual 
sensory information.  
As previously mentioned, maturation of the MEC has recently been suggested to occur in 




instructive signal in SCs in LII, which spreads directionally to LII PCs, and cells of the CA3, 
CA1, dentate gyrus, subiculum, LV MEC and lastly LII LEC, throughout the first month of 
post-natal life (Donato et al., 2017). Although this study was in mice, they propose LII SCs 
become fully mature at approximately P14, which is also around eye opening (in rats and 
mice).  
The nature of this instructive signal from LII SCs is currently unknown, but I propose that a 
surge in gamma activity, consequent on eye opening, may provide the source of excitation, 
which may kick-start the development of the MEC. Indeed, it is becoming increasingly 
apparent that rhythmic brain activity has critical roles in structuring the development of 
cortical networks (Lowel and Singer, 1992, Singer, 1995, Uhlhaas et al., 2009). Specifically, 
neuronal oscillations allow the precise temporal coordination of pre- and postsynaptic 
neuronal activity which leads to the modification of synapses, or STDP, which has major 
roles in shaping the maturation of the cortex (Song and Abbott, 2001). As mentioned in the 
Introduction to this thesis, one of the defining features of the MEC is the presence of grid 
cells. These cells have grid-like firing patterns which map out the environment, acting as a 
metric and reflecting the structure of local space (Hafting et al., 2005). Of yet, the 
mechanisms underlying the development of grid cell firing patterns is unknown, but some 
models theorise the involvement of synchronised brain activity, particularly theta nested 
gamma-oscillations (Pastoll et al., 2013a, Solanka et al., 2012, Solanka, 2015). Moreover, 
current available experimental evidence places the emergence of grid cell firing at around 
~P19 (Wills et al., 2012).  
This has led me to the hypothesis that the onset of gamma oscillatory activity in layer II 
(~P16) is linked to increased sensory input consequent on eye-opening (~P14), which I 
propose may also be linked to the development of synaptic organisation leading to grid cell 
activity. In support of this hypothesis, the literature strongly suggests there is a dorsal to 
ventral maturation of the MEC accompanied by an inhibitory gradient intrinsically linked to 
the power of GFO along this axis (Beed et al., 2013, Ray and Brecht, 2016, Stensola et al., 
2012). Interestingly, a progressive change in the size of spatial scales represented by grid 




patterns are noted in the ventral MEC, which are present at the onset of exploratory 
behaviour/eye opening (Brun et al., 2008). 
This hypothesis could be investigated using visual deprivation (reared in darkness) 
experiments to determine if the increased GFO in LII is a result of visual sensory input. 
Moreover, it would be interesting to determine if disrupting GFO during development 
affects the synaptic organisation and connectivity of grid cells, and determine if GFO are 
important for the development of grid cell firing patterns.  
Another interesting phenomena was the disappearance of a beta oscillation upon eye 
opening in the deep layers of the MEC. Indeed, beta oscillations have been identified in 
deep layers of other cortical areas, such as the somatosensory cortex, also via KAR 
activation (Roopun et al., 2006). Beta oscillations have distinct pharmacological properties, 
for example they are dependent on gap junctions and have a lower sensitivity to GABAaR 
blockade compared with gamma rhythmogenesis, of which they can exist independently 
from. Neuronal activity involving gap junctions has been associated with the immature 
developing nervous system, therefore its possible beta oscillations may have a temporal 
role in maturation of the deep MEC prior to eye opening (Dupont et al., 2006). Further 
experiments to block gap junctions and GABAaR (at a lower concentration) will help classify 





























8.1 Overall developmental changes to excitation and inhibition 
Chapters 3 and 4 from this thesis aimed to directly compare changes in the properties of 
spontaneous excitation and inhibition during post-natal development in the rat MEC. 
Moreover, to identify lamina specific differences in sEPSC and sIPSC activity in the age 
groups studied (P8-11 and P20-27). Changes to background excitation and inhibition are 
summarised in Fig. 8.1 below.  
 
 
Figure 8.1: Changes to overall excitation and inhibition in neonate and juvenile neurones. 
(A) Charge transfer values of sEPSCs in neonate (NEO: LII=red, LV=blue) and juvenile (JUV: 
LII=black, LV=green) neurones. (B) Charge transfer values of sIPSCs in neonate (NEO: LII=red, 
LV=blue) and juvenile (JUV: LII=black, LV=green) neurones. (C) Charge transfer values from 
both EPSCs and IPSCs of all groups.  
 
We concluded that background excitation levels were higher in LII v LV at both stages of 
development (Fig. 8.1A). The lamina ratios of excitation in LV:LII were 1:3.5 in neonate and 
1:1.9 in juvenile neurones. Previous work from this lab comparing background excitation in 
adult rats also found higher levels in LII v LV, but only marginally (LV:LII; 1:1.2), indicating 
the levels of excitation may continue to equalise into adulthood. In agreement, Donato et 




LV MEC, compared to in LII, therefore the difference in activity may well become less 
prominent with in older, adult rats (Donato et al., 2017).  
Despite this, the relative change in excitation during development was much more 
pronounced in LV (+130%) compared to in LII (+30%).  
The developmental increase in background inhibition was much more substantial in LII 
(+690%), but there was also a marked increase in LV (+300%). The level of inhibition in 
neonates was similar in both layers, but dominated the superficial layers of juvenile 
neurones, in agreement with previous studies in this lab (Jones and Woodhall, 2005, 
Woodhall et al., 2005, Greenhill et al., 2014). The significant increase in the frequency of 
IPSCs during this developmental time period correlates with a recent study showing 
expression of PV-containing interneurones occurred at around P21 (Ueno et al., 2017).  
Noticeable developmental changes were also observed in the kinetics of both inhibitory 
and excitatory events, summarised in Fig. 8.2 and discussed fully in section 3.4. Generally, 
in LII MEC, rise and decay time were much faster in the older age group, in both EPSPs and 
IPSPs, which, coupled to the heightened inhibitory tone, may predispose this layer to the 
generation of synchronised neuronal network activity in the juvenile MEC, and indeed, this 
is exactly what we saw in chapter 7 (Fig. 7.6). In LV, a similar pattern was observed 
regarding excitatory events, however, the kinetics of IPSPs were actually slower in the older 
juvenile groups, which, among other reasons previously discussed, may reflect inputs from 
different subtypes or somatodendritic locations of interneurones or different GABAAR 





Figure 8.2: Developmental changes to EPSC and IPSC kinetics. (A) Average rise times and 
(B) decay times of sEPSCs in neonate (NEO: LII=red, LV=blue) and juvenile (JUV: LII=black, 
LV=green) neurones. (C) Average rise times and (D) decay times of sIPSCs in neonate (NEO: 
LII=red, LV=blue) and juvenile (JUV: LII=black, LV=green) neurones.  
 
Decay time kinetics are significantly influenced by  the composition and cellular distribution 
of GABAARs, which changes during the course of neuronal maturation (Wisden et al., 1992). 
Generally, IPSPs get faster during post-natal development due to the upregulation of α1 
and α4 subunits, and down-regulation of α3 and α5 GABAAR subunits, shown in other areas 
of the cortex (Bosman et al., 2002, Dunning et al., 1999, Hutcheon et al., 2000) and 
hippocampus (Cohen et al., 2000). It is therefore unusual that the kinetics of inhibitory 
events in LV MEC became much slower during development, contrary to changes observed 
in other cortical regions, including LII MEC shown in this thesis (Fig. 8.2). There are no other 
comparative developmental studies on IPSC kinetics in the MEC laminas, though studies in 
the adult MEC do show slower decay times in LV IPSCs relative to in LII (Woodhall et al., 
2005). In addition, other lamina comparisons of EPSC kinetics from this lab showed LV 
neurones had faster EPSPs compared to LII, in accordance with this thesis, showing these 
characteristics are remarkably similar, even across studies.  
It is not unreasonable to suggest that the prolonged inhibition (due to slower kinetics) in 
the deep layers is a means to counteract the substantial quickening of excitation observed 
in the same layer during post-natal development. Especially considering the high 




2005, Jones and Heinemann, 1988), compared to in LII (Dhillon and Jones, 2000). As such, 
the deep layers of the MEC have been previously demonstrated to have a pronounced 
susceptibility to epileptogenesis (Jones and Lambert, 1990, Jones, 1993, Avoli et al., 1996). 
The exact mechanisms underlying the development of epilepsy are still unknown, but 
broadly involve an imbalance between excitation and inhibition within neuronal networks, 
and the EC has been heavily implicated (Spencer and Spencer, 1994, Lothman et al., 1990).  
Altered GABAAR function, as a result of aberrant subunit expression, has been identified in 
both human patients and animal models of TLE (Brooks-Kayal et al., 1998, Gibbs et al., 
1997). In theory, such alterations in LV MEC could affect the physiological increase in decay 
time throughout development, which coincident with the clear developmental quickening 
of excitatory neurotransmission, could lead to a reduced inhibitory tone and predisposition 
to hyper-excitable and pathologically synchronous network activity. Indeed, many current 
anti-epileptic drugs, such as benzodiazepines, target GABAARs, act to increase the 
amplitude and decay time of IPSCs (Macdonald and Barker, 1978). Prolonging IPSC decay 
time enables summation of multiple synaptic inputs, increasing the overall inhibitory 
“tone” of GABAergic synapses, and decreasing the likelihood of hypersynchronous 
neuronal activity underlying seizures (Otis and Mody, 1992, Edwards et al., 1990).  
Thus, the developmental changes to the properties of excitatory and inhibitory 
neurotransmission determined in chapters 3 and 4 of thesis may have important 
implications for the generation of both physiological and pathological synchrony in LII and 
LV MEC. 
8.2 Overall developmental changes to KAR function at glutamatergic 
synapses 
Chapter 5 provided evidence of the presence of two types of KAR involved in glutamatergic 
neurotransmission in LII and LV MEC. Firstly, experiments with UBP-310 on sEPSCs and 
mEPSCs identified a KAR containing the GluK1 subunit, which was highly tonically active, 
located at presynaptic terminals. The lack of an effect of the GluK1-containing KAR, ATPA, 
was surprising, especially considering its ability to significantly increase spontaneous 




activity of GluK1-containing KARs in LIII MEC, therefore it is entirely possible that the lack 
of an effect is because this receptor was already tonically activated by ambient glutamate. 
In addition, there was often a small decrease in the frequency of sEPSCs associated with 
ATPA, which may reflect receptor desensitisation as a result of excessive activation. Whilst 
this theory makes sense, it was confounded by the fact that UBP-310 reversed the 
substantial increase in excitation in response to KA, implying the GluK1-containing KAR was 
responsible for this activity in the first place. However, taken together with the lack of 
effect of ATPA on its own, and the considerable tonic facilitation of glutamate by 
presynaptic GluK1-containing KARs, it may be more likely that KA was acting at KAR that 
did not contain the GluK1 subunit, and the decrease in sEPSC frequency after UBP-310 is 
due to the substantial (~50-60%) reduction in tonic glutamate release at the terminals. 
Alternatively, as previously mentioned in chapter 5, the discrepancy of these results may 
also be explained by calling into question the specificity of UBP-310, as reports have 
identified antagonism at GluK3 KAR subunits (Perrais et al., 2009).  
Either way, it would seem that KA acts at KARs on principal cells which may activate 
recurrent excitatory connections in LII MEC, however, recurrent excitation between LII 
neurones is weak or non-existent in the EC (Dhillon and Jones, 2000, Couey et al., 2013, 
Pastoll et al., 2013a, Fuchs et al., 2016), though this is being questioned by a study showing 
connectivity of pyramidal (12%) cells onto stellate neurones in LII, and pyramidal cells in LIII 
(Winterer et al., 2017). Unfortunately, elucidation of the exact subunits of postsynaptic 
KARs mediating KA induced recurrent excitation awaits the development of more selective 
subunit antagonists.  
Pinpointing the location of KARs that modulate GABAergic neurotransmission was tricky 
because experiments looking at mIPSCs in the presence of TTX await completion. However, 
we identified interesting developmental differences in inhibitory neurotransmission in 
response to activation of the GluK1-containing KAR with ATPA. Specifically, ATPA had no 
effect on spontaneous GABA release in juvenile rats, but significantly increased the 
frequency, amplitude and decay time of sIPSCs in neonate neurones. It is particularly 
interesting that the response to ATPA in neonate neurones parallels an observed increase 




Molnar (unpublished data, Fig. 1.6). This transient peak in expression, coupled with a clear 
functional difference at this age, may lead us to speculate a role for the GluK1-containing 
KAR in activity dependent maturation of the MEC, as seen in other regions (Lauri et al., 
2005, Lauri et al., 2003).  
Overall, the results from Chapter 6 point towards the presence of a presynaptic KAR 
enhancing inhibitory transmission in neonate and juvenile neurones. Moreover, it seems 
likely there is a KAR located at the soma/dendrites of interneurones, as has previously been 
reported in the hippocampus, but direct interneuronal recordings must be achieved to 
confirm this.  
Overall, we show that KARs can directly mediate postsynaptic excitation at glutamatergic 
synapses, and likely do not contain the GluK1 subunit. Secondly, we show that KARs 
containing the GluK1 subunit are located presynaptically, where they are highly tonically 
active and contribute substantially to ongoing spontaneous glutamate release. Third, we 
suggest the presence of a presynaptic GluK1-containing KAR located at GABAergic 
terminals, and lastly, we suggest the presence of a GluK1-containing KAR located at the 
soma/dendrites of interneurones, mediating powerful synchronised network activity which 
appears to be developmentally regulated.  
We are only beginning to understand the physiological functions of KARs in both mature 
and immature networks. Work is still confounded by the lack of pharmacological specificity 
of current drugs, and the plethora of functions in the modulation of both excitatory and 
inhibitory neurotransmission which appear to differ during development.  
8.3 KARs in synchronised neuronal activity during development 
Synchronised neuronal activity in the gamma frequency (30-80Hz; GFO) can be generated 
across all laminas of the adult MEC via activation of KARs (KA-O). KA-O are dependent on 
KARs containing the GluK1 subunit and fast GABAAR mediated inhibitory neurotransmission 
driven by NMDAR phasic excitation (Cunningham et al., 2003, Middleton et al., 2008a, 




in synchronised network activity during development. In combination with patch clamp 
data in Chapter 5 and 6, we aimed to determine the roles of KARs at both a synaptic and 
network level.  
In the juvenile rat MEC, KARs were clearly very powerfully involved in the generation and 
maintenance of GFO, with activity dominating the superficial layers. On the other hand, 
synchronised activity in the neonate MEC was much slower, at a beta frequency, and was 
more powerful in the deep layers. This correlates nicely with the stronger response of 
sIPSCs to KA in the deep layers of neonate neurones, and vice versa in juvenile neurones. 
As discussed in Chapter 7, the mechanisms underlying these differences may relate to KAR 
expression or functioning, or the level of maturation of neurotransmitter systems 
supporting the rhythm. However, given that LV MEC apparently matures much later than 
LII (Donato et al., 2017), it may be suggested that the increased response to KA in LV is not 
due to a more advanced maturation of the microcircuitry underlying the activity, but 
perhaps a reflection on KAR functioning in LV at this stage of development. Unpublished 
data from Molnar et al. pointed to altered expression of KARs during post-natal 
development, leading to the assumption that KARs may have important roles in the 
development of cortical networks. Moreover, developmentally down-regulated expression 
of KARs that occur in parallel with maturation of the circuitry have also been reported in 
other brain regions. For example, presynaptic KARs are down-regulated in the 
hippocampus (Lauri et al., 2005, Sallert et al., 2007), and at thalamocortical synapses in the 
barrel cortex (Kidd and Isaac, 1999, Kidd et al., 2002), whereas postsynaptic KARs are 
developmentally downregulated in the nociceptive pathways in the spinal cord (Stegenga 
and Kalb, 2001). 
Functionally, the dynamic actions of KARs at both inhibitory and excitatory synapses enable 
the generation of patterned and synchronised activity, as shown in this thesis, which is 
critical for plasticity, and an emerging idea is that KARs have roles during synapse 
maturation.  In the hippocampus, a tonically active KAR that facilitates glutamate release, 
as well as interneurones excitability, is gradually lost in a manner that parallels circuit 
maturation during the first 2 postnatal weeks of life of the rat (Lauri et al., 2005, Lauri et 




another mechanism to account for the downregulation of KARs is currently up for debate. 
Nonetheless, temporally correlated neuronal activity is crucial in wiring developing 
networks (Katz, 1993, Palva et al., 2000), therefore the clear roles of KARs in network 
synchrony (Chapter 7), their ability to modulate both excitatory (Chapter 5) and inhibitory 
(Chapter 6) neurotransmission, and the indication of altered expression patterns during 
development (Molnar et al. unpublished data; Fig. 1.6), would strongly implicate these 
receptors as having roles in shaping the development of the MEC circuitry.   
Recurrent bursts of synchronised network activity are a general feature of developing 
cortical networks, or indeed the developing CNS in vertebrates as a whole (O'Donovan, 
1999), and have been identified in the hippocampus (Palva et al., 2000) and MEC (Jones 
and Heinemann, 1989, Cunningham et al., 2006b). In the superficial layers of the MEC, 
Jones et al. reported pronounced spontaneous bursting activity in neonate rats aged P9-
13. Interesting, similar bursts of activity were also observed in extracellular recording 
related to this thesis (Fig. 9.7, appendix), and in accordance with Jones et al., the 
spontaneous bursting activity was dependent on NMDARs. In addition, application of UBP-
310 in a separate set of experiments also abolished the bursts (Fig. 9.7). The prevalence of 
these spontaneous bursts appeared to decrease with age (data not shown, example P18: 
17events/hour vs P13: 243 events/hour). Moreover, in Chapter 6 we showed that the 
ability of ATPA to induce synchronised GABA release onto principal cells appears to be 
developmentally downregulated, providing further evidence of temporal roles of KARs in 
post-natal development. By virtue of this, it may be suggested that KARs could act as a 
functional enhancement of synaptic activity in immature neurones, which could influence 
and shape the formation of synaptic circuitry.   
Lastly, this work has opened up new avenues linking the development of rhythmic brain 
activity in the superficial layers of the MEC with increased sensory input consequent on eye 
opening, which, hypothetically, may be linked to the development of synaptic organisation 





8.4 KARs, pathological synchrony and neurodevelopmental disorders 
KARs mediate postsynaptic depolarisation, modulate synaptic release of neurotransmitters 
and have been shown to have roles in the maturation of neural circuits during development 
in the hippocampus (Lauri and Taira, 2012, Lauri et al., 2005, Maingret et al., 2005, Lauri et 
al., 2006). Previous work from this lab (Chamberlain, 2009, Chamberlain et al., 2012) and 
work in this thesis has identified KARs located pre- and post-synaptically at excitatory and 
inhibitory synapses, where they are ideally located to mediate synchronised neuronal 
network activity in the developing and mature cortex (Chapter. 7). In addition, we have 
identified altered GluK1-cotnaining KAR functioning during post-natal development, which 
may pose consequences for maturation of the MEC. With the wide ranging actions in both 
the immature and mature MEC, it is not surprising that aberrant KAR functioning is 
associated with many neurological disorders, particularly associated with 
neurodevelopment, including autism (Jamain et al., 2002, Shuang et al., 2004), 
schizophrenia (Beneyto et al., 2007, Shaltiel et al., 2008, Shibata et al., 2006) Alzheimer’s 
disease (Palop and Mucke, 2016) and epilepsy (Li and Rogawski, 1998, Li et al., 2010, 
Lucarini et al., 2007), which are all separately associated with the EC (Salmond et al., 2005, 
Baiano et al., 2008, Salmenperä et al., 2000, Vismer et al., 2015, Fuhrer et al., 2017) and 
abnormal network synchrony (see (Uhlhaas and Singer, 2010)). Cognitive deficits are a 
major symptom of many neurological disorders, which are often paralleled by 
abnormalities in neuronal synchronisation, including GFO. For example, EEG recordings 
show abnormal GFO in patients with schizophrenia (Uhlhaas and Singer, 2010, Sun et al., 
2011, Williams and Boksa, 2010). A question to ask is whether the dysfunction in the co-
ordination of neural activity in such disorders is the result of disconnection, or is it due 
deficits in synchronised neural responses needed for the propagation of signals. Besides, 
network disconnectivity may actually be a result of aberrant synchrony during 
development, which is essential for the maturation of neural circuitry and connectivity, and 
indeed, the KAR is heavily implicated in this process.  
Whatever the reason, the clear roles of KARs in network synchrony during development 




target, in many disorders of abnormal neuronal synchrony, including schizophrenia and 
epilepsy. 
8.5 Therapeutic targeting of KARs 
The original aims of this thesis set out to establish the normal physiological roles of KARs in 
during development, with a view to apply this knowledge to understand the development 
of how pathological synchrony may manifest specifically in the MEC. Moreover, this data 
may shed light on the potential of KARs as targets for new therapeutic interventions for 
diseases of aberrant neuronal synchrony.  
 
Figure 8.3: The roles of KARs in influencing cognition by modification neuronal and circuit 
activity. Dysregulation of these activities could lead to disequilibrium leading to disease 
states. Adapted from Lerma et al. (2013).  
Data from this thesis has identified KARs located presynaptically at terminals of both 
excitatory and inhibitory synapses, where they act to facilitate glutamate or GABA release 
onto principals. Selectively targeting these receptors may provide a means of increasing or 
decreasing the general inhibitory or excitatory tone of the MEC, respectively, helping to 




preventing action potential propagation.  On the other hand, targeting postsynaptic KARs 
may encourage network synchrony in disorders where neuronal communication is lacking. 
However, the long awaited development of more specific and novel antagonists are 
essential for understanding the precise functions of KARs in the MEC, and their therapeutic 
potential.  
My results have demonstrated several roles for KARs in LII and LV of the MEC in mediating 
synchronised neuronal activity at the level of the synapse and the network as a whole. 
Moreover, that the activity of KARs in the MEC undergoes profound changes during 
development, which may have implications for the maturation of synaptic networks and 
the development of cognition associated with the MEC, such as spatial navigation and 
memory processes. These findings could be relevant for the development of novel 
therapeutic targets for neurodevelopmental disorders involving pathological synchrony 
and the MEC.  
8.6 Overview and wider implications 
The time period of post-natal development studied here in the rat is approximately 
correlated to a young adolescent human. At this time, many key neurodevelopmental 
processes are undergoing maturational changes across the whole brain which bare 
consequences related to sensorimotor, psychosocial and cognitive functioning. These 
processes include neuronal proliferation and myelination, development of the immune 
system (microglia) and the blood brain barrier, and synaptogenesis/pruning (Semple et al., 
2013). The intensity of development over a relatively short period of time is likely why 
adolescence is a period of vulnerability for neuropsychiatric disease. The results from this 
thesis show that both excitatory and inhibitory neurotransmission, specifically within the 
MEC, undergo dramatic maturation during early adolescent brain development. In 
particular, there is an increase in synaptic noise which is thought to enable neuronal 
multiplexing of activity within a network, for example, gamma oscillations and grid cell 
activity. In addition, increased synaptic noise has been theorised to decrease the likelihood 
of seizures generation in the network. The results from this thesis also clearly defined the 




development, which is pivotal in the development of cognitive processing associated with 
the MEC and the parahippocampal region in general. Neurotransmitter changes during 
early postnatal development coupled with decreased synaptic noise may render the 
immature brain inherently more prone to seizure activity, or other disorders of synchrony, 
compared to an older brain, and it is likely that such activity may have further 
consequences by interfering during critical periods of synaptic formation and pruning 
(Semple et al., 2013).   
 
 
Figure 8.4: A summary of the developmental changes in excitation and inhibition in the 



























9.1 Build-up and stability of KA-O 
To determine the effects of various pharmacological agents on KA-O, we first had to 
determine if the KA-O were stable. LII MEC KA-O appear to build-up and stabilise after 1 
hour KA, however, the stability of KA-O in LV was more variable. On the other hand, the 
frequency of KA-O stabilised after 1 hour application of KA in both LII and LV MEC of all age 
groups tested. The build-up of KA-O after application of 400 nM KA, in all ages and layers, 
is summarised in figure 9.1.  
 
 
Figure 9.1: A summary of the developmental changes in excitation and inhibition in the 
MEC. Graphs show mean and SEM of the amplitude LII (A), amplitude LV (B), frequency LII 
(C) and frequency LV (D) of KA-O induced after bath application of KA. Amplitude of LII, but 
not LV, appears to stabilise after 1 hour KA. The frequency of KA-O remains stable in both 






9.2 Gender differences in KA-O 
Throughout this thesis male and female rats were used. No attempts were made to 
differentiate between male and female in the first 4 results chapters, however, male and 
female analysis was conducted on KA-O. Most of the comparisons showed similar patterns 
of activity in males versus females in terms of amplitude and frequency throughout 
development, summarised in figures 9.2 and 9.3, respectively.  
 
Figure 9.2: Gender differences in the amplitude of KA-O. Changes to KA-O amplitude follow 
a similar pattern in LII of both male (blue) and female (red) KA-O, though female KA-O reach 
a maximum amplitude sooner. In LV, the increase in amplitude in the P12-15 age group is 








Figure 9.3: Gender differences in the frequency of KA-O. Changes to KA-O frequency follow 
a similar pattern in LII of both male (blue) and female (red) KA-O, though female KA-O have 
a more gradual developmental increase in KA-O, compared to a more step-wise increase in 
frequency from a beta to a gamma band in the male group of both layers. This is due to a 







On closer analysis, an interesting observation was found in the youngest age group (P8-11), 
such that there was a small, but very significant, difference in the frequency of KA-O in 
males versus females. Specifically, the mean frequency of KA-O in the youngest (P8-11) was 
sigificantly faster in males (19.0 ± 0.5 Hz; n = 15) compared to females (16.9 ± 0.4 Hz, n = 
23) in both layers (same values, P < 0.05). There were no further statistically significant 
differences in the frequency of KA-O in the older age groups. A comparison of the 
differences in the frequency of KA-O in the youngest and oldest age group can be seen in 
figure 9.4.  
 
 
Figure 9.4 Gender differences in the frequency of KA-O at P8-11 and P24-27. The mean 
frequency of KA-O was significantly slower in female versus male slices, in both layers (P < 
0.01; Mann Whitney test). There were no gender differences in the oldest age groups.  
 
Male and female comparisons were also made when looking at the build-up and stability 
of KA-O. It appeared that, whilst KA-O built-up and stabilised after about 1 hour application 
of KA in MEC slices from male rats, slices from female rats did not appear to stabilise.  
The developmental gender differences in KA-O may reflect altered maturation of 
GABAergic neurotransmission. Many studies have addressed this issue (in the 




expression at P7, an effect which is eliminated by P14 (Nunez and McCarthy, 2007). It is 
possible that similar sex differences may also be present in the MEC. Indeed, brain 
oscillations in humans also show gender influences (Nanova et al., 2011, Guntekin and 
Basar, 2007, Gron et al., 2000).  
Gender differences in the MEC may have consequences for the development of cognition 
associated with this brain region, particularly spatial processing. Spatial reasoning and 
navigation experiments have previously determined gender bias in the organisation of 
spatial cognition in rats (Sneider et al., 2015). Female rats rely more on the frontal cortex 
for spatial navigation, whereas male rats depend more on the MEC (Gron et al., 2000), a 
trait which has been confirmed in human functional MRI studies. Despite this, current 
studies have not addressed these gender differences. Future experiments to address 
determining physiological gender differences in the development of cognition in the MEC 
would be useful to understand the differences in symptoms or morbidity of neurological 
disorders associated with this brain region. 
 
Figure 9.5: The build-up of KA-O in male and female LII Graphs show mean and SEM of the 
amplitude of KA-O in male (A) and female (B) slices, frequency of KA-O in male (C) and 




to stabilise after 1 hour KA. The frequency of KA-O remains stable in both later after 1 hour 
KA. 
 
Figure 9.6: The build-up of KA-O in male and female LV. Graphs show mean and SEM of 
the amplitude of KA-O in male (A) and female (B) slices, frequency of KA-O in male (C) and 
female (D) slices after bath application of KA. Amplitude of KA-O does not stabilise in LV. 
The frequency of KA-O remains stable in male and female slices after 1 hour KA. 
 
9.3 Spontaneous bursts in neonate LII MEC 
Whilst recording extracellular activity in LII of the MEC, it became apparent that bursting 
activity would present spontaneously, in the absence of any pharmacological manipulation. 
The prevalence of the bursts appeared to decrease with age (data not shown), and were 
dependent on both NMDA and GluK-1 containing KARs (Fig. 9.7C&D). Such activity has been 
reported previously in the MEC, and may reflect endogenous synchronised network activity 





Figure 9.7: Spontaneous bursting activity in LII. (A) Powerspectra analysis of a single burst. 
(B) Raw traces of LFP recordings of a single and (C) multiple spontaneous bursts in LII MEC. 
(D) Graph showing the mean number of bursts before and after the application of UBP-310 
(20 μM), and (D) DL-AP5 (20 & 40 μM) with a wash-out in both plots. Bursts were dependent 
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